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ABSTRACT 
Our understanding of human brain development and function is still incomplete. 
Unfortunately, the field of neuroscience lacks representative human-specific models 
to accompany the animal studies. Access to human brain tissue for research purposes 
is limited, encouraging the utilization of novel approaches such as human pluripotent 
stem cell (hPSC)-derived neurons. Within the last few decades, research on hPSCs 
has undergone enormous expansion. Growing expectations are aimed at the 
application of stem cells and their derivatives in regenerative medicine, drug 
screening and disease modeling. 
The main focus of this thesis was to evaluate the potential of hPSC-derived neural 
cultures in mimicking certain characteristics of central nervous system (CNS) 
development and functionality. The results were intended to help validate the utility 
of stem cell models for translational neuroscience applications. For this purpose, the 
differentiation capacities of hPSC-derived neuronal cells generated with two 
generally used differentiation methodologies were compared. The functional 
maturation of neurons following a prolonged differentiation time and optimization 
of culture conditions was assessed in network-level analyses. The results were 
complemented with a functional comparison to the widely used rodent in vitro model. 
Since astrocytes are the cells surrounding neurons and supporting neuronal 
functionality in the CNS, special focus was also placed on their role in both normal 
and neuroinflammatory conditions, the latter of which is typical of CNS insults. 
The results of this thesis suggest that hPSC-derived neuronal cultures recapitulate 
many of the characteristics of CNS development in vivo. Specific chemical induction 
accelerated neural differentiation, leading to high cell purity and yield. Prolongation 
of the differentiation time increased the proportion of endogenously formed 
astrocytes and promoted the functionally mature activity type of neurons. 
Furthermore, the emergence of robust neuronal activity and the long-term 
maintenance of functional networks were achieved with the selection of defined 
laminin isoform as a culture substrate. With this improvement, the hPSC-derived 
networks exhibited time frames and stages of activity development similar to those 
of their rodent counterparts. However, marked variability was detected in the activity 
patterns between the rodent and human networks, which could relate to differences 
viii 
in their maturation stage or interspecies dissimilarities. Finally, hPSC-derived 
astrocytes were exposed to specific inflammatory stimuli. Their response showed 
distinct characteristics of astrogliosis observed in CNS diseases, and the studied 
neuronal effects suggested polarization into a neurosupportive phenotype. 
Established controlled co-cultures with human neurons and astrocytes provide an 
alternative hPSC-based platform for modeling cell interactions in the context of 
health and disease. 
In conclusion, the work presented in this thesis advances the development of 
functional hPSC-derived neuronal networks, confirms the role of astrocytes as 
significant partners in these networks, and encourages their translation into human-
specific models for neuroscience research. 
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TIIVISTELMÄ 
Ymmärryksemme ihmisaivojen kehityksestä ja toiminnasta on edelleen puutteellista. 
Valitettavasti neurotieteiden alalta puuttuu edustavia ihmisspesifisiä malleja, jotka 
täydentäisivät eläinmalleilla tehtäviä tutkimuksia. Ihmisaivokudoksen saatavuus 
tutkimustarkoituksiin on rajoitettua, mikä kannustaa uusien lähestymistapojen, kuten 
ihmisen monikykyisistä kantasoluista johdettujen hermosolujen hyödyntämistä. 
Muutaman viime vuosikymmenen aikana ihmisen monikykyisiin kantasoluihin 
liittyvä tutkimusala on laajentunut valtavasti. Kasvavat odotukset kohdistuvat 
kantasolujen ja niiden johdannaisten soveltamiseen regeneratiivisessa lääketieteessä, 
lääkkeiden seulonnassa ja tautien mallinnuksessa. 
Tämän tutkimuksen pääpainona oli arvioida ihmisen monikykyisistä kantasoluista 
johdettujen hermosoluviljelmien potentiaalia jäljitellä tiettyjä keskushermoston 
kehityksen ja toiminnallisuuden tunnusmerkkejä. Tulosten on tarkoitus auttaa 
validoimaan kantasolumallien hyödyllisyys soveltavan neurotieteen 
käyttötarkoituksissa. Tätä varten verrattiin kahdella yleisesti käytetyllä 
erilaistusmenetelmällä tuotettujen ihmisen monikykyisistä kantasoluista johdettujen 
hermosolujen erilaistumiskykyä. Hermosolujen toiminnallista kypsymistä arvioitiin 
sekä pidennetyn erilaistusajan jälkeen, että viljelyolosuhteiden optimoinnin 
seurauksena verkostotason analyyseillä. Tuloksia täydennettiin vertailemalla näiden 
verkostojen toiminnallisuutta laajalti käytettyyn jyrsijäperäiseen solumalliin. Koska 
astrosyytit ovat hermosoluja ympäröiviä soluja ja ne tukevat keskushermoston 
toiminnallisuutta, erityistä huomiota kiinnitettiin myös astrosyyttien rooliin sekä 
normaaleissa että tulehduksellisissa olosuhteissa, joista jälkimmäinen on tyypillinen 
tila keskushermoston vaurioissa. 
Tämän väitöskirjan tulokset viittaavat siihen, että ihmisen monikykyisistä 
kantasoluista johdetut hermosoluviljelmät toistavat useita in vivo olosuhteissa 
tapahtuvia keskushermoston kehityksen vaiheita. Erityinen kemiallinen induktio 
tehosti hermosoluerilaistusta johtaen korkeaan solupuhtauteen ja saantoon. 
Erilaistusajan pidennys lisäsi endogeenisesti muodostuvien astrosyyttien osuutta 
viljelmässä ja edisti hermosolujen toiminnallisuudessa havaittua kypsää 
aktiivisuustyyppiä. Lisäksi valitsemalla viljelypinnoitteeksi tietty laminiini-isoformi 
saavutettiin vahva, pitkäkestoinen hermosoluaktiivisuus muodostuneissa 
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verkostoissa. Tämän kehitystyön ansiosta kantasoluista johdetut hermoverkot 
osoittivat samankaltaista ajallista ja vaiheittaista toiminnallisuuden kehitystä, kuin 
vastaavat jyrsijöistä eristetyt hermosolut. Jyrsijä- ja ihmisverkostojen 
toiminnallisuuden muodoissa havaittiin kuitenkin myös huomattavia eroavaisuuksia, 
mikä saattaa liittyä eroihin niiden kypsyysasteissa tai lajien välisiin eroavaisuuksiin. 
Lopuksi ihmisen monikykyisistä kantasoluista johdetut astrosyytit altistettiin tietyille 
tulehduksellisille tekijöille. Niiden vaste osoitti keskushermoston sairauksissa 
tyypillisesti havaitun astroglioosin erityispiirteitä, ja tutkitut hermosoluihin 
kohdistuvat vaikutukset viittasivat polarisaatioon hermosoluja tukevaksi 
fenotyyppiksi. Tutkimuksessa luodut kontrolloidut ihmisen hermosolujen ja 
astrosyyttien yhteisviljelmät tarjoavat vaihtoehtoisen kantasolupohjaisen alustan 
solujen vuorovaikutusten mallintamiseksi sekä terveessä että sairauskonteksteissa. 
Yhteenvetona voidaan todeta, että tämän väitöskirjan tulokset edistävät 
toiminnallisten ihmisen monikykyisistä kantasoluista johdettujen 
hermosoluverkkojen kehittämistä, ne vahvistavat astrosyyttien roolia merkittävinä 
kumppaneina näissä verkostoissa sekä rohkaisevat kantasolujen soveltamiseen 
ihmisspesifisinä malleina neurotieteen tutkimuksissa. 
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1 INTRODUCTION 
Derivation of human embryonic stem cells (hESCs) and the later discovery of human 
induced pluripotent stem cells (hiPSCs) hold promise for the establishment of 
human-specific models in the field of neuroscience (Paèca, 2018; Takahashi et al., 
2007; Thomson et al., 1998). Collectively, these two cell types are termed human 
pluripotent stem cells (hPSCs) due to their capacity for self-renewal and 
differentiation into all cell types of the body, including those in the central nervous 
system (CNS) (Avior et al., 2016; Zirra et al., 2016). Regenerative medicine was 
among the first application targets for stem cells, and development of stem cell 
therapies to replace lost neurons in neurodegenerative diseases provides hope for 
the patients (Parmar, 2018; Steinbeck and Studer, 2015). Stem cell-derived neurons 
also offer novel tools for basic and translational research, including human 
neurodevelopmental biology and toxicity studies (Hofrichter et al., 2017; Kirwan et 
al., 2015). hiPSCs maintain the genetic background of the patient thus presenting 
opportunities for modeling genetic disorders and opening avenues for personalized 
medicine and drug discovery (Avior et al., 2016; Chung et al., 2013). Use of human-
specific cells may help to translate results from animals to humans, for example in 
the case of drug testing. However, the stem cell field still requires development of 
methodologies and system validation. 
Since the first reports on hPSC-derived neuronal cultures, numerous 
differentiation protocols have been introduced (Lancaster et al., 2013; Mertens et al., 
2016; Shi, Yichen et al., 2012; Zhang, S-C et al., 2001b; Zhang, Yingsha et al., 2013). 
The protocols try to mimic the general principles learned from developmental 
neurobiology, for example the timed exposure to growth factors and morphogens 
guiding neural fate (Suzuki and Vanderhaeghen, 2015). Over the years, the methods 
for neuronal differentiation have advanced, leading to the acquisition of more 
homogenous populations of neuronal cells that closely represent their in vivo 
equivalents and contain lower number of undesired cell types (Floruta et al., 2017; 
Kirkeby et al., 2012). Culture media with defined chemical compositions have been 
refined to direct neuronal cell fate, support maturation and decrease experimental 
variation (Bardy et al., 2015; Chambers et al., 2009; Gunhanlar et al., 2018). The 
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extracellular matrix (ECM) components used as culture substrates provide additional 
signals influencing neuronal differentiation and maturation, but these have not been 
studied as extensively (Hagbard et al., 2018). 
The structural development of the CNS is largely intertwined with functional 
development (Luhmann et al., 2016). The functional activity of neurons arises well 
before the postnatal period and is closely linked to the developmental migration, 
differentiation and apoptosis of neurons (Golbs et al., 2011; Luhmann and 
Khazipov, 2018). Aberrant neuronal function underlies neurodevelopmental 
disorders as well as neurodegenerative diseases in adults (Ebert and Greenberg, 2013; 
Pievani et al., 2014). Therefore, the functionality of the generated neurons has always 
been a major focus of research in the stem cell field. Unfortunately, functional 
maturation is not obtained with many of the available neuronal differentiation 
protocols. Also, improving the functional maturation of hPSC-derived neurons that 
currently best represent the midgestational fetal stage is an important step towards 
creating more representative models (Livesey et al., 2016; Weick, 2016). 
Astrocytes, the major glial cell type of the CNS, play a pivotal role in the 
promotion of neuronal synaptogenesis and functional maturation (Clarke and 
Barres, 2013; Verkhratsky and Nedergaard, 2018). Astrocyte support has been 
considered a requisite for the development of functional activity in hPSC-derived 
neuronal cultures (Johnson et al., 2007; Odawara et al., 2014). Interestingly, 
astrocytes also have a very distinct response to and role in pathological conditions. 
Upon CNS injury or disease, they undergo dramatic phenotypic changes, termed 
astrocyte reactivation (Ben Haim et al., 2015). Astrocytes alter their morphological 
appearance and modulate many of their homeostatic and metabolic functions 
(Sofroniew and Vinters, 2010). The resulting effects on neuronal cells can be either 
beneficial or detrimental depending on the cellular milieu, which brings another 
dimension of complexity to the mechanisms of pathological conditions (Liddelow, 
S. A. et al., 2017; Zamanian et al., 2012). hPSC-derived models provide an alternative, 
human-specific system for better understanding neuron-astrocyte interactions 
(Oksanen et al., 2017; Park et al., 2018; Santos et al., 2017). 
The focus of this thesis was to study the potential of hPSC-derived neuronal cells 
as human-specific models for neuroscience. This research shows ability of hPSC-
derived neuronal cells to form mature functional networks, which is essential for 
hPSC model utility in different applications. Additionally, the role of astrocytes in 
the neuronal networks during normal and inflammatory environments was 
presented. Results consolidate the utility of hPSC-derived neural platforms for future 
studies involving both healthy and detrimental conditions. 
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2 LITERATURE REVIEW 
2.1 Central nervous system 
The central nervous system (CNS) comprises the brain and the spinal cord, which 
receives, processes and transfers information from all parts of the body by 
interfacing with the peripheral nervous system (PNS) (Stiles and Jernigan, 2010). 
Anatomically, the CNS can be roughly divided into the forebrain, midbrain, 
hindbrain, and spinal cord. At the macroscopic scale, the superficial part of the brain 
contains the cortex, wherein most neuronal cell somas are situated in a layered 
structure. This is also referred to as the gray matter. The more internal white matter 
contains axons extending from neuronal cell somas that form tracks between brain 
regions. The brain stem also contains several nuclei, wherein neuronal cell bodies are 
concentrated, and relays information to and from the cortex (Stiles and Jernigan, 
2010). At the microscopic scale, the main cell types of the CNS include neurons and 
supporting glial cells, that is, astrocytes, oligodendrocytes and microglia. Neurons 
receive and transfer information in the form of electrical activity (Budday et al., 
2015). Neurons typically have one longer projection called an axon, which transfers 
the information to a recipient cell. Multiple shorter branching projections, called 
dendrites, are responsible for collecting signals arising from the surrounding cells 
and transferring them to the neuronal soma (Budday et al., 2015; Stiles and Jernigan, 
2010). Connections serving as points of information transfer are called synapses and 
are generally formed between a presynaptic axon and a postsynaptic dendrite (Stiles 
and Jernigan, 2010). Astrocytes maintain the homeostatic balance and provide 
metabolic and structural support for neurons (Verkhratsky and Nedergaard, 2018). 
They also take charge of the enormous energy demand caused by the electrical 
signaling of neurons. In past decades, research has focused on the role of astrocytes 
in synaptogenesis, the maintenance of healthy synaptic communication and the 
regulation of synaptic transmission (Verkhratsky and Nedergaard, 2018). Astrocyte-
specific functions are discussed in more detail in chapter 2.5. Oligodendrocytes are 
the myelinating glial cells, and their main task is to insulate neuronal axons with 
myelin sheaths, thereby facilitating and accelerating information transfer 
(Stadelmann et al., 2019). The brain also includes microglial cells, which are the 
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nervous system derivative of macrophages participating in immune surveillance and 
clearance of metabolites (Ginhoux et al., 2010). 
2.1.1 Development of the central nervous system 
Nervous system development begins with the multipotent ectodermal cells of the 
gastrula-stage embryo (Zirra et al., 2016). The developmental process of neurulation 
begins as the neuroepithelial cells start forming the neural groove along the midline 
of the neural plate (Figure 1A) (Stiles and Jernigan, 2010). As the groove further 
folds into the neural tube, the neuroepithelial cells transition to radial glial cells, 
which undergo asymmetric cell division to produce neurons or intermediate cells, 
including intermediate progenitors and basal radial glia. The differentiated cell types 
migrate outward from the apicobasally oriented radial glia and ultimately generate 
neurons and glial cells (Kelava and Lancaster, 2016). Later, as a result of neural 
patterning, these cells form various brain regions, including the forebrain, midbrain 
and hindbrain. The spinal cord forms from the lower part of the neural tube, whereas 
the PNS originates from the tissue above the neural tube, which is called the neural 
crest (Zirra et al., 2016). 
The molecular signals leading to neural induction from the ectoderm involve 
suppression of the bone morphogenic protein (BMP) and Nodal pathways (Mertens 
et al., 2016; Suzuki and Vanderhaeghen, 2015; Zirra et al., 2016). In addition to this 
so-called default pathway, fibroblast growth factor (FGF) and wingless (Wnt) 
signaling have been shown to mediate neural induction (Martynoga et al., 2012; 
Muñoz-Sanjuán and Brivanlou, 2002). Following neural induction, the different 
anatomical brain domains start to specify along the rostrocaudal and dorsoventral 
axes (Suzuki and Vanderhaeghen, 2015). Gradients of different morphogens from 
several organizing centers control the regional specification of the future forebrain, 
midbrain, hindbrain and spinal cord. The “default” pathway results in rostral 
phenotypes, while caudalization can be induced by retinoic acid (RA), Wnts or FGFs 
(Figure 1B). Specification in the dorsoventral axis is controlled by BMP, Wnt and 
Sonic hedgehog (Shh) signaling. This intricate regional patterning of neural 
progenitor cells enables the later formation of a large diversity of neurons and glial 
cells (Suzuki and Vanderhaeghen, 2015; Tao and Zhang, 2016). 
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Figure 1.  Neural development of the central nervous system. (A) Neural induction through the process 
of neurulation leading to the fetal brain and eventually to the adult brain. (B) Signaling cues 
involved in dorsoventral and rostrocaudal regional patterning of the CNS. Abbreviations: 
BMP, bone morphogenetic protein; Wnt, Wingless-related integration site; Shh, sonic 
hedgehog; FGF, fibroblast growth factor; RA, retinoic acid. Image is modified from Mertens 
et al. 2016 and Suzuki and Vanderhaeghen 2015. 
Temporal development, during which neurons are generated first followed by 
glia, has been widely conserved across different species. In rodents, this switch from 
neurogenesis to astrogenesis occurs at late embryonic stages (approximately E18), 
and the development of astrocytes peaks postnatally (Miller and Gauthier, 2007). In 
humans, astrocytes appear at midgestation and develop in fetal and postnatal periods 
(Semple et al., 2013). Astrocytes are initially generated from the radial glia in the 
ventricular zone (VZ) and subventricular zone (SVZ) and are later developed by the 
division of local astrocytes (Jiang and Nardelli, 2016). The switch from neurogenesis 
to gliogenesis is controlled by several intrinsic signaling cues and requires both the 
inhibition of neurogenic factors and the induction of gliogenic factors (Okano and 
Temple, 2009). For example, neurogenin 1 (Ngn1) attenuates gliogenesis, while the 
proglial genes nuclear factors 1A and 1B (NFIA/B) initiate the formation of glial 
cells. In addition, a series of epigenetic changes, including histone modifications and 
DNA demethylation, enables the transcription of glial-specific genes upon 
stimulation (Okano and Temple, 2009). The IL-6 family members ciliary 
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neurotrophic factor (CNTF), leukemia inhibitor factor (LIF) and cardiotriphin-1 
(CT-1) have been recognized as secreted signals promoting astrogenesis (Sloan and 
Barres, 2014). Additionally, the BMP and Notch signaling molecules play a role in 
inducing the development of astrocytes (Sloan and Barres, 2014). 
2.1.2 Corticogenesis 
The cerebral cortex is a complex structure consisting of six layers in which layer-
specific neurons are produced in a sequential order. In rodents, neurogenesis begins 
on approximately E9.5 and continues through the first two postnatal weeks (Semple 
et al., 2013). In humans, neurogenesis occurs mainly during gestation. It is initiated 
at approximately 5 gestational weeks and completed by 28 weeks (Meyer et al., 2000). 
Corticogenesis begins in the VZ and proceeds to form a neighboring proliferative 
area termed the SVZ (Figure 2). In these regions, the cortical progenitors are 
generated in a temporal inside-out manner, meaning that the early-born deep-layer 
neurons are produced first, followed by late-born superficial-layer neurons (Kelava 
and Lancaster, 2016). The newly born neurons in the cerebral cortex are guided by 
radial glia to migrate basally to their particular cortical locations. The cortical plate 
starts to form all the different cortical layers as late-born neurons migrate past the 
pre-existing early-born neurons (Molyneaux et al., 2007). The different cortical layer-
specific neurons have their own characteristic patterns of gene expression and 
connectivity, which result from temporal patterning (Toma and Hanashima, 2015). 
Deep-layer neurons, at layers V and VI, typically express transcription factors such 
as Tbr1 and Ctip2 and extend mostly to subcortical targets. Upper-layer neurons, 
layers II-IV, express the transcription factors Brn1/2, Cux1/2 and Satb2, form 
intracortical connections and promote thalamocortical communication (Toma and 
Hanashima, 2015). Most neurons generated in the dorsal forebrain are excitatory 
neurons. Cortical inhibitory interneurons are mostly formed ventrally, after which 
they tangentially migrate to the cortical plate (Kelava and Lancaster, 2016; Letinic et 
al., 2002; Yu, X. and Zecevic, 2011). 
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Figure 2.  Cortical neurogenesis. Cortical excitatory neurons are produced at the dorsal part of the 
cortex, whereas interneurons are generated ventrally at the medial ganglionic eminence, 
from where they migrate dorsally and integrate into the excitatory neuronal network. The 
cortical plate forms in an inside-out manner from the progenitor pool in the ventricular and 
subventricular zones. Abbreviations: MGE, medial ganglionic eminence; VZ, ventricular 
zone; SVZ, subventricular zone; CP, cortical plate; Satb2, Special AT-rich sequence-binding 
protein 2; Cux1, Homeobox protein cut-like 1; Brn2, Brain-specific homeobox/POU domain 
protein 2; Ctip2, COUP-TF-interacting protein 2; Tbr1, T-box brain 1. Image is modified from 
Andersson and Vanderhaegen 2014 and Suzuki and Vanderhaeghen 2015. 
2.1.3 Human-specific features of neural development 
The development of the human CNS has long attracted the interest of researchers, 
and despite experimental challenges, studies have confirmed that many aspects of 
development follow the same principles as those observed in animal models (Kelava 
and Lancaster, 2016). However, some of the features differ, and many of these 
differences give rise to the improved cognitive abilities of humans (Sherwood et al., 
2006). Humans have the largest brain size in relation to their body size, and the 
neuron density in humans is several times higher than that in the rodent brain 
(Herculano-Houzel, 2014; Kelava and Lancaster, 2016). In particular, the surface and 
thickness of the neocortex have been considerably enlarged throughout hominid 
evolution, resulting in increased cell numbers and diversity of cortical neurons 
(Suzuki and Vanderhaeghen, 2015). 
Another distinct feature of human brain development is its prolonged cell 
division, amplification of progenitor cells and generation of neurons (Kelava and 
Lancaster, 2016). In the developing cortex, the neurogenic zones and their 
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progenitor pools are vastly more elaborate than their rodent counterparts (Lancaster 
et al., 2013). Similarly, axonal growth, dendritic spine maturation and synaptogenesis 
last for an extended time. Human neurons also exhibit prolonged 
electrophysiological maturation and variation in the neurotransmitter system 
(Semple et al., 2013). In human systems, full maturation of neurons can take months 
or even years (Figure 3) (Suzuki and Vanderhaeghen, 2015). 
Astrocytic complexity in the human brain is distinctive and has increased 
throughout primate evolution with respect to both the morphology and density of 
astrocytes (Oberheim et al., 2006; Oberheim et al., 2009; Sherwood et al., 2006). 
Furthermore, transcriptional comparison between human and mouse astrocytes has 
revealed that only 30% of human astrocyte-enriched genes are found in mice 
astrocytes (Zhang, Ye et al., 2016). In the cerebral cortex, the neuron-glial cell ratio 
has increased from 0.4 in rodents to an estimated 1.4 in humans (Oberheim Bush 
and Nedergaard, 2017). Human astrocytes are on average 3 times larger, contain 10 
times more processes, and present faster calcium waves than rodent astrocytes 
(Oberheim et al., 2009). At the same time, through this development, human 
astrocytes are expected to be capable of contacting and controlling ~2 million 
 
Figure 3.  Timeline for cortical development in humans and rodents. Human development is 
characterized by extended progenitor cell amplification, neurogenesis and maturation. The 
sequential generation of cortical layer-specific neurons followed by gliogenesis is shown. 
Image is modified from Andersson and Vanderhaegen 2014. 
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synapses, while in rodents, the estimate is only 0.1 million synapses (Oberheim et al., 
2006). In addition to the two main classes of astrocytes, the protoplasmic gray matter 
and fibrous white matter astrocytes, primates also possess additional astrocyte 
subtypes. Interlaminar and polarized astrocytes are found only in primates 
(Oberheim et al., 2006). 
2.2 Stem cells 
Stem cells are undifferentiated cells that have the ability to become specific cells of 
various tissue types depending on their differentiation capacity and environmental 
conditions. They are usually characterized by their ability to divide either unlimitedly, 
such as pluripotent embryonic stem cells, or with certain limitations, such as adult 
tissue-specific stem cells (Zakrzewski et al., 2019). Stem cells with these differing 
capacities originate mainly from two sources: embryos and adult tissues (Thomson 
et al., 1998; Zakrzewski et al., 2019). Stem cells can also be derived from fully 
differentiated adult cells via genetic reprogramming technologies (Takahashi et al., 
2007). In adult tissues, stem cells can be found, for example, in the brain, blood, 
bone marrow, skin and skeletal muscles, and they reside in specific locations called 
the stem cell niche (Zakrzewski et al., 2019). In the brain, a small population of radial 
glia remains in specific regions in the subventricular zone of the lateral ventricles and 
the dentate gyrus of the hippocampus (Martynoga et al., 2012). Next, human 
pluripotent stem cells and their neural derivatives are described in more detail. 
2.2.1 Human pluripotent stem cells 
Human pluripotent stem cells (hPSCs) are defined by their unlimited capacity to 
divide and produce cells of all three germ layers: the endoderm, mesoderm and 
ectoderm (Zirra et al., 2016). hPSCs include human embryonic stem cells (hESCs) 
derived from the inner cell mass of blastocyst-stage embryos and human induced 
pluripotent stem cells (hiPSCs) genetically reprogrammed from adult somatic cells 
(Takahashi et al., 2007; Thomson et al., 1998). The derivation of hESC lines is highly 
regulated, and in Finland, couples undergoing in vitro fertilization treatments can 
donate surplus, poor-quality embryos for research use (Skottman, 2010). The hiPSCs 
are often preferred because they do not raise ethical concerns as severe as research 
utilizing embryos (Shi, Yanhong et al., 2017). Derivation of pluripotent cells from 
 30 
human somatic cells using reprogramming methods was first described in 2007 by 
Yamanaka and colleagues (Takahashi et al., 2007). In short, somatic cells were 
introduced with four pluripotency-inducing transcription factors, called the 
“Yamanaka factors”. The original research included retroviral transfection with the 
transcription factors octamer-binding transcription factor 3/4 (OCT3/4), SRY-box 
2 (SOX2), Kruppel-like factor 4 (KLF4) and V-Myc avian myelocytomatosis viral 
oncogene homolog (C-MYC) (Takahashi et al., 2007). Since then, other 
combinations of transcription factors and other viral or nonviral means of 
transporting or expressing specific factors have been experimented successfully (Shi, 
Yanhong et al., 2017; Yu, J. et al., 2007). Despite their different origins, hESCs and 
hiPSCs are generally considered to resemble each other and to have similar surface 
marker expression, self-renewal abilities and capacities to differentiate into mature 
cell types (Avior et al., 2016). However, there are known differences; for example, 
persistence of the former epigenetic memory of somatic cells has been observed in 
hiPSCs. Both hESCs and hiPSCs are considerably promising for use in regenerative 
medicine and drug development, and hiPSCs derived from human patient-specific 
cells are a major target for modeling human disorders due to the genetic background 
of the donor (Avior et al., 2016; Steinbeck and Studer, 2015). 
2.2.2 Neuronal differentiation 
The neurodevelopmental events discovered in vivo can be mimicked to achieve 
neuronal differentiation in vitro. For example, timed applications of different 
environmental cues, such as mitogens and morphogens, can be used to generate 
neurons showing a high level of brain regional specificity (Suzuki and 
Vanderhaeghen, 2015). The very first reports on neuronal differentiation from 
hESCs date back to the early 21st century (Reubinoff et al., 2000; Reubinoff et al., 
2001; Zhang, S-C et al., 2001a). Neural induction was established using the three-
dimensional (3D) embryoid body (EB) method, which resulted in the formation of 
neural rosette structures resembling early neural tube development (Zhang, S-C et 
al., 2001a). When these EBs were plated in adherent cultures, the neural rosettes 
could be further mechanically or enzymatically isolated to enrich the neuronal 
population. Neural conversion could also be induced in the presence of FGF2-
containing media, and these cultures could be continuously maintained, passaged 
and enriched in 3D; thus, they were commonly termed neurospheres (Lappalainen 
et al., 2010; Nat et al., 2007). 
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An important advance in the field of in vitro neuronal differentiation was the 
development of the so-called dual SMAD inhibition method (Chambers et al., 2009). 
Neural induction is achieved in more controlled conditions using combined 
inhibition of the BMP pathway and the Noggin and Activin/Transforming growth 
factor-β (TGF-β) pathway with SB431542. This protocol enabled the differentiation 
of homogenous neural cultures in fully adherent conditions without the need for 
rosette isolation. The principle of dual SMAD inhibition has been used in various 
differentiation methods, including adherent cultures, neurospheres and, most 
recently, brain organoid cultures (Pasca et al., 2015; Shi, Y. et al., 2012). 
Three-dimensional cultures beneficially allow neural cells to acquire a more 
elaborate morphology and form a cytoarchitecture that better recapitulates brain 
complexity (Lehmann et al., 2019). Within the last few years, cerebral organoids have 
become increasingly popular to research because neural cells can self-assemble into 
large tissues with defined brain regions within organoids (Lancaster et al., 2013). 
Organoid culture starts with the same principles as the EB protocol, but the cells are 
usually encapsulated in a Matrigel matrix droplet. Organoids are cultured and 
expanded for an extended time in a spinning bioreactor to ensure efficient nutrient 
exchange. The development of organoids can be established in the absence of 
external cues or alternatively directed with timed exposure to morphogens (Amin 
and Paşca, 2018; Lancaster et al., 2013). Depending on the culture conditions and 
maturation time, the organoids can grow over several millimeters in diameter and 
contain multiple brain regions with variable populations of progenitor cells and 
mature neural cell types, including neurons, astrocytes and oligodendrocytes 
(Madhavan et al., 2018; Pasca et al., 2015). 
Following technological advances in hiPSC reprogramming, approaches 
involving the direct conversion of fibroblasts or hPSCs into induced neuronal (iN) 
cells have become more common (Mertens et al., 2016; Zhang, Yingsha et al., 2013). 
Genetic reprogramming by viral delivery of specific transcription factors generally 
results in highly homogenous neuronal populations in a short period of time. Direct 
conversion from fibroblasts also has the advantage of better preserving the aging-
specific signatures of the cells (Mertens et al., 2016). However, the conversion 
efficiency of somatic cells is still not as good as the neuronal reprogramming of 
hiPSCs (Zhang, Yingsha et al., 2013). Direct conversion from mouse fibroblasts was 
originally established by introducing three transcription factors (BAM factors): Brn2, 
Ascl1 and Myt1L (Mertens et al., 2016). In human cells, a fourth transcription factor, 
NeuroD1, or specific microRNAs are required (Wapinski et al., 2013). On the other 
hand, neurogenin 2 (Ngn2) has also been shown to efficiently convert adult human 
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fibroblasts into iN cells (Zhang, Yingsha et al., 2013). This approach is also most 
commonly used for the generation of iN cells from hiPSCs. The specification of 
different neuronal subtypes upon direct conversion can be further influenced by the 
simultaneous application of extrinsic cues, morphogens or small molecules, as was 
elegantly shown by Liu and colleagues (Liu et al., 2013). 
The production of regional- or neurotransmitter-specific neurons is usually an 
important goal in all of these neuronal differentiation approaches (Suzuki and 
Vanderhaeghen, 2015). Regional patterning of hPSC-derived neural progenitor cells 
(NPCs) follows the same principles as those previously described for in vivo neural 
development (Figure 1B). Without specific morphogens, hPSCs differentiate into a 
dorsal forebrain phenotype and generate mostly neurons with glutamatergic 
properties (Espuny-Camacho et al., 2013; Shi, Y. et al., 2012). The dorsal forebrain 
identity of NPCs can be maintained with dual SMAD inhibition and simultaneous 
blockage of the Wnt pathway with molecules such as Dickkopf-related protein1 
(DKK1) (Mariani et al., 2012). More ventrally derived inhibitory neurons can be 
generated with the introduction of Shh (Floruta et al., 2017; Maroof et al., 2013). 
Patterning along the rostrocaudal axis has been established with the dose-dependent 
activation of Wnt signaling using glycogen synthase kinase 3 (GSK3) inhibitors, 
including CHIR99021 (CHIR) (Suzuki and Vanderhaeghen, 2015). Together with 
Shh and FGF8 signaling, this establishment leads to midbrain dopaminergic 
phenotypes (Kirkeby et al., 2012). Increasing activation WNT signaling will result in 
posterior hindbrain phenotypes (Kirkeby et al., 2012). Furthermore, the posterior 
hindbrain cerebellar and spinal cord motor neuron identities are obtained with 
concomitant manipulation of RA and FGFs (Suzuki and Vanderhaeghen, 2015; Zirra 
et al., 2016). 
Within the past two decades, substantial progress has been made regarding the 
differentiation of hPSC-derived neuronal cultures. Many protocols follow common 
principles inspired by in vivo development. Temporal development in vitro also 
presents prolonged neurogenesis, similar to that observed in humans. 
2.2.3 Astrocyte differentiation 
Astrogenesis follows neurogenesis, but the signaling mechanisms important for 
astrocyte specification and heterogeneity are not as well established (Jiang and 
Nardelli, 2016). Traditional neuronal differentiation methods based on chemical cues 
typically produce a certain proportion of astrocytes, especially after extended culture 
 33 
times (Lappalainen et al., 2010). The first report on directed astrocyte differentiation 
from hPSCs was published in 2011 by Krencik and colleagues (Krencik, R. et al., 
2011). They used the EB method to induce neural fate, continued culturing 
neurospheres in medium containing FGF and epidermal growth factor (EGF) for 
several weeks, and matured the differentiated astrocytes in the presence of LIF, 
ciliary neurotrophic factor (CNTF) or fetal bovine serum (FBS). Interestingly, they 
were also able to show regional specification of astrocytes along the rostrocaudal and 
dorsoventral axes using RA, Shh and FGF8, similar to what has been established 
with neurons (Krencik, R. et al., 2011). Since then, most efforts to generate pure 
populations of astrocytes rely on the expansion of glial progenitors after the 
neurogenic stage established either with the EB method or the dual SMAD inhibition 
protocol (Tao and Zhang, 2016; Tcw et al., 2017). These glial progenitors can be 
further regionally specified with RA or Shh and differentiated into mature astrocytes 
in the presence of different combinations of growth factors, such as CNTF, BMP, 
brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor 
(GDNF) and insulin-like growth factor (IGF) (Lundin et al., 2018; Roybon et al., 
2013; Serio et al., 2013; Shaltouki et al., 2013; Tcw et al., 2017). More recently, genetic 
approaches have also been introduced to achieve efficient and fast astrocyte 
differentiation. Expression of the transcription factors Sox9 and NFIB or NFIA 
results in the rapid conversion of astrocytes from pluripotent stem cells (Canals et 
al., 2018; Li et al., 2018). 
In general, the astrocyte differentiation protocols utilizing chemical induction are 
lengthy, potentially taking up to six months. Astrocyte characterization is also 
lacking, and identifying the different astrocyte subtypes is currently challenging due 
to a shortage of suitable markers (Krencik, Robert and Ullian, 2013). 
2.3 Functional development of the brain 
Functional activity depends on membrane potential, which is established during 
development by the distribution of ions across the plasma membrane owing to the 
expression of specific ion channels and pumps (Bean, 2007). In mature neurons, the 
resting membrane potential is approximately -65 mV. The information transfer 
between neurons is carried by an action potential, which occurs as changes in neuron 
membrane potential cross a threshold (Bean, 2007). The opening of plasma 
membrane voltage-gated ion channels quickly depolarizes the neuron, and action 
potential is propagated along the axon all the way to the presynaptic boutons 
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(Radivojevic et al., 2017). The two major types of synapses include electrical synapses 
that arise in the early stages of functional development and chemical synapses that 
are formed later (Luhmann and Khazipov, 2018). In the latter, synaptic vesicles 
containing neurotransmitters are released into the synaptic cleft as a result of action 
potential arrival. Neurotransmitters can have either excitatory or inhibitory effects 
when binding to their specific receptors on the postsynaptic site, resulting in either 
depolarization or hyperpolarization of the postsynaptic neuron (Bean, 2007; 
Luhmann and Khazipov, 2018; Radivojevic et al., 2017). 
2.3.1 Stages of activity development 
Spontaneous activity arises early in various regions of the developing CNS and is 
developed largely through similar sequences of events in both rodents and humans 
(Kilb et al., 2011; Luhmann and Khazipov, 2018). Activity development follows a 
temporal sequence of patterns that is similarly reproduced in most CNS regions, 
such as the cortex, spinal cord, cerebellum and hippocampus (Luhmann and 
Khazipov, 2018). Additionally, the mechanisms that shape the various patterns of 
activity are surprisingly similar between these regions. These include electrical 
coupling, excitatory effects of γ-aminobutyric acid (GABA), pacemaker-like hub 
neurons and synaptic and extrasynaptic effects of neurotransmitters (Blankenship 
and Feller, 2010; Kilb et al., 2011). In the cortex, the earliest born neurons present 
more mature functional properties than those born later and may act as hub neurons 
during development (Luhmann et al., 2016). In addition, inputs are received from 
the subcortical areas, including the thalamus, which helps drive the activity 
(Luhmann et al., 2016). The development of spontaneous activity in the mouse 
cortex can be described in four distinct sequences to illustrate the general stages and 
mechanisms involved (Figure 4). 
The initial form of activity is asynchronous firing consisting of sparse spikes 
originating from single neurons. Calcium has a central role in the early activity before 
the appearance of voltage-gated sodium and potassium channels and the generation 
of sodium-dependent action potentials (Corlew et al., 2004). With further 
development, the glutamatergic and GABAergic neurons in the cortex start firing 
their first action potentials (Egorov and Draguhn, 2013). However, during these 
early stages, the neurons are not yet functionally connected to electrical or chemical 
synapses (Luhmann and Khazipov, 2018). 
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Figure 4.  Development of functional activity in the cortex. Four distinct stages can be recognized in 
the functional development of the cortex. (A) The initial sign of functional activity is 
uncorrelated single-cell firing. (B) The first form of correlated firing is mediated by gap 
junction-coupled electrical synapses. (C) Chemical synapses are formed between 
glutamatergic (light gray) neurons, and most electrical synapses are ultimately removed. 
Eventually, inhibitory GABAergic neurons (dark gray) are involved in bursting, and the 
activity also includes thalamic inputs. (D) In the final stages, the adult type of activity is 
achieved. Abbreviations: SPA, synchronous plateau assemblies; EGO, early gamma 
oscillations. Image is modified from Luhmann and Khazipov, 2018. 
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Next, the first correlated activity emerges, which relies mostly on electrical 
synapses formed by connexin-containing gap junctions between adjacent neurons 
(Dupont et al., 2006; Uhlén et al., 2015). Gap junctional coupling allows the spread 
of calcium transients between cells contributing to synchronic activity, but these 
events are still local, extending only short distances (Egorov and Draguhn, 2013). 
Several different activity patterns relying on electrical synapses and calcium ions 
between groups of cells are reported; examples include the synchronous plateau 
assemblies (SPAs, 0.001 Hz) and beta-oscillations (Allène et al., 2008; Dupont et al., 
2006). These activity patterns take place during the late embryonic and early 
postnatal periods in mice (Egorov and Draguhn, 2013). 
In the third stage, electrical synapses, which serve as templates for the 
development of chemical synapses, are mostly removed as the formation of chemical 
synapses between glutamatergic neurons begins (Luhmann and Khazipov, 2018). 
One immature pattern of activity is the slow delta waves, which arise during postnatal 
development and extend over larger areas of the networks involving many neurons 
(Luhmann and Khazipov, 2018). While delta waves involve the subcortical thalamic 
inputs and can therefore be observed only in vivo, comparable activity patterns 
termed early network oscillations (ENOs, frequency ~0.01 Hz) dependent on 
corticocortical connections are also reproduced in preparations in vitro (Garaschuk 
et al., 2000). Delta waves may or may not contain additional oscillatory components, 
such as early gamma oscillations (EGOs, 30-50 Hz) and spindle bursts (5-25 Hz) 
(Luhmann and Khazipov, 2018). Both EGOs and spindle bursts are transient activity 
patterns during development, and they cease in rodents after approximately the first 
postnatal week. They initially involve only glutamatergic input, but with further 
development, they also show temporal increase in GABAergic currents (Luhmann 
and Khazipov, 2018). 
The giant depolarizing potentials (GDPs, ~0.1 Hz) observed in the hippocampus 
and cortex after the first postnatal week require GABA-dependent connections and 
are coordinated by GABAergic hub neurons (Blankenship and Feller, 2010; Egorov 
and Draguhn, 2013). It is important to note that GABA actions are initially excitatory 
due to the high intracellular chloride concentration in neurons (Ben-Ari et al., 2007). 
This excitation is eventually switched to inhibition as chloride transporter expression 
is altered, resulting in changes in the chloride balance and the hyperpolarizing effect 
of GABA (Ben-Ari et al., 2007). 
Finally, the adult type of activity is formed after three to four postnatal weeks and 
is strongly modified by input from the sensory systems, including vision and hearing, 
and by motor activity (Egorov and Draguhn, 2013). In adult animals, cortical activity 
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is described by adult type-specific response discharges, which are superimposed by 
a continuous background of network oscillations. These processes depend on both 
excitatory and inhibitory signaling and can be very complex, propagating assemblies 
of signals (Egorov and Draguhn, 2013). 
In the cortices of human preterm babies, spontaneous bursting is known as 
spontaneous activity transients (SATs) (Arichi et al., 2017). The most well-described 
activity patterns are delta brushes, which are equivalent to spindle bursts in rodents 
(Arichi et al., 2017; Khazipov and Luhmann, 2006). Although the exact 
neuroanatomical source of activity in humans has not been described in detail, delta 
brushes play an important role in the structural and functional development of the 
cortex (Arichi et al., 2017; Tolonen et al., 2007). Electroencephalography (EEG) 
recordings of infants have indicated that a high incidence of delta brushes is linked 
to normal mental development (Iyer et al., 2015). 
2.3.2 Functions of early activity 
It is not always acknowledged that electrical activity affects embryonic and postnatal 
developmental processes as much as genetic programs (Luhmann et al., 2016). It is 
important for the generation of neurons, cell death, migration, differentiation and 
formation of networks (Kilb et al., 2011). Calcium activity in the ventricular zone 
directly affects neurogenesis and progenitor cell proliferation (Luhmann et al., 2015). 
Early asynchronous activity also has a trophic effect and guides the migration of 
neurons (Egorov and Draguhn, 2013). Trophic factors further affect dendritic 
branching in neurons via an activity-dependent mechanism, and electrical activity 
plays an important role in axonal arborization, supporting neuronal maturation (Kilb 
et al., 2011). The programmed cell death mechanism, apoptosis is partly controlled 
by network activity, and disturbances or silencing of activity during development can 
have drastic effects on the normal apoptosis rate and elevate neuronal cell death rates 
(Golbs et al., 2011). Waves of activity have been linked to the generation of specific 
cortical architectures. They can also elicit activity-dependent potentiation of 
connections, following to some extent the “cells that fire together wire together” 
principle (Luhmann and Khazipov, 2018). 
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2.4 Neuronal functionality in vitro 
2.4.1 Measurements of functional activity in vitro 
Neuronal activity in vitro is traditionally measured from acute or organotypic slices of 
brain tissue or from dissociated cell cultures. Brain slices maintain the 
cytoarchitecture of the brain, although some tissue damage and cell death occur as a 
result of the slice preparation procedure. Dissociated cultures can re-establish axonal 
networks and recapitulate some activity patterns observed in vivo despite the loss or 
the original structural tissue complexity (Pasquale et al., 2008). The activity of 
neurons can be measured at many levels, starting from microscale recordings using 
the patch clamp method, via which single cells are poked with very sharp patch 
pipettes, and the ionic currents across the membrane and voltage changes are 
measured (Petersen, 2017). Network-level electrical activity events of several 
neurons can be evaluated with optical methods, such as fluorescent calcium imaging 
(Grienberger and Konnerth, 2012). Additionally, extracellular recordings of the 
activity of a group of neurons can be achieved simultaneously with microelectrode 
array (MEA) measurements (Obien et al., 2014). In addition to conventional 
pharmacological and electrical neuronal stimulation, novel selective stimulation 
approaches have been reported. A technique called optogenetics, in which 
genetically encoded light-sensitive ion channels or pumps are activated by light, has 
become an increasingly popular tool (Klapper et al., 2017). Next, the methods for 
measuring network functionality in vitro utilized in this thesis, calcium imaging and 
MEA measurements, are described in more detail. 
2.4.1.1 Calcium imaging 
Calcium is a very important second messenger involved in the regulation of many 
cellular processes (Grienberger and Konnerth, 2012; Gu et al., 1994). Calcium influx 
can originate from two sources, via specific channels on the plasma membrane or 
via release from internal stores, mostly from the endoplasmic reticulum; however, 
mitochondria are also involved in calcium homeostasis (Grienberger and Konnerth, 
2012). Calcium imaging has been established as a reliable tool for studying functional 
activity at the network level (Forostyak et al., 2013; Gu et al., 1994; Kerr et al., 2005). 
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During action potentials, the depolarization of a neuron opens voltage-gated ion 
channels, including voltage-gated calcium channels, which results in calcium 
transients (Grienberger and Konnerth, 2012). These calcium transients can be 
imaged utilizing specialized dyes, fluorescent calcium indicators that bind to calcium 
(Bootman et al., 2013). The resulting image series of several neurons experiencing 
transient calcium concentration increases depict the functional activity of neurons. 
The benefit of calcium imaging is its single-cell resolution in a network of cells; 
however, the temporal resolution is poor owing to the slow kinetics of calcium 
transients compared to action potential currents (seconds vs. milliseconds) (Kerr et 
al., 2005). 
2.4.1.2 Microelectrode array measurements 
MEAs represent a technique for recording neuronal activity at the network level with 
very high (millisecond) temporal resolution. The array of microelectrodes measures 
changes in the extracellular field resulting from the activity of neuronal cells cultured 
on top of embedded electrodes (Obien et al., 2014). The method is thus noninvasive 
and can be used to follow the development of networks over several weeks of culture 
(Charlesworth et al., 2015; Ito et al., 2014). The trade-off of MEAs is spatial 
resolution. Neuronal activity results from the transmembrane current, which can be 
detected by electrodes even across tens to hundreds of micrometer distances (Egert 
et al., 2002). Therefore, the resulting recorded electric field depends on the number 
of active neurons and on the magnitude and distance of the signal from the recording 
electrode (Obien et al., 2014). The single-unit activity, which is known as the 
extracellular action potential (EAP), or spike, results from the rapid intracellular 
influx of Na+ ions followed by efflux of K+ ions, producing extracellularly recorded 
signals characteristic of negative spikes and small positive increases thereafter 
(Buzsáki et al., 2012). Usually, the recorded signal consists of the multiunit activity 
of several neurons firing action potentials in close vicinity to the electrodes (Obien 
et al., 2014). MEAs can also detect local field potentials (LFPs) arising from the 
activity of a very large population of neurons, which presents a low-frequency band 
signal (less than 300 Hz) and is usually filtered out from the analysis (Einevoll et al., 
2013). Several different MEA device types are on the market, from single-well MEAs 
to multiwell plate format MEAs enabling more high-throughput analyses. An 
interesting upcoming technology is CMOS-based high-density MEAs, which contain 
an array of thousands of electrodes, improving the special resolution of the 
measurements (Obien et al., 2014). 
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2.4.2 Functionality of hPSC-derived neuronal cultures 
Neuronal activity and functional circuits are the key elements that underlie the 
information processing required for complex behavior and cognitive properties. 
hPSC-derived neurons provide a unique human-specific model for studying network 
function during development, in disease and during pharmacological exposure 
(Hartlaub et al., 2019). Many CNS disorders present abnormalities in the channels 
and synapses affecting normal synaptic signaling of neurons. The functional maturity 
level of hPSC-derived neurons has been a common topic of research since the neural 
identity must closely match that of the in vivo counterparts to reliably model 
pathological processes. 
2.4.2.1 Functional properties of hPSC-derived neurons 
Ion channel composition affects the membrane properties driving the functionality 
of neurons, and therefore membrane properties were among the first functional 
traits of hPSC-derived neurons to be studied (Johnson et al., 2007). Single-cell patch 
clamp studies have repeatedly shown that the passive membrane properties of hPSC-
derived neurons resemble those of the late embryonic stages in rodents and those of 
the mid to late gestational stages in humans with some maturation after extended 
culture times (Johnson et al., 2007; Weick, 2016). The active membrane properties 
directly linked to action potential generation have also been shown to be partially 
underdeveloped, resulting in immature spiking patterns (Chinchalongporn et al., 
2015; Gunhanlar et al., 2018; Johnson et al., 2007). 
As mentioned in previous chapters, hPSC-derived neurons differentiate by 
default into forebrain glutamatergic subtypes with varying proportions of 
GABAergic neurons (Suzuki and Vanderhaeghen, 2015). Glutamatergic excitatory 
neurotransmission is a major driver of cortical type activity through N-methyl-D-
aspartate (NMDA) and ߙ-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) receptors (Livesey et al., 2016). Both immature and mature receptor 
subtype compositions have been characterized in hPSC-derived neurons and shown 
to exhibit the expected maturation over time (Kirwan et al., 2015; Livesey et al., 
2014). Reports have even shown that hPSC-derived networks can support NMDA-
dependent synaptic plasticity, suggestive of functional maturation (Kirwan et al., 
2015). 
The GABAergic system is a very important local controller of excitatory 
networks. Studies on hPSC-derived excitatory networks revealed GABAA receptor-
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mediated currents, but pharmacological dissection demonstrated immature receptor 
composition (James et al., 2014; Livesey et al., 2014). In time, GABAergic neurons 
also demonstrate spiking pattern maturation and increased sensitivity to GABAergic 
antagonists (Nicholas et al., 2013; Weick, 2016). During early development, GABA 
binding to the GABAA receptor exerts an excitatory depolarizing effect due to the 
high intracellular chloride concentration (Ben-Ari, 2002). The chloride concentration 
decreases during development as a shift occurs in the expression of the chloride 
transporters NKCC1 and KCC2 (Ben-Ari, 2002). Similar development has been 
observed in the maturation of hPSC-derived networks (Livesey et al., 2014). 
The network level activity of hPSC-derived neurons is scantily described in the 
literature (Table 1), partly because achieving robust network activity has been 
difficult with the current culture methods. The first stem cell studies reporting 
network activity with MEAs were performed with mouse ESC-derived cultures (Illes 
et al., 2007), and hESC-derived neuron reports followed shortly thereafter (Heikkilä 
et al., 2009). In both reports, the network activity developed from sparse spiking to 
more pronounced spike trains and, finally, to mature bursting phenotypes (Heikkilä 
et al., 2009; Illes et al., 2007). More recently, elaborate network level analyses have 
been performed with calcium imaging (Kirwan et al., 2015; Mäkinen et al., 2018) and 
MEA setups (Frega et al., 2017; Izsak et al., 2019; Mäkinen et al., 2018; Odawara et 
al., 2016; Trujillo et al., 2019). These networks have demonstrated sensitivity to 
common glutamatergic and GABAergic receptor blockers (Heikkilä et al., 2009; 
Odawara et al., 2016). However, many other MEA studies still show very low 
bursting activity and localization of synchronic activity to clustered areas instead of 
wider participation of the network. 
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2.4.2.2 Improving the functional maturation of hPSC-derived neurons 
Enhancement of the functional maturation of hPSC-derived neurons and 
optimization of culture conditions to support electrical activity has been important 
for the generation of representative in vitro models. hPSC-derived neuronal cultures 
have been shown to undergo spontaneous maturation in time (Weick, 2016). 
Additionally, specialized culture media have been developed with the idea of 
improving electrical activity and allowing long-term maintenance of functional 
hPSC-derived neurons (Bardy et al., 2015). These media are chemically defined, and 
with appropriate supplements, it is suggested that they better match the in vivo 
environment. In the optimized medium, the concentration of inorganic salts was 
adjusted closer to the physiological range, and the amount of neuroactive amino 
acids was decreased. Additionally, the energy levels, mainly glucose, and osmolarity, 
were adjusted to mimic more native brain conditions. The culture medium was 
demonstrated to mediate its effect via strengthening silent synapses and may 
therefore indirectly enhance neuronal maturation (Bardy et al., 2015). 
Selective supplements are regularly used with basal media to improve long-term 
survival, neurite outgrowth and synaptogenesis. The most commonly used 
supplements include the N2 and B27 commercial products in place of serum (Bardy 
et al., 2015). In addition, several neurotrophic and other factors are used, such as 
BDNF, GDNF, cyclic adenosine monophosphate (cAMP), RA, ascorbic acid (AA), 
the γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-
butyl ester (DAPT) and laminin (Bardy et al., 2015; Borghese et al., 2010; Gunhanlar 
et al., 2018; Shi, Y. et al., 2012). The selection of factors should always be performed 
with caution because these can have very specific effects on the functional 
development of neurons (Lepski et al., 2013; Livesey et al., 2014). 
The effect of the extracellular matrix (ECM) on the development of hPSC-
derived neuronal cultures has not been addressed often in the literature, although 
the ECM is known to mediate important signals regulating cellular effects (Long and 
Huttner, 2019; Zhang, Dawei et al., 2017). Laminins are heterotrimeric ECM 
glycoproteins, and the different laminin isoforms contain varying combinations of 
three subunits: alpha, beta and gamma chains (Domogatskaya et al., 2012). In 
particular, the animal-derived basement membrane extracts Matrigel and mouse 
laminin, which contains mostly laminin-111 (α1, β1, γ1), are often used as culture 
substrates in neuronal differentiation (Hagbard et al., 2018). However, improved 
survival and functional maturation has been demonstrated on laminin alpha5 chain 
substrates (Hyysalo et al., 2017; Odawara et al., 2018; Zhang, Dawei et al., 2017). 
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These defined human recombinant ECM proteins are also more attractive options 
than animal-derived components that suffer from batch-to-batch variation (Kirkeby 
et al., 2017; Niclis et al., 2017). 
Glial cells, astrocytes, have also been shown to play a critical role in supporting 
neuronal maturation and functionality, specifically by inducing synaptogenesis. 
Rodent astrocytes are succesfully used as feeder layers for hPSC-derived neurons in 
functional studies (Johnson et al., 2007; Odawara et al., 2014), but results obtained 
with hPSC-derived astrocyte co-cultures are still variable (Klapper et al., 2019; 
Kuijlaars et al., 2016; Lischka et al., 2018; Odawara et al., 2018). In addition, the role 
of endogenously generated astrocytes in hPSC-derived neuronal cultures is scantily 
described (Izsak et al., 2019; Lappalainen et al., 2010). Astrocyte functions are next 
discussed in more detail. 
2.5 Astrocytes 
Astrocytes are the most numerous cell type in the CNS and have aroused increasing 
research interest in recent decades thanks to new findings regarding their functions. 
Astrocytes were first believed to serve only as structural support and substance 
between neurons, giving rise to the historical neuroglia name “nerve glue” 
(Kettenmann and Verkhratsky, 2008). Astrocytes are a heterogeneous population of 
cells that possess distinct properties in different areas of the CNS. They also have a 
very different role in disease states, termed astrocyte reactivation (Sofroniew and 
Vinters, 2010) 
2.5.1 Physiological functions of astrocytes 
The morphological complexity and locations of numerous astrocyte processes 
enables them to actively monitor and regulate their microenvironment. Astrocytes 
regulate brain homeostasis via the extracellular buffering of water, ion and pH levels  
(Allaman et al., 2011). They can control local cerebral blood flow based on the 
activity and energy demand of neurons and participate in the maintenance of blood-
brain barrier integrity (Marina et al., 2018; Takano et al., 2006). One key function of 
astrocytes is to provide structural support for neurons and synthesize extracellular 
matrix proteins and adhesion molecules (Sofroniew and Vinters, 2010). They also 
take part in the sustainment of neuronal activity by releasing energy substrates and 
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trophic factors (Clarke and Barres, 2013). Close positioning with synapses also 
protects neurons from excitotoxic insults via the recycling of neurotransmitters from 
the synaptic cleft (Allen, 2014). The gap junctional coupling between astrocytes 
allows the formation of functional networks and the spreading of second messengers 
such as calcium and inositol trisphosphate (IP3) and metabolic products, glucose 
and adenosine trisphosphate (ATP) (Sofroniew and Vinters, 2010). Thus, astrocytes 
have a major role in maintaining the homeostatic and metabolic balance in the CNS. 
2.5.2 Astrocyte-neuron communication 
Astrocytes have a central role in the control of synapse formation and function 
(Baldwin and Eroglu, 2017; Clarke and Barres, 2013; Craig et al., 2006). Several 
synaptogenic astrocyte-secreted factors have been identified that contribute to the 
initial synapse formation, transformation of silent synapses into active ones and 
pruning of unnecessary synapses (Clarke and Barres, 2013). These secreted 
molecules include thrombospondins and glypicans (Allen et al., 2012; 
Christopherson et al., 2005). Astrocytes are in tight contact with synapses, 
particularly the postsynaptic dendritic spines, and have contact-mediated effects on 
synapse development and stabilization (Clarke and Barres, 2013). 
Astrocytes have their own communication system that is based on calcium 
transients (Cornell-Bell et al., 1990). Calcium can spread within a network of gap 
junction-coupled astrocytes, but local calcium increases in the soma and processes 
of astrocytes are also detected, and functions of these local calcium transients are 
only beginning to be understood (Volterra et al., 2014). Astrocytes also express 
receptors for a variety of neurotransmitters and other signaling molecules, allowing 
them to communicate and respond to environmental cues. At least half of the 
synaptic connections in the CNS are estimated to contain an enshrouding astrocyte 
(Verkhratsky and Nedergaard, 2018). These observations have led to hypotheses and 
debate about the direct role of astrocytes in regulating synaptic transmission in the 
so-called tripartite synapse (Araque, A. et al., 1999; Araque, Alfonso et al., 2014; 
Nedergaard and Verkhratsky, 2012). In this paradigm, the activation of astrocytes by 
neurotransmitters induces calcium transients and the release of neuroactive 
molecules called gliotransmitters (such as ATP, glutamate and D-serine), further 
regulating synaptic transmission and plasticity (Araque, Alfonso et al., 2014). 
Considering the intricate communication and cooperation between neurons and 
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astrocytes, it is not difficult to comprehend the problems arising from the loss of 
normal functions in disease states. 
2.5.3 Astrocyte reactivation 
Following CNS injury or disease, astrocytes undergo transformation into a reactive 
state that is characterized by altered gene expression and morphological and 
functional changes that may depend on the severity of the insult (Ben Haim et al., 
2015; Blanco-Suárez et al., 2017; Dossi et al., 2018). Different environmental stimuli, 
such as infection, CNS trauma, systemic inflammation, and chronic 
neurodegeneration, can elicit astrogliosis (Sofroniew and Vinters, 2010). These 
stimuli are mediated by a variety of molecular triggers, such as inflammatory 
cytokines, microbial antigens, myelin debris, aggregated proteins typical for 
neurodegenerative diseases and hypoxic conditions present during stroke (Pekny et 
al., 2019; Ponath et al., 2018; Sofroniew and Vinters, 2010). Reactivation is often 
accompanied by infiltration of immune cells and interaction with microglia, 
increasing the complexity of the subsequent events (Sommer et al., 2019; Yun et al., 
2018). 
Astrocyte heterogeneity is also evident in their reactive state, as both 
neuroprotective and neurotoxic phenotypes have been reported (Anderson, M. A. 
et al., 2016; Rodríguez-Arellano et al., 2016). Reactivation can lead to excess 
proliferation, astrocyte scar formation and inhibition of axonal growth (Sofroniew 
and Vinters, 2010). Astrocytes can secrete cytokines and chemokines that further 
increase the inflammatory reaction and release excitotoxic levels of glutamate, nitric 
oxide or other toxic molecules compromising neuronal survival (Sofroniew and 
Vinters, 2010). On the other hand, astrocytes may limit inflammation and tissue 
damage and facilitate regeneration (Colombo and Farina, 2016). In fact, an elegant 
study has demonstrated that distinct astrocyte phenotypes result from different 
environmental stimuli. Treatment of mice with bacterial lipopolysaccharide led to a 
harmful reactive astrocyte phenotype, while ischemic insult by middle cerebral artery 
occlusion resulted in a more beneficial state (Zamanian et al., 2012). These two 
phenotypes were named neurotoxic A1 and neuroprotective A2 astrocytes, although 
there is still speculation about several other unidentified reactive astrocyte 
phenotypes (Liddelow, Shane A. and Barres, 2017). 
Astrocyte reactivation has been reproduced in vitro. Liddelow and colleagues 
provided evidence that the neurotoxic A1 astrocyte phenotype can be replicated in 
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vitro by combinatorial treatment with IL-1α, TNF-α and complement component 
C1q (Liddelow, S. A. et al., 2017). Many other studies have also experimented with 
a variety of cytokines and inflammatory factors to create representative in vitro 
models for reactive astrocytes (Hamby et al., 2012; Perriot et al., 2018; Ronco et al., 
2014). To better understand human astrocytes and disease, fetal-derived astrocytes 
and glioma cell lines have been utilized (Hoffmann et al., 2015; van Scheppingen et 
al., 2018; Zhang, Ye et al., 2016). More recently, an increasing number of papers on 
hPSC-derived reactive astrocytes have been published (Lundin et al., 2018; Perriot 
et al., 2018; Roybon et al., 2013; Tcw et al., 2017), and the first reports combined 
other cell types, such as neurons, microglia and leukocytes, to better understand their 
interplay in disease (Park et al., 2018; Santos et al., 2017; Sommer et al., 2019). Table 
2 lists some of the key publications in which hPSC-derived astrocyte reactivation has 
been explored. 
 49 
Ta
bl
e 2
.  
Re
ac
tiv
ati
on
 of
 hP
SC
-d
er
ive
d a
str
oc
yte
s. 
N
eu
ro
n
-s
p
ec
if
ic
 e
ff
ec
ts
 
N
A
 
N
A
 
N
A
 
N
A
 
48
 h
 o
f c
o-
cu
ltu
re
 w
ith
 IL
-1
β-
tre
at
ed
 a
st
ro
cy
te
s r
ed
uc
ed
 
ne
ur
on
 su
rv
iv
al 
an
d 
de
nd
rit
ic 
le
ng
th
. 
N
A
 
IL
, i
nt
er
le
uk
in
; T
N
F,
 tu
m
or
 n
ec
ro
sis
 fa
ct
or
; I
FN
, i
nt
er
fe
ro
n;
 N
F-
кB
, n
uc
le
ar
 f
ac
to
r 
ka
pp
a-
lig
ht
-c
ha
in
-e
nh
an
ce
r 
of
 a
ct
iv
at
ed
 B
 c
el
ls;
 C
CL
5,
 C
-C
 m
ot
if 
ch
em
ok
in
e 
lig
an
d 
5;
 L
cn
2,
 li
po
ca
lin
 2
; P
ol
y(
I:C
), 
po
ly
in
os
in
ic-
po
lyc
yt
id
yl
ic 
ac
id
; L
PS
, l
ip
op
ol
ys
ac
ch
ar
id
e;
 A
β4
2,
 β
-a
m
yl
oi
d 
42
. 
R
ea
ct
iv
e 
as
tr
oc
yt
e 
ch
ar
ac
te
ri
za
ti
on
 
Ti
m
e-
 a
nd
 d
os
e-
de
pe
nd
en
t I
L-
6 
an
d 
IL
-8
 se
cr
et
io
n.
 
A
s s
in
gl
e 
st
im
ul
at
io
n 
TN
F-
α 
in
du
ce
d 
th
e 
m
os
t s
ig
ni
fic
an
t t
ra
ns
cr
ip
to
m
ic
 
ch
an
ce
s. 
A
ll 
st
im
ul
an
ts
 re
su
lte
d 
in
 d
iff
er
in
g 
se
cr
et
io
n 
pr
of
ile
s o
f p
ro
- a
nd
 a
nt
i-
in
fla
m
m
at
or
y 
fa
ct
or
s. 
Co
-s
tim
ul
at
io
n 
w
ith
 T
N
F-
α 
an
d 
IL
-1
β 
led
 to
 a
 fu
rth
er
 
sh
ift
 in
 th
e 
tra
ns
cr
ip
to
m
ic 
pr
of
ile
 a
nd
 h
ad
 a
 sy
ne
rg
ist
ic 
ef
fe
ct
 o
n 
se
cr
et
io
n.
 
In
du
ct
io
n 
of
 N
F-
кB
 si
gn
ali
ng
 b
y 
TN
F-
α 
an
d 
IL
-1
β 
st
im
ul
at
io
n.
 
Im
pa
ire
d 
gl
ut
am
at
e 
up
ta
ke
 a
nd
 la
ct
at
e 
re
le
as
e 
by
 a
ll 
th
re
e 
st
im
ul
an
ts
. 
U
pr
eg
ul
at
io
n 
of
 IL
-8
, C
CL
5,
 an
d 
Lc
n2
 an
d 
se
cr
et
io
n 
of
 IL
-6
. 
IL
-1
β 
in
cr
ea
se
d 
an
d 
TN
F-
α 
de
cr
ea
se
d 
G
FA
P-
po
sit
iv
e 
ce
ll 
po
rti
on
. 
La
rg
er
 p
or
tio
n 
of
 c
el
ls 
se
cr
et
ed
 IL
-6
 a
nd
 IL
-8
 w
ith
 IL
-1
β 
st
im
ul
at
io
n 
th
an
 w
ith
 
TN
F-
α 
st
im
ul
at
io
n.
 
IL
-1
β 
el
ic
ite
d 
tra
ns
cr
ip
to
m
ic
 c
ha
ng
es
 re
lat
ed
 to
 in
fla
m
m
at
io
n.
 
Re
sp
on
se
 to
 in
fla
m
m
at
or
y 
st
im
ul
at
io
n 
w
ith
 d
os
e-
de
pe
nd
en
t I
L-
6 
se
cr
et
io
n.
 
A
β4
2 
in
du
ce
d 
se
cr
et
io
n 
of
 a
 w
id
e 
ra
ng
e 
of
 in
fla
m
m
at
or
y 
m
ol
ec
ul
es
. 
St
im
u
la
ti
on
 
IL
-1
β 
(1
0,
 5
0 
ng
/m
l) 
or
  
TN
F-
α 
(1
0,
 5
0 
ng
/m
l),
  
fo
r 2
4 
h 
or
 4
8 
h 
IL
-1
β 
(1
0 
ng
/m
l) 
an
d/
or
  
TN
F-
α 
(1
0 
ng
/m
l) 
or
  
IL
-6
 (1
00
 n
g/
m
l),
  
fo
r 5
 d
ay
s 
TN
F-
α 
(5
0 
ng
/m
l),
   
IL
-1
β 
(1
0 
ng
/m
l) 
an
d 
 
IF
N
γ 
(1
00
 U
/m
l),
  
fo
r 1
0 
m
in
, 1
6 
h 
or
 4
8 
h 
IL
-1
β 
(1
0 
ng
/m
l) 
or
  
TN
F-
α 
(5
0 
ng
/m
l),
  
fo
r 7
 d
ay
s 
IL
-1
β 
(1
0 
ng
/m
l) 
or
  
TN
F-
α 
(5
0 
ng
/m
l),
 
fo
r 5
 h
 o
r 2
4 
h 
po
ly
(I
:C
) (
50
, 1
00
 n
g/
m
l) 
or
 L
PS
 (1
0,
 5
0 
μg
/m
l) 
or
 
A
β4
2 
(5
, 1
0 
μM
), 
fo
r 2
4 
h 
St
u
d
y 
Lu
nd
in
 e
t 
al.
 2
01
8 
 Pe
rr
io
t e
t 
al.
 2
01
8 
Po
na
th
 e
t 
al.
 2
01
8 
 Ro
yb
on
 
et
 a
l. 
20
13
 
Sa
nt
os
 e
t 
al.
 2
01
7 
Tc
w
 e
t a
l. 
20
18
 
 50 
2.6 Applications of stem cell-derived neuronal networks 
In addition to therapeutic applications in regenerative medicine, hPSC-derived 
neuronal networks are considered potential human models in many translational 
stem cell applications (Yap et al., 2015). hPSC-derived models have allowed 
researchers to show that similar mechanisms in neural development are conserved 
through the evolution of humans and rodents (Suzuki and Vanderhaeghen, 2015). 
Some of the major species-specific differences have also been confirmed with these 
models, such as the prolonged progenitor amplification of hominid species (Eiraku 
and Sasai, 2012; Shi, Yichen et al., 2012). 
hiPSCs can be derived from the somatic cells of patients suffering from genetic 
disorders and differentiated into a specific neuronal cell types to study diseased cell 
phenotypes and mechanisms in vitro (Avior et al., 2016; Sandoe and Eggan, 2013). 
hPSC-derived neurons represent the fetal stage of development and are thus best 
suited for modeling neurodevelopmental disorders (Deneault et al., 2018; Frega et 
al., 2019; Russo et al., 2018). Additionally, many neurodegenerative diseases with 
typically late onset have been studied (García-León et al., 2018; Kouroupi et al., 2017; 
Mehta et al., 2018). Despite great discoveries in neuroscience, the development of 
therapeutic molecules in the treatment of neurological disorders has not been 
successful (Cummings, 2018). Many drugs have been shown to be effective in 
preclinical animal studies but still fail in clinical trials. The reasoning behind this 
could point to interspecies differences or the fact that animal models do not properly 
represent human diseases (Cummings, 2018; Pankevich et al., 2014). hPSC-derived 
neuronal cells can also be utilized for screening new, prospective drugs as an 
alternative to animal models (Elitt et al., 2018; Lee et al., 2012). 
We are constantly exposed to numerous chemicals, and there is enormous 
pressure to perform chemical safety tests, including neurotoxicological assessments 
using animal studies, which are laborious, costly, and ethically problematic (Yap et 
al., 2015). The application of hPSC-derived neuronal models for developmental 
neurotoxicology is advantageous and may reveal interspecies differences regarding 
the effects of different chemicals (Baumann et al., 2016; Ylä-Outinen et al., 2010). 
Understanding the potential and recognizing the limitations of stem cells and 
their derivatives is of high importance, as it will improve the utility of hPSC-derived 
networks as human-specific model systems. 
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3 AIMS OF THE STUDY 
The aim of this thesis was to evaluate the potential of hPSC-derived neuronal cells 
for studying the development and maturation of functional networks. Special focus 
was placed on the role of astrocytes in healthy and detrimental conditions. The 
specific aims of the studies are as follows: 
 
1. To compare the differentiation of hPSC-derived neuronal cultures with 
neurosphere and adherent methods (Studies I and II). 
 
2. To improve the functional maturation of hPSC-derived neurons through 
prolonged differentiation time and selection of defined culture substrate 
(Studies I and II). 
 
3. To compare the activity development of hPSC-derived neurons and rat 
cortical cultures, and distinguish their specific activity feature profiles (Study 
II). 
 
4. To study astrocyte reactivation and astrocyte-neuron interactions using the 
hPSC-based platform (Study III). 
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4 MATERIALS AND METHODS 
4.1 Cell culture 
4.1.1 Ethical issues 
The National Authority for Medicolegal Affairs Finland approved research with 
human embryos (Dnro 1426/32/300/05). The Pirkanmaa Hospital District ethics 
committee provided supportive statements for the derivation, culture and expansion 
of hESC (R05116) and hiPSC lines (R08070) for research purposes. 
A local authority approved the animal license (ELLA-Animal Experiment Board 
of Regional State Administrative Agency for Southern Finland, 
ESAVI/10300/04.10.07/2016). Rat cortical cultures were prepared according to the 
institutional guidelines of the University of Helsinki (license number KEK17-016). 
4.1.2 hPSC culture 
The hESC and hiPSC lines used in this study and their specific information are listed 
in Table 3. The hPSCs were cultured on top of the human feeder cell layer (CRL 
2429, ATTC, Manassas, VA, USA) in Dulbecco’s Modified Eagle’s Medium 
(DMEM) containing 20% KnockOut serum replacement (both from Gibco, 
Thermo Fisher Scientific, Waltham, MA, USA) as described previously (Rajala et al., 
2007). For Studies II and III, before differentiation, the hPSCs were transferred and 
expanded in feeder-free conditions on plates coated with the human recombinant 
laminin isoform LN521 (BioLamina, Sundbyberg, Sweden) and with Essential 8 Flex 
medium according to previously published method (Hongisto et al., 2017). 
The pluripotency of the hPSC lines was confirmed regularly with 
immunocytochemical staining, and the differentiation capacity was confirmed using 
an embryoid body formation assay. All cultures maintained a normal karyotype and 
were mycoplasma free. 
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Table 3.  The hPSC lines used in this thesis. 
hPSC line Type Gender Method Publication Study 
Regea 08/023 hESC male NA (Skottman, 2010) I, II, III 
04311.WTs hiPSC female Sendai virus (Ojala et al., 2016; 
Paavilainen et al., 
2018) 
I 
10212.EURCCs hiPSC female Sendai virus (Kiamehr et al., 2019) II, III 
IMR90-4* hiPSC female retrovirus (Yu, J. et al., 2007) II 
*Commercial cell line from WiCell, Madison, Wisconsin, USA 
4.1.3 Neurosphere differentiation 
Neurosphere differentiation was performed according to Lappalainen et al. (2010) 
to obtain a mixed population of neurons and astrocytes (Study I). Briefly, hPSC 
colonies were mechanically removed and transferred onto ultra-low-attachment 
plates for formation of embryoid bodies and differentiation of neurospheres. The 
neural differentiation medium consisted of 1:1 DMEM/F-12 and Neurobasal, 1× 
B27, 1× N2, 2 mM Glutamax (all from Gibco, Thermo Fisher Scientific), 25 U/ml 
penicillin/streptomycin (Lonza Group Ltd., Bazel, Switzerland) and 20 ng/ml FGF2 
(R&D Systems Inc., Minneapolis, MN, USA). The medium was refreshed every two 
to three days, and neurospheres were mechanically passaged once a week. Cultured 
cells were maintained for 8 or 15 wks, mechanically cut into small aggregates 50-200 
μm in diameter (Ø) containing 5,000-10,000 cells, and plated in adherent culture for 
up to 5 wks. Plastic plates were coated with 10 μg/ml mouse laminin, and MEA 
plates were coated with 0.05% polyethyleneimine (PEI) and 20 μg/ml mouse laminin 
(both from Sigma-Aldrich, St. Louis, MO, USA). After the final plating, FGF2 was 
omitted to promote differentiation, and after one week, 4 ng/ml FGF2 (R&D 
Systems Inc.) and 5 ng/ml BDNF (ProSpec-Tany TechnoGene Ltd., Rehovot, 
Israel) were added to support maturation. 
4.1.4 Adherent neuronal differentiation 
Adherent differentiation of mixed neuron and astrocyte culture was performed 
according to Shi et al. (2012) with some modifications (Studies II and III). First, a 
single-cell suspension of hPSCs was established enzymatically with Tryple Select 
(Gibco, Thermo Fisher Scientific), and cells were plated at a density of 5 × 105 
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cells/cm2 on plates coated with 100 μg/ml poly-L-ornithine (PO, Sigma-Aldrich) 
and 15 μg/ml LN521 (BioLamina) or Matrigel (Corning, New York, USA) in E8 
medium supplemented with 10 μM Rock inhibitor (Y-27632, Sigma-Aldrich). Neural 
maintenance medium (NMM) consisted of 1:1 DMEM/F12 containing Glutamax 
and Neurobasal, 1% B27 containing retinoid acid, 0.5% N2, 0.5 mM Glutamax, 0.5% 
NEEA, 50 μM 2-mercaptoethanol (all from Thermo Fisher Scientific), 2.5 μg/ml 
insulin (Sigma-Aldrich) and 0.1% penicillin/streptomycin (Thermo Fisher 
Scientific). For neural induction on days 1-12, the NMM was supplemented with 
100 nM LDN193189 and 10 μM SB431542 (both from Sigma-Aldrich), and the 
medium was refreshed daily. Single-cell passaging on day 12 was carried out with 
StemPro Accutase (Thermo Fisher Scientific), and cells were plated at a density of 
2.5 × 105 cells/cm2 on plates coated with 100 μg/ml PO and 15 μg/ml LN521 or 
mouse laminin in neural induction medium supplemented with 10 μM Rock 
inhibitor. For NPC proliferation on days 13-25, the NMM was supplemented with 
20 ng/ml FGF2 (Thermo Fisher Scientific). NPCs were passaged on days 17, 21 and 
25 with StemPro Accutase and cryopreserved on day 21 in neural proliferation 
medium containing 10 μM Rock inhibitor and 10% DMSO (Sigma-Aldrich). From 
day 26 onwards, the NMM was supplemented with 20 ng/ml BDNF, 10 ng/ml 
GDNF (both from R&D Systems Inc.), 500 μM cAMP and 200 μM AA (both from 
Sigma-Aldrich) for neuronal maturation. At the final plating on day 32, the cells were 
plated at a 50,000 cells/cm2 density on plastic plates and at a 1 × 106 cells/cm2 
density on MEAs in neural maturation medium supplemented with 10 μM Rock 
inhibitor. Plastic plates were coated with PO and LN521 or with mouse laminin as 
described previously, and MEAs were coated with 0.1% PEI and 50 μg/ml LN521 
or mouse laminin. The medium was refreshed every two to three days. 
4.1.5 Astrocyte culture 
Commercial hiPSC-derived astrocyte progenitor cells were cultured according to the 
manufacturer’s instructions (ax0083, Axol Bioscience Inc., UK; Study III). In short, 
astrocyte progenitors were cultured in Astrocyte Basal Medium containing 
Supplements A-C. Cells were expanded at a 100,000 cells/cm2 density on plastic 
plates coated with Matrigel (Corning). Astrocytes were differentiated for 24 days 
before experiments and passaged with StemPro Accutase once a week; the medium 
was refreshed every other day. The cell density at the final plating prior to 
experiments was 80,000 cells/cm2. 
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For astrocyte reactivation, cells were treated with 10 ng/ml human recombinant 
TNF-α and 10 ng/ml human recombinant IL-1β (both from PeproTech Inc., New 
York, USA) for seven days. Astrocyte-conditioned medium (ACM) was collected 
from control and treated astrocytes to characterize the astrocyte-secreted factors and 
evaluate the neuron-specific effects of ACM on viability and functionality. 
Additionally, a control medium not incubated with astrocytes was prepared. 
4.1.6 Rat cortical cultures 
Cortex tissue was harvested from E17-18 Wistar rat embryos according to a 
published protocol (Sahu et al., 2019) (Study II). Cortical cells were cultured in 
Neurobasal Medium supplemented with 2% B27, 2 mM Glutamax and 1% 
penicillin/streptomycin (all from Thermo Fisher Scientific). Cells were plated at a 
100,000 cells/cm2 density on plastic plates and at a 2.5 × 105 cells/cm2 density on 
MEAs coated with 25 μg/ml poly-D-lysine (PDL, Sigma-Aldrich). The medium was 
changed every two to three days. 
4.2 Molecular biology characterization 
4.2.1 Gene expression analysis 
Reverse transcription-polymerase chain reaction (RT-PCR) was performed in Study 
I, and quantitative real-time PCR (qRT-PCR) was performed in Study III. RNA was 
isolated with a NucleoSpin RNA Kit (Macherey-Nagel, Düren, Germany). cDNA 
was generated using a High Capacity cDNA Reverse Transcription Kit (Thermo 
Fischer Scientific). The RT-PCR and qRT-PCR protocols and primers are described 
in detail in the original publications (Studies I and III). The RT-PCR products were 
separated electrophoretically, and qRT-PCR data were analyzed using the delta Ct 
method (Livak and Schmittgen, 2001). The gene expression levels were normalized 
to that of the GAPDH or GUSB housekeeping gene. Information on the analyzed 
genes is listed in Table 4. 
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Table 4.  Genes analyzed with RT-PCR and qRT-PCR. 
Gene symbol Gene name Method Study 
FOXG1 Forkhead box G1 RT-PCR I 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase RT-PCR, qRT-PCR I, III 
GBX2 Gastrulation brain homeobox 2 RT-PCR I 
GFAP Glial fibrillary acidic protein qRT-PCR III 
GUSB Glucuronidase beta qRT-PCR III 
KCC2 Potassium chloride cotransporter 2 RT-PCR I 
LMX1A LIM homeobox transcription factor 1 alpha RT-PCR I 
NKCC1 Na-K-Cl cotransporter 1 RT-PCR I 
OTX2 Orthodenticle homeobox 2 RT-PCR I 
4.2.2 Immunocytochemical staining 
Immunocytochemical staining was performed on 4% paraformaldehyde-fixed 
samples according to the original publications (Studies I-III). The primary 
antibodies used in the staining protocol are listed in Table 5. Secondary antibodies 
consisted of AlexaFluor-488, AlexaFluor-568, and AlexaFluor-647 dyes diluted 
1:200 or 1:400 (all from Thermo Fisher Scientific). Samples were imaged with an 
Olympus IX51 microscope equipped with an Olympus DP30BW camera (Olympus 
Corporation, Hamburg, Germany), a LSM780 Laser Scanning Confocal Microscope 
equipped with a Quasar spectral GaAsP detector (Carl Zeiss, Jena, Germany) or a 
Nikon A1R+ Laser Scanning Confocal Microscope equipped with an A1-DUG 
GaAsP Multi Detector Unit (Nikon, Tokyo, Japan). Image data were quantified with 
CellProfiler and CellProfiler Analyst software (Carpenter et al., 2006; Jones et al., 
2008). 
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Table 5.  Primary antibodies used for immunocytochemical staining. 
Antibody 
symbol 
Protein name  Species Dilution Supplier Study 
Brn2 Brain-specific 
homeobox/POU domain 
protein 2 
 goat 1:400 GenScript II 
β-tubulin Beta tubulin III   chicken 1:4000 Abcam I, II 
β-tubulin Beta tubulin III   mouse 1:1000 Sigma-Aldrich I-III 
β-tubulin Beta tubulin III  rabbit 1:2000 GenScript I-III 
Ctip2 COUP-TF-interacting 
protein 2 
 rat 1:500 Abcam II 
FoxG1 Forkhead box G1  rabbit 1:500 Abcam II 
GABA γ-aminobutyric acid  rabbit 1:1000 Sigma-Aldrich I, II 
GAD67 Glutamic acid 
decarboxylase 67 
 mouse 1:100 Millipore I, II 
GFAP Glial fibrillary acidic 
protein 
 chicken 1:4000 Abcam I-III 
Ki67 Ki-67 protein  rabbit 1:800 Millipore III 
MAP2 Microtubule-associated 
protein 2 
 chicken 1:4000 Novus 
Biologicals 
I 
MAP2 Microtubule-associated 
protein 2 
 rabbit 1:400 Millipore I-III 
Pax6 Paired box 6  rabbit 1:1000 BioLegend II 
PSD-95 Postsynaptic density 
protein 95 
 mouse 1:50 Abcam II 
PSD-95 Postsynaptic density 
protein 95 
 rabbit 1:100 Cell Signaling 
Technology 
I 
Satb2 Special AT-rich sequence-
binding protein 2 
 mouse 1:200 Abcam II 
S100β S100 calcium binding 
protein B 
 mouse 1:500 Abcam I, II 
Syn Synaptophysin  mouse 1:2000 Sigma-Aldrich I 
Syn Synaptophysin  rabbit 1:2000 Abcam II 
Tbr1 T-box brain protein 1  rabbit 1:1500 Abcam II 
vGlut1 Vesicular glutamate 
transporter 1 
 guinea 
pig 
1:1000 Millipore I 
vGlut1 Vesicular glutamate 
transporter 1 
 rabbit 1:2000 Synaptic 
Systems 
II 
Vim Vimentin  mouse 1:500 Dako III 
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4.2.3 Western blot 
Western blot analysis was carried out to measure the total levels of glial fibrillary 
acidic protein (GFAP) in astrocytes (Study III). Cultures were washed with 
phosphate-buffered saline (PBS) and lysed with Laemmli sample buffer (Bio-Rad 
Laboratories Inc., Hercules, CA, USA). Proteins were separated on 10% Mini-
Protean TGX Precast Gels and transferred to PVDF membranes using a Trans-Blot 
Turbo Transfer System (both from Bio-Rad Laboratories Inc.). The membranes 
were blocked with 5% milk in 0.05% Tween 20/TBS buffer for 1 h. The primary 
antibodies anti-GFAP (chicken, 1:30000, Abcam, Cambridge, UK) and anti-β-actin 
(mouse, 1:2000, Santa Cruz Biotechnology, Dallas, Texas) were incubated for 1 h at 
RT. The secondary antibodies used were goat anti-mouse IgG-HRP (goat, 1:2000, 
Santa Cruz Biotechnology) and goat anti-chicken IgY-HRP (goat, 1:30,000, Thermo 
Fisher Scientific). Proteins were detected using ECL Prime Western Blotting System 
reagent (Sigma-Aldrich) and imaged with a ChemiDoc XRS+ System (Bio-Rad 
Laboratories Inc.). 
4.2.4 Glutamate uptake 
Glutamate uptake by astrocytes was analyzed with a Glutamate Assay Kit (Abcam; 
Study III). First, cells were washed with PBS supplemented with 1% bovine serum 
albumin (BSA) for 30 min at 37 °C. Then, the cells were incubated with 100 μM 
glutamate in PBS for 1 h at 37 °C. After the PBS wash and lysis with the assay buffer, 
the cell lysate concentration was analyzed according to the manufacturer`s 
instructions. 
4.2.5 ELISA and cytokine array 
The secretion profile of astrocytes was evaluated in Study III. The secretion of IL-6 
into the culture medium was analyzed with a Human IL-6 Uncoated ELISA Kit 
(Thermo Fisher Scientific). Absorbance was measured at 450 nm (Wallac Victor 
1420).  
A wider secretion profile was measured with a Proteome Profiler Array (Human 
XL Cytokine Kit, R&D Systems Inc.). The resulting membranes were imaged with 
a ChemiDoc imaging system (Bio-Rad Laboratories). A total of 105 different 
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cytokines, chemokines and other inflammatory molecules were analyzed. A full list 
of analytes can be found in the original publication (Study III). 
4.2.6 Viability assays 
The viability, cytotoxicity and apoptosis of neurons were evaluated after 48 h of 
ACM treatment with the Apo-Tox-Glo Triplex assay according to the 
manufacturer’s protocol (Promega, Madison, WI, USA). Additionally, the viability 
of neurons during co-culture with astrocytes in a microfluidic device was assessed 
using the Live/Dead Viability/Cytotoxicity Kit (Thermo Fisher Scientific) (Study 
III). Live staining with 0.1 μM calcein-AM was applied for 30 min, and samples were 
imaged immediately. The area covered by live-stained neuronal axons was quantified 
with CellProfiler software. 
4.3 Functional characterization 
4.3.1 Microelectrode array measurements 
MEA measurements of neurosphere-differentiated cells were performed with an 
MEA60 amplifier (Multi Channels System, MCS, Reutlingen, Germany; Study I), and 
those of adherent differentiated cells were performed with the Axion Maestro system 
(Axion Biosystems, Atlanta, GA, USA; Studies II and III). 
With the MEA60 system, 60-6well MEA200/30iR-Ti-w/o arrays (MCS) with 9 
electrodes per well were used. Culture wells were separated with a 6-well silicone 
chamber, SpikeBooster (Kreutzer et al., 2012). Measurements were performed at 
37 °C twice a week for 10 min. Recordings were obtained using MC_Rack software 
at a 50 kHz sampling frequency. 
For the Axion Maestro system measurements, cells were plated on CytoView 
MEA 48 or CytoView MEA 12 plates with 16 and 64 electrodes per well, respectively 
(both from Axion Biosystems). Measurements were obtained with AxIS software at 
a 12.5 kHz sampling frequency. Recordings were performed at 37 °C, and a 5% CO2 
atmosphere control was used for recordings over 10 min. Spontaneous activity was 
measured twice a week for 10 min. Pharmacological responses (Study II) were 
recorded for 30 min. The pharmacological reagents included γ-aminobutyric acid 
(GABA, 10 μM, Sigma-Aldrich) and the GABAA receptor antagonist gabazine 
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(30 μM, Sigma-Aldrich). In the ACM experiments (Study III), 50% of the medium 
was replaced with ACM, and recordings were performed for 10 min immediately, 
after 1 h, 4 h and 24 h exposure. 
4.3.2 Microelectrode array data analysis 
The spike detection from MCS data (Study I) was performed with MC_Rack, and 
spikes were detected from 200 Hz high-pass filtered data when their amplitude 
crossed the threshold of 5 × the standard deviation of noise. The active electrode 
criterion was experimentally set to 2 spikes/min. Burst analysis was performed with 
the cumulative moving average (CMA) method (Kapucu et al., 2012) embedded in a 
custom MATLAB script (Mathworks, Natick, MA, USA). Burst analysis was 
performed for electrodes with over 10 spikes/min, and additional criteria included a 
minimum of three spikes per burst and a maximum of 2000 ms interspike interval 
(ISI) in the burst. 
For Axion data analysis (Studies II and III), data were filtered with a 200 Hz 
lower passband frequency and a 3000 Hz upper passband frequency. Spike detection 
was performed with a threshold value of 4.5 × the estimate of the noise standard 
deviation according to a previous publication (Quiroga et al., 2004), followed by 
processing with a stationary wavelet transform-based Teager energy operator 
(SWTTEO) algorithm (Mayer et al., 2018) embedded in a custom MATLAB script. 
The criterion for an active electrode was 10 spikes/min. Burst analysis was 
performed with the logISI algorithm (Pasquale et al., 2010) embedded in the R 
package meaRtools (Gelfman et al., 2018). Burst analysis was performed only for 
burst-detecting electrodes. Additionally, a minimum of five spikes constituted a 
burst, and short bursts were merged when the computed ISI threshold was less than 
100 ms. A cutoff of 100 ms was applied as the minimum time required between 
bursts. Connectivity analysis was performed according to the correlated spectral 
entropy (CorSE) method reported previously (Kapucu et al., 2016). Connectivity 
maps were plotted for electrode pairs with a CorSE value >0.7. Principal component 
analysis (PCA) was performed in MATLAB according to a previous publication (Ylä-
Outinen et al., 2019). In short, a total of seven MEA activity features were included: 
spike rate, spike time tiling coefficient (STTC, using a default time bin of 50 msec), 
burst rate, burst duration, spike frequency in burst, spikes in burst and percentage of 
spikes in bursts. Values were normalized using the standard score method and 
plotted against three major principal components. 
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4.3.3 Calcium imaging and data analysis 
Calcium imaging was performed in Study I. For calcium imaging experiments, cells 
were loaded with 4 μM Fluo-4 AM (Thermo Fisher Scientific) in neural 
differentiation medium for 30 min in an incubator. Before imaging, the cells were 
washed with culture medium. During acquisition, cultures were imaged every 0.5 sec 
at 36±0.5 °C and under perfusion with a physiological solution containing 140 mM 
NaCl, 10 mM HEPES, 10 mM D-glucose, 3.5 mM KCl, 1.25 mM NaH2PO4, 2 mM 
CaCl2 and 1 mM MgCl2 (all from Sigma-Aldrich) dissolved in dH2O. Imaging was 
performed with an Olympus IX61 inverted microscope, an Andor iXon 885 
EMCCD camera (Andor Technology, Belfast, Northern Ireland) and a Polychrom 
V monochromator (TILL Photonics, Munich, Germany). Images were acquired with 
TILL Photonics Live Acquisition software and analyzed with the SimplePCI 
software package (Hamamatsu Corporation, Sewickley, PA, USA). Neurons were 
identified based on a fast response to a high K+ concentration (50 mM). The 
percentage of neurons responding to GABA (100 μM, Sigma) application with a 
calcium increase was quantified. 
4.4 Microfluidic device 
To create controlled neuron/astrocyte co-cultures, a microfluidic device developed 
in-house was used (patent: WO2015092141A1). The three cell compartments (two 
neuronal compartments and one astrocyte compartment) are connected to an axonal 
compartment via microtunnels. The small microtunnels restrict the cell somas to the 
cell compartments while allowing interactions between cell processes in the axonal 
compartment. The detailed design, fabrication and assembly of the microfluidic 
device is described in the original publication (Study III). 
The hPSC-derived neurons and astrocytes were plated in the neuronal and 
astrocyte compartments, respectively. Neurons were plated at a density of 1.5 × 105 
cells/cm2, and the astrocyte density was 50,000 cells/compartment. The same 
coating, comprising 250 μg/ml PO (Sigma-Aldrich) and 20 μg/ml LN521 
(BioLamina), was used for both neurons and astrocytes. After three days, the 
astrocyte compartment was treated with 10 ng/ml human recombinant TNF-α and 
10 ng/ml human recombinant IL-1β (both from PeproTech Inc.) for 72 h. 
Experimental groups included 1) a group with neurons only (Neu), 2) a group with 
neurons only and cytokine treatment via the astrocyte compartment (Neu+IL-
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1β/TNF-α), 3) a group with neurons and astrocytes (Neu+Ctrl astro), and 4) a group 
with neurons and astrocytes and cytokine treatment via the astrocyte compartment 
(Neu+Reactive astro). Cultures were stained for neuronal and astrocyte markers, and 
viability staining was performed to visualize the effect of treatment on the axonal 
density in the axonal compartment, as described previously. 
4.5 Statistical analysis 
For data with a Gaussian distribution, a parametric independent-sample T-test was 
used. When the data followed a non-Gaussian distribution, a nonparametric Kruskal-
Wallis test followed by the Mann-Whitney U test was performed. When differences 
between ACM treatment groups were analyzed from the MEA data, delta values 
were calculated by subtracting the baseline value from the treatment value. 
Bonferroni correction was used for multiple comparisons. Correlations were 
assessed with Spearman’s rho. Statistical tests were performed with SPSS Statistics 
software (IBM Corp., Armonk, NY, USA). A p-value of <0.05 was considered 
statistically significant. University statistician Heini Huhtala, MSc, was consulted 
regarding the statistical tests. 
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5 RESULTS 
5.1 Neuronal differentiation with suspension neurosphere and 
adherent methods 
The neuronal cells used in this study were differentiated with either a suspension 
neurosphere method (Study I) or an adherent method with dual SMAD inhibition 
(Studies II and III). In the first part of the results section, neuronal cells produced 
with the two methods are characterized. Both of the differentiation methods are 
presented in detail in the schematic illustrations, which indicate the timelines, culture 
matrices, growth factors and small molecules used for chemical induction (Figure 
5A-B). In short, via the neurosphere method, hPSCs were differentiated in the 
presence of FGF2 for the standard 8 weeks  or, alternatively, for a prolonged period 
of 15 weeks to increase the proportion of glial cells and improve maturation. Cells 
were plated on mouse laminin substrate in adherent culture for up to 5 weeks for 
final maturation, which was further promoted by FGF2 and BDNF treatments. 
The adherent differentiation process can be divided into three stages: 12-day 
neural induction with dual SMAD inhibition, NPC proliferation with FGF2, and 
final maturation in the presence of the neurotrophic factors BDNF, GDNF, cAMP 
and AA. The neural induction was carried out on either a Matrigel matrix or on a 
more defined LN521 culture substrate. Similarly, subsequent differentiation was 
performed on either mouse laminin or LN521 substrates. The produced NPCs could 
be stored in cryobanks and further differentiated into neurons and astrocytes for use 
in experiments. To evaluate the neurosphere differentiation method, the hESC line 
08/023 and the hiPSC line 04311.WTs were used. The adherent neuronal 
differentiation method was established with the same hESC line 08/023 and two 
hiPSC lines, 10212.EURCCs and IMR90-4. Data from the different hPSC lines are 
mostly pooled in the results section but are shown separately in the original 
publications. 
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Figure 5.  Neuronal differentiation with the neurosphere and adherent methods. Schematic 
illustrations of (A) the neurosphere and (B) adherent methods depicting the time frame, 
stages of differentiation, culture substrate and factors involved. (C) RT-PCR analysis of the 
expression of forebrain (FOXG1, OTX2), midbrain (LMX1A) and hindbrain (GBX2) 
transcripts in two of the neurosphere-differentiated hPSC lines at the 8+1 wk time point 
(hESC line 08/023 and hiPSC line 04311.WTs). GAPDH was used as a housekeeping gene. 
Immunocytochemical staining of the neuroectodermal markers (D) Pax6 and (E) FoxG1 
after 12 days of neural induction with the adherent method. The scale bar represents 100 
μm. (F) The percentage of Pax6-positive cells in all three hPSC lines (hESC line 08/023 
and hiPSC lines 10212.EURCCs, IMR90-4) was quantified on day 12 of adherent 
differentiation. Abbreviations: EB, embryoid body; NPC, neural progenitor cell; mLN, mouse 
laminin. 
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5.1.1 Specification of neural progenitor cells and generation of neurons 
Without additional regional specifications, the neural differentiation of hPSCs is 
known to follow the “default” pathway, where the rostral forebrain phenotype is the 
first to emerge (Suzuki and Vanderhaeghen, 2015). Here, successful neural induction 
and brain region identities in neurosphere-differentiated cultures were evaluated 
from determining the expression of transcripts in the forebrain (FOXG1, OTX2), 
midbrain (EN1) and hindbrain (GBX2) (Study I). Analysis revealed that the cultures 
represent a mixed CNS culture with strong expression levels of the forebrain markers 
FOXG1 and OTX2 (Figure 5C). Additionally, the efficiency of neural induction with 
the adherent differentiation method was assessed (Study II). Staining and 
quantification of the neuroectodermal marker Pax6 revealed that over 90% of the 
cells were Pax6-positive (Figure 5D and F). The produced NPCs were further 
characterized by staining for FoxG1, an important transcription factor for 
specification of the rostral cortex (Figure 5E). 
To evaluate the differentiation capacity, the amount of MAP2- and/or β-tubulin-
positive neurons was quantified after differentiation with both the neurosphere 
method (Study I) and the adherent method (Study II). First, the neurosphere method 
produced neurons efficiently, as the portion of neurons was 74% after 8 weeks of 
neurosphere differentiation followed by 4 weeks of adherent maturation (8+4 wks, 
Figure 6A). A significant decrease in the proportion of neurons to 66% was observed 
after prolonged neurosphere differentiation for 15+4 wks (8+4 wks vs. 15+4 wks, 
p=0.008; Figure 6A). In adherent neuronal differentiation, the neuron percentage 
was 72% after 7 wks (Figure 6B). Similarly, it decreased later, as 49% of the cells 
were neuronal at the 11 wks time point (7 wks vs. 11 wks, p<0.001; Figure 6B). 
Analysis of the neuronal subtypes confirmed that both neuronal differentiation 
methods (Studies I-II) primarily produced glutamatergic excitatory neurons 
expressing vGlut1 (Figure 6A-B). Cultures also contained GABAergic inhibitory 
neurons, as determined by GABA and GAD67 staining (Figure 6A-B). Furthermore, 
synaptic connections were formed and identified with presynaptic synaptophysin 
and postsynaptic PSD-95 staining (neurosphere method, after 8+4 wks; adherent 
method, after 11 wks; Figure 6A-B). 
Different cortical layer markers from the adherent-differentiated neurons were 
stained (Study II). Expression of the early-born deep cortical layer-specific markers 
Ctip2 and Tbr1 was detected after 7 wks of differentiation (Figure 6C-D). The 
generation  of  late-born  upper  layer-specific  neurons  was  initiated after 7 wks as  
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Figure 6.  Differentiation of neuronal cell types. The neuronal population was characterized following 
(A) neurosphere differentiation and (B) adherent differentiation. The number of neurons was 
quantified by MAP2 and/or β-tubulin staining. Glutamatergic neurons were stained with 
vGlut1, and GABAergic neurons were stained with GABA and GAD67. The formation of 
synapses was assessed with synaptophysin (Syn) and PSD-95 staining. (C) Generation of 
cortical layer-specific neurons from adherent-differentiated cultures was evaluated with 
staining of the early-born deep layer-specific markers Ctip2 and Tbr1 and the late-born 
upper layer-specific markers Brn2 and Satb2. Neurons were labeled with β-tubulin. The 
scale bar is 50 μm in all images. (D) The proportions of different layer-specific neurons 
among the whole cell population were quantified after 7 and 11 weeks. For quantification, 
data are pooled from all hPSC lines. Data are presented as Tukey box plots showing median 
and interquartile range with whiskers extending out to min and max values within 1.5 times 
the interquartile range. Statistical analyses with the Mann-Whitney U test show differences 
between time points (* p<0.05, ** p<0.01, *** p<0.001). 
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shown by Brn2 staining. However, it continued during the follow-up period because 
only a few Satb2-positive cells were present after 11 wks (Figure 6D). 
Together, these results show that both differentiation methods produced 
neuronal cells efficiently, and cultures contained mixed populations of glutamatergic 
and GABAergic neurons. The adherent method resulted in the typical sequential 
generation of cortical layer-specific neurons. Overall, the neurogenesis period 
starting from pluripotent stage was shorter with the adherent method than with the 
neurosphere method. 
5.1.2 Generation of endogenous astrocytes 
Many neuronal differentiation protocols are known to produce a certain amount of 
endogenous astrocytes from the same neural progenitors that give rise to neurons. 
Here, the capability of the neurosphere (Study I) and adherent (Study II) 
differentiation protocols to produce astrocytes was evaluated with S100β and GFAP 
staining. Quantification of the percentage of GFAP-positive cells revealed that the 
neurosphere differentiation method produced only a modest 3% of astrocytes after 
8+4 wks (Figure 7A). After 15+4 wks of differentiation, the astrocyte proportion 
was significantly increased to 15% (8+4 wks vs. 15+4 wks, p<0.001; Figure 7A). The 
adherent differentiation protocol also produced a considerable portion of astrocytes. 
The astrocyte percentage was quantified using the results from both S100β and 
GFAP staining. The percentage of S100β-positive astrocytes increased from 5% at 
7 wks to 38% at 11 wks (7 wks vs. 11 wks, p<0.001; Figure 7B). The increase in the 
portion of GFAP-positive astrocytes was also significant, from 0.5% at 7 wks to 20% 
at 11 wks (7 wks vs. 11 wks, p<0.001; Figure 7B). These results indicate that both 
differentiation methods produce endogenous astrocytes after an extended period of 
differentiation, but this time frame starting from pluripotent stage is shorter with the 
adherent method. 
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Figure 7.  Generation of endogenous astrocytes. The numbers of astrocytes in the (A) neurosphere-
differentiated and (B) adherent-differentiated cultures was evaluated by staining for GFAP 
and S100β. The scale bar represents 100 μm. Quantifications are of pooled data from 
different hPSC lines and are shown as Tukey box plots. Significant differences between 
time points were determined by the Mann-Whitney U test (* p<0.05, ** p<0.01, *** p<0.001). 
5.2 Functional maturation of the hPSC-derived neuronal 
networks 
Functional activity is initially observed as uncorrelated single spikes and tonic spike 
trains, but with maturation, increased bursting and connectivity is observed, as the 
activity is orchestrated into synchronous network bursts (Heikkilä et al., 2009; 
Wagenaar et al., 2006). Neuronal cultures differentiated using both the neurosphere 
and adherent methods generated electrophysiologically active networks (Studies I 
and II). However, MEA measurements demonstrate that the activity levels were 
substantially different between the networks produced using the two differentiation 
methods (Figure 8A-B). Raster plots presenting the spike intensities of single 
networks show that the neurosphere-differentiated neurons presented mainly 
uncorrelated spiking and bursting activity (Figure 8A), while the adherent-
differentiated neurons achieved synchronous network level bursting (Figure 8B). 
Further maturation of the activity was achieved via the neurosphere method with a 
prolonged differentiation time (Study I) and via the adherent method with 
optimization of the culture substrate (Study II), which are described in more detail. 
Additionally, maturation of the GABAergic system was observed with both methods 
(Studies I and II). 
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Figure 8.  Functional activity of neurons as measured with microelectrode arrays. Spike intensity raster 
plots presenting the activity of (A) neurosphere- and (B) adherent-differentiated neurons as 
determined by microelectrode arrays (MEAs). Both images show a 10-minute measurement 
of a single MEA well with 9 or 16 electrodes after approximately 8 weeks of differentiation 
from the pluripotent stage. The intensity scale bar on the right represents the spike 
frequency (Hz). 
5.2.1 Prolonged neurosphere differentiation results in an increased burst 
rate and burst compaction 
Neural cells were differentiated with the neurosphere method for either the standard 
8 wks or for a prolonged period of 15 wks (Study I). After this, the neurospheres 
were dissociated and plated on MEA plates for functional measurements over 5 wks. 
The studied hPSC lines (hESC line 08/023 and hiPSC line 04311.WTs) developed 
spiking activity after both differentiation periods (8 wks and 15 wks), but the 
detection of mature bursting activity was the specific focus of the study. A significant 
increase in the number of bursts was observed after the prolonged differentiation 
time, suggesting functional maturation (Figure 9A-B). 
Characterization of the burst features, spike frequencies in bursts and burst 
durations revealed differences between the two studied hPSC lines. When data from 
the five weeks of measurements were combined and divided into groups by hPSC 
line (08/023 and 04311.WTs) and differentiation time (8 wks and 15 wks), all groups 
showed a strong correlation between the two features, as the spike frequency in 
bursts increased with a decreasing burst duration (Spearman’s rho, Figure 9C-D). 
However, unlike the hiPSC line 04311.WTs, the hESC line 08/023 showed an 
increased spike frequency in bursts and a shortened burst duration after the 
prolonged 15 wk differentiation period. This burst compaction was more distinct in 
the 08/023 line than in the 04311.WTs line, suggesting efficient functional 
maturation (Figure 9C). Taken together, these results suggest that prolonged 
differentiation can improve functional maturation, as determined by the observation 
of increased burst rates and burst compaction. 
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Figure 9.  Bursting activity in neurosphere-differentiated networks on MEA. The number of bursts per 
minute was increased in (A) 08/023 hESC-derived and (B) 04311.WTs hiPSC-derived 
neural networks as a result of prolonged differentiation for 15 wks. Statistical significance at 
each time point on MEA was assessed with the Mann-Whitney U test, and significant 
differences are denoted as * p<0.05, ** p<0.01, and *** p<0.001. Correlations between the 
spike frequency in burst and burst duration were determined from data obtained from five 
weeks of measurement from the (C) 08/023 and (D) 04311.WTs lines. The median result 
for each feature and time point are marked with a solid line. The Mann-Whitney U test was 
used for statistical assessment, and correlations were determined using Spearman’s rho 
(ρ). Significance differences are marked in the images. 
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5.2.2 The laminin-521 substrate improves the functional activity of 
adherent-differentiated neuronal networks 
The effect of α5 laminin substrates on the promotion of functional activity on the 
MEA has previously been shown for neurosphere-differentiated cultures (Hyysalo 
et al., 2017). Here, the human recombinant laminin isoform LN521 was optimized 
as a culture substrate for adherent neural differentiation with the aim of improving 
functional development (Study II). As a comparison, cells were also cultured with 
the commonly used mouse laminin substrate. Both substrates supported the 
generation of MAP2- and β-tubulin-positive neurons and S100β-positive astrocytes 
(Figure 10A). However, when activity was measured on MEA, there was a substantial 
increase in the percentage of active electrodes observed in the networks cultured on 
LN521 compared to those cultured on mouse laminin (Figure 10B). Additionally, 
the spike and burst rates of neurons cultured on LN521 were higher than those of 
neurons cultured on mouse laminin (Figure 10 C-D). This result demonstrated the 
superiority of the LN521 substrate for the functional development of neurons, and 
LN521 was thereafter used as the sole substrate for adherent differentiation. 
 
 
Figure 10.  Functional activity of neurons differentiated on mouse laminin and human recombinant 
laminin-521 substrates. (A) Immunocytochemical staining showing the differentiation of 
neurons (MAP2 and β-tubulin) and astrocyte progenitors (S100β) on mouse laminin (mLN) 
and human recombinant laminin-521 (LN521). The scale bar is 100 μm. MEA 
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measurements of cultures differentiated on either mLN and LN521 demonstrate differences 
in the development of the (B) percentage of active electrodes, (C) spike rate (Hz) and (D) 
number of bursts per minute. Data are presented as Tukey box plots. Significant differences 
between substrates at each time point were determined by the Mann-Whitney U test (* 
p<0.05, ** p<0.01, *** p<0.001). 
5.2.3 GABAergic maturation and inhibitory input in hPSC-derived networks 
The presence of GABAergic cells, determined by immunocytochemical staining, in 
both neurosphere- and adherent-differentiated cultures raised the question of 
whether maturation of the GABAergic system and inhibitory networks modulating 
the activity were observable (Studies I and II). 
Maturation of the GABAergic system was assessed via calcium imaging of the 
neurosphere-differentiated networks (Study I, Figure 11A). After the standard 8 wks 
of differentiation, the neuronal responses to GABA application were largely 
excitatory (Figure 11B), but occasionally, GABA was also found to inhibit 
spontaneous activity (Figure 11C). With a prolonged 15 wk differentiation time 
period and adherent maturation, the excitatory effect of GABA was decreased in 
both of the studied hPSC lines (Figure 11D-E). Gene expression analysis 
simultaneously revealed  change in the chloride transporter subtype from NKCC1 
to KCC2 (Figure 11F), which has been demonstrated to be important for the 
excitatory to inhibitory switch occurring during the development of the GABAergic 
system (Ben-Ari et al., 2007). 
The inhibitory GABAergic input associated with network activity was inspected 
in the adherent-differentiated cultures (Study II). MEA measurements were 
performed until synchronic network activity was well established after 4 wks on the 
MEA. Then, pharmacological modulation of the network with GABA and the 
GABAAR antagonist gabazine was tested. Application of GABA resulted in a typical 
silencing of the network activity (Figure 11G-H). Few irregular spikes were detected, 
but clear bursts of activity were absent (Figure 11 G). Gabazine had the opposite 
effect, as it significantly increased the overall spike rate (Figure 11 G-H). In summary, 
the functional results obtained from both calcium imaging and the MEA 
experiments show that GABAergic maturation occurs in hPSC-derived networks 
and that inhibitory networks modulating synchronic burst activity are present. 
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Figure 11.  Roles of GABAergic maturation and input in the functionality of hPSC-derived neuronal 
networks. (A) To perform the calcium imaging experiments, neurosphere-differentiated cells 
were loaded with the fluorescent calcium indicator Fluo-4 AM. The pseudocolor image 
shows the high calcium concentration in red. The scale bar is 100 μm. Typical calcium 
traces of (B) the excitatory effect of GABA and the (C) inhibition of spontaneous activity after 
GABA application. (D, E) Percentages of neuronal cells responding to GABA application 
with excitation in the studied hPSC. (F) Expression of the chloride transporters NKCC1 and 
KCC2 in the hPSC lines differentiated by the neurosphere method. The analyzed hPSC 
lines are hESC line 08/023 and hiPSC line 04311.WTs. (G) Example images of adherent-
differentiated neuronal MEA signals under control conditions and pharmacological treatment 
with GABA and gabazine. The raw MEA signal from one electrode over one minute is shown 
above, and the spike intensity raster blots from the entire MEA well over a 5-minute 
recording is shown below. (H) Spike rate changes after pharmacological treatments. 
Quantifications are presented as Tukey box plots, and statistical analyses were performed 
with the Kruskal Wallis test followed by the Mann-Whitney U test (* p<0.05, ** p<0.01, *** 
p<0.001). 
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5.3 Functional comparison of hPSC-derived neuronal networks 
and rodent in vitro counterparts 
5.3.1 Temporal development of network activity 
Rat embryonic cortical cultures have been established as the gold standard in the 
MEA field (Charlesworth et al., 2015; Wagenaar et al., 2006). Therefore, the 
development of spontaneous activity of the adherent-differentiated human cortical 
networks was compared with that of their rodent counterparts (Study II). hPSC-
neurons were pre-differentiated for 32 days to begin active neurogenesis and rat 
neurons were isolated from day 17-18 embryos following plating on MEA. The time 
frames and stages of activity development were similar between hPSC-derived and 
rat networks. Representative images of typical firing patterns show that 
asynchronous spike activity was detected during the first two weeks of measurement 
on MEA (Figure 12A-B). Occasional spiking was followed by tonic spike trains 
before the organization of activity into network-level synchronous bursts (Figure 
12A-B). The highest activity peak, determined by median spike and burst rates, was 
detected between 2-4 wks on MEA in both hPSC-derived and rat networks (Figure 
12C-D). The rat networks presented higher spike and burst rates than the hPSC-
derived networks after the initiation of network-level activity at approximately 3-4 
wks on MEA. While the rat networks were mostly silenced after five weeks in vitro, 
the hPSC-derived networks were maintained for several weeks (Figure 12C-D). 
The functional connectivity between spatially distant areas of the network was 
determined by analyzing the entropy between a pair of electrodes (Kapucu et al., 
2016). Functional connectivity maps from as set of MEA recordings revealed a 
gradual increase in connectivity over time (Figure 12E). The formation of functional 
connections was observed in hPSC networks after 3 wks on MEA and in rat 
networks after 2 wks on MEA. After 4 wks, the networks expanded over the 64-
channel array and subsequently declined as the 5 wk time point approached (Figure 
12E). Further network level analysis was performed by calculating the synchrony 
measure spike time tiling coefficient (STTC) (Cutts and Eglen, 2014). According to 
quantification, the rat networks presented earlier initiation and exhibited higher 
levels of synchrony than the hPSC-derived networks (Figure 12F). Overall, in both 
hPSC-derived and rat networks, the activity developed through similar activity states 
and on the same time scale, but the level of activity was more pronounced in the rat 
networks. 
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Figure 12.  Temporal development of spontaneous activity in hPSC-derived and rat cortical networks. 
Typical asynchronous and synchronous firing patterns of (A) hPSC-derived and (B) rat 
networks recorded from three electrodes at the 2 and 4 wk time points. (C) Development of 
the spike rate and (D) bursting activity over 11 wks on MEA. Data are pooled from three 
experiments with two different hPSC lines. (E) Functional connectivity maps of 10-minute 
recordings showing the development of hPSC-derived and rat networks over time. A 
connectivity strength (CorSE) value of 0.7 was used for plotting. (F) Quantification of 
network synchrony using the spike time tiling coefficient (STTC). Quantitative data are 
shown as the median and interquartile range. Significant differences between hPSC-derived 
and rat networks at each time point were determined by the Mann-Whitney U test (* p<0.05, 
** p<0.01, *** p<0.001). 
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5.3.2 Principal component analysis reveals distinct activity features of 
hPSC-derived neurons 
Principal component analysis (PCA) was utilized to efficiently summarize the 
functional profiles of the hPSC-derived and rat networks (Study II). Analysis was 
performed on data from three cell batches and on recordings from three subsequent 
days at the peak of activity. We assessed seven different activity features, including 
the spike rate, STTC, burst rate, burst duration, spike frequency in bursts, number 
of spikes in bursts and percentage of spikes in bursts. The 7-dimensional feature 
vector was plotted in 3-dimensional space to visually assess the differences between 
hPSC-derived and rat networks. A clear segregation of the two network types was 
observed, with very little overlap between some of the analyzed wells (Figure 13). 
Most of the differences were explained by the first principal component (PC), which 
accounted for over 50% of the variation. Overall, the first three principal 
components described 94% of the variation between hPSC-derived and rat 
networks, confirming the distinct activity feature profile of hPSC-derived neurons. 
 
Figure 13.  Principal component analysis of hPSC-derived and rat network activity features. Principal 
component analysis (PCA) was utilized to separate hPSC- and rat-derived networks based 
on variation in MEA activity consisting of seven spike, burst and network activity features. 
Data from several cell batches and three subsequent time points showing the highest spike 
rates were analyzed. The data points are plotted in 3-dimensional space, where each dot 
represents one MEA well. The three principal components account for the amount of 
variation of the data shown in parenthesis. 
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5.4 Modeling astrocyte-neuron interactions in vitro 
Astrocytes play an important role in both brain development and pathology 
(Sofroniew and Vinters, 2010). To mimic the pathological state, hiPSC-derived 
astrocytes were stimulated with inflammatory cytokines, and their characteristics and 
neuron-specific effects were investigated (Study III). 
5.4.1 Reactivation of hiPSC-derived astrocytes 
CNS injury and disease elicit inflammatory conditions, as numerous 
proinflammatory factors are released at the affected region, changing the local 
homeostasis and cell behavior (Colombo and Farina, 2016). A 7-day cytokine 
treatment regimen with IL-1β and TNF-α was followed to stimulate astrocyte 
activation in vitro (Study III). The morphology of astrocytes was monitored, and a 
typical change from a filamentous to a polygonal shape was observed within 7 days 
of cytokine administration (Figure 14A-B). Inflammatory conditions also induced 
modest astrocyte proliferation, as determined by Ki67 staining (Figure 14C). 
Additionally, modifications of the astrocyte-specific structural intermediate filament 
network were observed, as GFAP downregulation was observed at both the mRNA 
and protein levels (Figure 14D-E). Astrocytes have an important role in the 
homeostatic control of extracellular space, and functional impairment was observed 
in the glutamate uptake mechanisms following cytokine treatment (Figure 14F). The 
response to cytokine exposure was also time-dependent, as the secretion of the 
inflammatory cytokine IL-6 was gradually increased over time (Figure 14G). In 
addition, a wide profile of secretion of other inflammatory factors from the culture 
medium was detected (Figure 14H). These included several chemokines, cytokines, 
and other inflammatory proteins, such as chitinase-3-like 1 (CHI3L1), osteopontin 
(OPN), pentraxin-3 (PTX3), serpine1 and vascular cell adhesion molecule-1 
(vCAM). Thus, hPSC-derived astrocytes readily respond to the inflammatory 
environment and exhibit multiple reactive astrocyte characteristics. 
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Figure 14.  Stimulation of the reactive astrocyte phenotype. (A) Morphological changes in response to 
cytokine treatment were evident with vimentin (Vim) and GFAP staining (white arrow). (B) 
Astrocyte morphology was quantified from vimentin-stained samples and presented as a 
histogram of circularity. The bin size is 0.05, and a value of 1.0 represents a perfectly circular 
object. (C) Increased proliferation following cytokine treatment was determined with Ki67 
staining. The DAPI nuclear stain is shown in blue, and the scale bar is 50 μm in all images. 
(D) Gene expression analysis showing downregulation of GFAP after cytokine treatment. 
(E) Lower GFAP protein levels in the stimulation group than in the control were also 
observed by Western Blot. β-actin was used as a loading control. (F) Glutamate uptake was 
impaired in treated astrocytes. (G) ELISA was carried out to detect IL-6 levels in the culture 
medium over time. (H) A proteome array was used to screen wider secretion profiles of 
cytokine-treated astrocytes. Factors with increased secretion are marked with a black 
rectangle and listed in the table. Red boxes indicate positive controls. 
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5.4.2 Neuron-specific effects of astrocytes 
The effects of astrocytes on neuronal cells were studied by assessing secreted factors 
in the astrocyte-conditioned medium (ACM) and in controlled co-cultures utilizing 
a microfluidic device (Study III). First, ACM experiments were performed to 
investigate whether the astrocyte secretion profile was directly neurotoxic. 
Astrocytes were treated over 7 days as previously described, and the culture medium 
was refreshed; ACM was collected from control and treated astrocytes 48 h later. A 
viability assay of neuronal cultures after 48 h of ACM exposure verified that the 
secreted factors did not compromise the morphology or survival of neurons, as no 
significant differences were observed when compared to the control medium (Figure 
15A-B). More sensitive functional measurements were performed with the MEA 
system. The ACM effect was studied on mature neuronal networks directly after 
application (acute) and at the 1 h, 4 h and 24 h time points. Functional measurements 
revealed that the ACM collected from both control and reactive astrocytes supported 
spike and burst activity over 24 h (Figure 15C-D). There were no statistically 
significant differences between the control (Ctrl) and reactive ACM groups. 
However, when compared to the control group, spike rates were increased directly 
after application in reactive ACM group and spike and burst rate were increased at 1 
h time point in control ACM group (Figure 15 C-D). 
Finally, controlled co-cultures of neurons and astrocytes were established 
utilizing microfluidics technology. The designed microfluidic device enabled the 
separation of astrocytes, neurons and their axons into different compartments that 
were connected via microchannels (Figure 15E). These microchannels permitted 
cell-to-cell contacts between neuronal axons and astrocytes and allowed fluid flow 
selectively across axonal and astrocyte compartments (Figure 15F-G; Study III 
Figure 6G-H). The effects of reactive astrocytes and the inflammatory milieu on 
axonal growth were examined in the microfluidic device. Cytokine treatment was 
applied solely to the astrocyte compartment (groups: Neurons [Neu]+Ctrl astrocyte 
[astro] and Neu+Reactive astro), and devices without astrocytes were prepared as 
controls (groups: Neu and Neu+IL-1β/TNF-α). After 72 h, the axonal density in 
their compartment was evaluated with the live stain calcein-AM (Figure 15H). 
Axonal density was found to be higher in the presence of cytokine-treated astrocytes 
than in control astrocytes (Figure 15I). These data, together with the viability and 
functional results, indicate that the reactive astrocyte phenotype is supportive of 
neurons. 
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Figure 15.  Neuron-specific actions of reactive astrocytes. (A) Immunocytochemical staining of neurons 
(MAP2+β-tubulin) treated with control medium (Ctrl), control astrocyte-conditioned medium 
(Ctrl ACM) or reactive ACM. (B) The viability, cytotoxicity and apoptosis of ACM-treated 
neurons was quantified after 48 h. (C) Functional measurements with MEA show changes 
in the spike rate after ACM exposure. (D) Additionally, the change in bursting activity was 
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evaluated following ACM treatments. Data are shown as Tukey box plots, and statistical 
analyses were performed with the Kruskal-Wallis test followed by the Mann-Whitney U test 
(*p<0.05). (E) Schematic representation of the microfluidic device used to co-culture 
neurons and astrocytes. (F) Neurons (β-tubulin) and astrocytes (GFAP, Vimentin) are 
restricted in their compartments by microchannels. (F, G) Neuronal axons and astrocyte 
processes can grow and interact in the axonal compartment. (H) The density of axons in the 
axonal compartment (white dotted box) was quantified from the calcein-AM live-stained 
samples. The scale bar represents 50 μm except for that in panel F, which is 100 μm. (I) 
Quantification of the area covered by axons in microfluidic devices containing only neurons 
(Neu), neurons with cytokine treatment of the astrocyte compartment (Neu+IL-1β/TNF-α), 
neurons and control astrocytes (Neu+Ctrl astro) and neurons and reactive astrocytes 
(Neu+Reactive astro). Data are presented as the mean±s.e.m. and statistical analyses were 
performed with independent-sample t-tests (*p<0.05). 
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6 DISCUSSION 
6.1 Considerations of the neurosphere and adherent neuronal 
differentiation methods 
Since the first reports on hPSC-derived neuronal cells, several differentiation 
methods and approaches have been developed to increase the purity of cultures and 
better mimic in vivo development (Chambers et al., 2009; Nat et al., 2007; Pasca et 
al., 2015; Shi, Y. et al., 2012; Zhang, S-C et al., 2001a). In the first two studies 
included in this thesis, neuronal cells were differentiated using two widely used 
methods, the neurosphere differentiation method (Study I) described previously by 
Lappalainen et al. (2010) and the adherent monolayer method with dual SMAD 
inhibition (Study II) that was modified from Shi et al. (2012) and further optimized 
in this thesis. The first aim of the thesis was to evaluate the outcomes of 
differentiation with gene and protein expression analysis. 
During development, neural fate is the “default” pathway that is triggered when 
cells are deprived of morphogens or treated with morphogen inhibitors such as 
SB431542 and LDN193189 targeting the TGFβ and BMP pathways (Suzuki and 
Vanderhaeghen, 2015). Here, without external patterning factors, the neuronal cells 
from both differentiation methods first exhibited a forebrain phenotype, as 
determined by FoxG1 expression (Studies I and II). Cells resulting from the 
neurosphere differentiation method were also found to express transcripts typical of 
midbrain and hindbrain phenotypes (Study I). This can be an expected outcome, as 
without additional inhibition of caudalizing signals, the extended culture and 
passaging of hPSC-derived neural cultures in the presence of FGF2 drives them to 
eventually adapt caudal identities (Shi, Yichen et al., 2012; Suzuki and 
Vanderhaeghen, 2015). Neural induction was particularly efficient with the adherent 
dual SMAD inhibition method, resulting in homogenous expression of the 
neuroectodermal marker Pax6 in all of the studied hPSC lines (Study II). 
The NPCs derived with both methods differentiated into neurons at similar 
efficiencies (Studies I and II). The proportion of neurons was over 70%, while the 
rest of the cultures consisted of glial cells and the remaining neural progenitors. 
Additionally, the timing for neurogenesis was comparable between the two methods. 
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However, the adherent method, which included more directed chemical induction 
with a variety of factors, seemed to be beneficial and promote faster differentiation. 
Overall, the time scale of neurogenesis reflects the prolonged development observed 
in humans compared to rodents. In general, the first hPSC-derived neurons are 
generated after one month of differentiation on average, while for example, mouse 
PSCs produce neurons within one week (Espuny-Camacho et al., 2013). 
Cortical neurogenesis of hPSC-derived cells largely follows the temporal patterns 
observed in vivo, where the six-layered structure is generated in an inside-out manner, 
with deep layer neurons born first and upper layer neurons migrating past later 
(Molyneaux et al., 2007). Analysis of the cortical layer-specific markers in the 
adherent-differentiated neurons revealed expression of the early-born deep-layer 
markers Ctip2 and Tbr1 (Study II). The upper layer marker Brn2 was present at the 
analyzed time points, but very few Satb2-positive cells were detected. Satb2 is usually 
detected in very late-born cortical neurons, and in fact, earlier reports on hPSC-
derived neurons have reported upregulation of Satb2 even as late as after 100 days 
of differentiation (Pasca et al., 2015; Shi, Y. et al., 2012). 
The emergence of endogenous astrocytes was also studied because they are 
known to arise from the common neural progenitor pool as neurons and are 
important for the support of neuronal maturation (Johnson et al., 2007; Qian et al., 
2000). In both methods, the proportion of astrocytes increased in long-term culture 
(Studies I and II), confirming other previous reports on hPSC-derived cultures 
(Espuny-Camacho et al., 2013; Pasca et al., 2015). The neurosphere method 
produced 15% GFAP-positive astrocytes after a prolonged differentiation period of 
15 wks, while the adherent method produced 20% astrocytes after 11 wks of 
differentiation as detected with the same marker. Thus, it seems that with the studied 
hPSC lines, the adherent protocol was more efficient at producing astrocytes. 
Additionally, as GFAP is not an optimal marker for astrocytes, the proportions of 
S100β-positive astrocytes and astrocyte progenitors were also quantified (Study II). 
A considerably larger portion of cells, 38%, were S100β-positive after 11 wks of 
adherent differentiation, indicating that GFAP should not be used as the sole marker 
for evaluating the astrocyte content in cultures, as suggested by several other studies 
(Krencik, Robert and Ullian, 2013; Lundin et al., 2018). 
In conclusion, some temporal differences were observed in the differentiation 
efficiencies of the two methods. Additionally, the original publications (Studies I and 
II) revealed variation in the differentiation capacity depending on the hPSC line. 
This is widely acknowledged in the literature showing that the intrinsic 
differentiation propensity of a particular hPSC line may affect the result (Kim et al., 
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2010; Osafune et al., 2008; Toivonen et al., 2013). Cell line-specific properties can 
be overcome, to some extent, with selection steps, such as rosette isolation and 
FACS sorting, which may improve the consistency and help remove undesired cell 
types (Muratore et al., 2014). Manipulation of signaling pathways with dual SMAD 
inhibition has been effectively shown to reduce the variability between cell lines 
during differentiation (Kim et al., 2010), and this strategy has been applied to both 
adherent and suspension cultures (Chambers et al., 2009; Pasca et al., 2015). 
Additionally, in adherent monolayer cultures, the cells are better exposed to an even 
distribution of growth factors and nutrients, whereas in aggregates, the increasing 
size creates concentration gradients (Muratore et al., 2014). Due to the vast number 
of differentiation protocols currently available for hPSC-derived neurons, it seems 
unlikely that any standardization will follow. Additionally, different types of 
protocols may be practical for particular applications. For example, 3D suspension 
cultures such as neurospheres and organoids may be more suited for studying the 
morphology and cytoarchitecture of the cells. On the other hand, adherent cultures 
achieved with chemical induction are often more homogenous and scalable. 
6.2 Achievement of mature functional activity in hPSC-derived 
neuronal cultures 
Understanding the genetic and protein-level characteristics of hPSC-derived 
neuronal cultures is important. To utilize these cells for studying human 
development or disease, their functional properties need to be determined. The 
second aim of the thesis was to assess functional maturation under different culture 
conditions. With the current differentiation protocols presented in the first two 
studies of this thesis, the development of functionally active networks on MEA was 
strikingly different between the two methods (Studies I and II). While the 
neurosphere-differentiated cultures presented merely uncorrelated spikes and bursts, 
the adherent-differentiated cultures developed highly correlated network bursting 
activity. Despite these different innate basal activities, functional maturation could 
be promoted with long-term differentiation and optimization of culture conditions. 
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6.2.1 Prolonged differentiation time for promotion of functional maturation 
It is well established that human brain development follows a very different temporal 
pattern from that of rodents, and the final maturation of neuronal cells takes months 
if not years (Anderson, S. and Vanderhaeghen, 2014). Therefore, the aim of Study I 
was to address how functional properties on MEAs change during the long-term 
differentiation of hPSC-derived neuronal cultures. Interestingly, the mature bursting 
activity was increased in neurosphere cultures differentiated for a prolonged period 
of 15 wks compared to that in cultures differentiated for the standard 8 wks. We also 
observed a correlation between burst features: increased spike frequency in the burst 
resulted in a shorter burst duration. The prolonged differentiation time had opposing 
effects on these features in the two studied hPSC lines. The studied hESC line 
showed burst compaction after prolonged differentiation, a phenomenon that has 
since been described in other studies (Tourigny et al., 2019). This could potentially 
result from the maturation of membrane ion channel composition, allowing faster 
repetitive action potential firing (Weick, 2016). The studied hiPSC line, however, did 
not show the same behavior, which could in part relate to the difficulty of 
maintaining hPSC-derived cultures for extended times. During prolonged expansion, 
undesired cell types may arise in the culture and affect development (Muratore et al., 
2014). 
It is tempting to speculate that the variation in the amount of endogenously 
generated astrocytes between the two studied hPSC lines described in the original 
publication (Study I) could partially affect the functional maturation. It has been 
demonstrated that astrocyte metabolic functions, glutamate and potassium uptake, 
are critical for the recurrent bursting activity of neurons (Karus et al., 2015). In 
mature synapses, astrocyte endfeet are known to enshroud and control synapses 
forming the so-called tripartite synapse (Araque, Alfonso et al., 2014). Additionally, 
in developing networks, astrocyte-secreted factors and direct contact can control 
synapse formation and maturation (Clarke and Barres, 2013). Both rodent and 
human astrocytes have been shown to induce synapse maturation and increase the 
excitability of hPSC-derived neurons, further supporting this viewpoint (Klapper et 
al., 2019; Odawara et al., 2014). 
In conclusion, extended culture times would be a natural approach for the 
functional maturation of neurons, and previous studies have shown successful long-
term culture for up to one year with the help of a rodent astrocyte feeder layer 
(Odawara et al., 2016). However, experiments involving the observation of hPSC-
derived neuron maturation for many months to years is not the most practical 
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approach considering the possible medical applications, such as drug screening and 
disease modeling. 
6.2.2 Use of the Laminin-521 substrate for development of functionally 
active cortical networks 
Our research group has previously shown that α5 laminin substrates can improve 
the attachment, outgrowth and functionality of neurosphere-differentiated cells 
upon plating in adherent culture on polystyrene plastic wells and MEA surfaces 
(Hyysalo et al., 2017). Our aim was to establish LN521 as a culture substrate for 
adherent neuronal differentiation (Study II), replacing the animal-derived Matrigel 
and mouse laminin substrates, which suffer from batch-to-batch variation (Muratore 
et al., 2014; Niclis et al., 2017). 
Over the years, new approaches have been developed to improve hPSC culture 
and the functionality of their neural derivatives. Focus has been largely on specific 
medium compositions, growth factors and small molecules (Bardy et al., 2015; 
Chambers et al., 2009; Chen et al., 2011; Niclis et al., 2017). However, ECM-cell 
interactions have proven to play an important role in providing signals guiding the 
cell phenotype (Hagbard et al., 2018). Here, the hPSCs were cultured according to 
the protocol described by Hongisto et al. (2017) utilizing feeder-free conditions on 
the LN521 substrate, which has been shown to support the pluripotent state 
according to other reports (Lu et al., 2014; Niclis et al., 2017). The following neural 
induction on Matrigel or LN521 and the neural differentiation on mouse laminin or 
LN521 equally supported the growth and morphological maturation of hPSC-
derived neurons and astrocytes. Previous studies have demonstrated the suitability 
of the α5 laminin substrates LN521 and LN511 in dopaminergic neuron 
differentiation (Doi et al., 2014; Lu et al., 2014; Niclis et al., 2017) and LN521 in 
astrocyte differentiation (Lundin et al., 2018). Our results further confirm that the 
LN521 substrate is suitable for cortical neural differentiation. Furthermore, it is 
encouraging that the same substrate could be used for both hPSC culture and 
subsequent neural differentiation without undesired pluripotent cells after neural 
induction. Better defined culture components, such as LN521, are preferred, 
especially in clinical research aimed at cell therapy, but basic research can also benefit 
from increased experimental reproducibility. 
The most remarkable difference between the mouse laminin- and LN521-
differentiated cultures was in functional development. The functional activity of 
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neurons differentiated on mouse laminin was very modest compared to that of 
networks differentiated on LN521. Compared to the mouse laminin differentiated 
neuronal cultures, the LN521-differentiated neurons presented a higher percentage 
of active electrodes, higher spike rate and higher burst rate over the follow-up period. 
This finding was in line with the group’s previous results obtained using 
neurosphere-differentiated cultures (Hyysalo et al., 2017). A recent publication has 
shed light on the possible mechanism of LN521 and neuron functionality. Omar and 
colleagues (2017) reported that laminin α5 regulates synapse stability during postnatal 
CNS development in mice (Omar et al., 2017). They were able to show spine 
stabilization of laminin α5-deficient neurons with the application of LN521 but not 
with LN111, the major constituent that is also in mouse laminin. Furthermore, 
laminin α5 was required for normal synapse density and function. In mouse 
hippocampal neurons, laminin α5 is deposited at the synapse by postsynaptic 
dendrite, and it acts through the integrin α3β1 adhesion receptor (Omar et al., 2017). 
Determining whether the observed LN521 effect is mediated via a similar 
mechanism in the hPSC-derived neuronal network would be an interesting direction 
for future studies. 
In summary, the superiority of LN521 over mouse laminin has now been verified 
with both the neurosphere method (Hyysalo et al., 2017) and the adherent 
differentiation with dual SMAD inhibition method. For LN521 adherent-
differentiated neurons, the level of activity corresponds with that of neurons 
resulting from the co-culture of rodent astrocytes (Frega et al., 2017; Odawara et al., 
2016), and LN521 is therefore considered the most suitable substrate for supporting 
functional maturation of hPSC-derived networks without externally applied 
astrocytes in fully humanized conditions. 
6.2.3 Inhibitory system in hPSC-derived networks 
Inhibitory neurons expressing GABA and GAD67 were present in the neuronal 
cultures, and we were interested in elucidating their role in maintaining the 
excitatory-inhibitory balance of the network. Calcium imaging experiments showed 
that in the neurosphere-differentiated cultures, a decreasing proportion of neurons 
showed an excitatory response to GABA application after prolonged differentiation, 
which is suggestive of functional maturation (Study I). In line with this, changes in 
the expression of the chloride transporters NKCC1 and KCC2 were observed. 
During early development, high intracellular chloride concentrations in neurons, 
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mainly due to NKCC1 transporter expression, results in depolarization upon GABA 
binding to its receptor (Ben-Ari et al., 2007; Ben-Ari et al., 2012). Increasing KCC2 
expression during development eventually causes changes in the chloride balance, 
allowing the hyperpolarizing inhibitory effect of GABA. Our data are consistent with 
previous patch clamp studies on hPSC-derived neurons showing a reduction in 
intracellular chloride levels and changes in chloride transporter expression as a result 
of prolonged differentiation (Livesey et al., 2014). 
The actual inhibitory input on network activity was investigated with adherent-
differentiated neurons (Study II). The actions of a GABAergic agonist and 
antagonist were evaluated once the synchronous network level activity developed on 
the MEA. The presence of GABA receptors was confirmed by the application of 
GABA, which silenced the network bursts, leaving only a low level of asynchronous 
spiking. The GABAA receptor antagonist gabazine blocked the inhibitory 
GABAergic networks, increasing the total activity. These results demonstrate that 
cortical networks exhibit a functional inhibitory system that regulates their activity. 
GABAergic signaling emerges before glutamatergic signaling during development 
and is thus a potential player in the initiation of network activity, a theme that is 
widely discussed in the literature (Allène et al., 2008; Ben-Ari et al., 2007; Garaschuk 
et al., 2000). The presence or absence of interneurons has been speculated to affect 
the initiation of robust network activity in hPSC-derived cultures (Livesey et al., 
2016; Weick, 2016). Previous reports on hPSC-derived cortical networks have, 
however, shown that inhibitory input is not necessary for the development of 
network oscillations (Kirwan et al., 2015; Mäkinen et al., 2018; Tukker et al., 2018). 
Nevertheless, our results, along with those of others, have demonstrated that 
inhibitory GABAergic systems can develop and modulate the synchronous activity 
of hPSC-derived networks (Ishii et al., 2017; Izsak et al., 2019; Odawara et al., 2016). 
Given these different observations, the amount and maturity of interneurons 
produced with various differentiation methods should be carefully considered, 
especially in disease modeling, as perturbation of excitatory-inhibitory balance is a 
key feature of numerous diseases (Blaesse et al., 2009; Livesey et al., 2016). 
6.3 Evaluation of the in vitro activity of human and rodent 
networks 
The third aim of this thesis was to compare the network activity of hPSC-derived 
neurons differentiated via the adherent protocol with those of rat cortical cultures, 
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often referred to as the “gold standard” for MEA recordings (Study II). One 
drawback prohibiting wider utilization of hPSC-derived neurons instead of rat 
cortical neurons is the time required for the detection of robust network activity. 
Here, we found that the activities of the pre-differentiated hPSC-derived neurons 
and rat cortical neurons developed in comparable time frames, as early as 3-4 wks 
after plating on MEAs. Very few studies have previously shown direct network-level 
comparisons between human and rat neurons in vitro. Tukker and colleagues (2016) 
followed the activity development of rat cortical cultures and commercially available 
hiPSC-derived neurons for 9 days on MEA (Tukker et al., 2016). During that time, 
they concluded that these two networks showed comparable results with respect to 
the numbers of active wells, electrodes and spikes. However, after only 9 days, they 
showed no bursting or synchronous activity (Tukker et al., 2016). Napoli and 
colleagues (2015) compared midgestational human fetal neurons and E18 rat 
neurons on MEAs (Napoli and Obeid, 2016). Rat neurons produced robust network 
activity after 10 days on MEA, exhibiting numerous active electrodes and high spike 
rates, while human fetal neurons showed a lower level of activity even after 40 days. 
However, they noted that human-derived cells might be less mature than rodent 
neurons and depend more on glial support and extracellular environment control 
(Napoli and Obeid, 2016). 
The stages of activity development were similar between the hPSC-derived and 
rat networks originating as asynchronous spikes, followed by more abundant spike 
trains and, finally, organization into highly synchronous network bursts (Study II). 
Thus, achieving human cortical type network bursting is now possible in the same 
time period as that required for rat cortical neurons. Until recently, synchronously 
active hPSC-derived neuronal networks were not often reported. Despite variations 
in cell culture protocols, measurement methods and data analyses, network bursting 
has been described to arise in a similar time frame and present comparable 
frequencies in most previous publications (Frega et al., 2017; Izsak et al., 2019; 
Kirwan et al., 2015; Kuijlaars et al., 2016; Odawara et al., 2016; Odawara et al., 2018; 
Tukker et al., 2018). Odawara and colleagues (2016) first reported a very long time 
period, up to 20 wks, for the complete maturation of networks. Later, they further 
refined culture systems showing network activity as early as 5 wks after beginning to 
measure (Odawara et al., 2018). More recently, Izsak and colleagues (2019) presented 
network bursting after 2 wks on MEA. Clearly, the time frame in which robust 
network activity can be achieved with hPSC-derived neurons is closing in on that 
achievable with their in vitro rodent counterparts. 
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Distinct differences between hPSC-derived and rat cultures were also observed 
in our experiments (Study II). Principal component analysis involving several spike, 
burst and network features demonstrated variation in the activity of the two network 
types. Segregation of data into separate clusters could indicate differences in the 
maturation stage or species-specific differences between the hPSC-derived and rat 
networks. Previous gene expression analyses point to the similarities of hPSC-
derived neurons and midgestational (~19-24 wks) human fetuses, which are known 
to resemble late-stage rodent embryos (embryonic development days 18-23) (Pasca 
et al., 2015; Stein et al., 2014; Weick, 2016). Distinct functional characteristics may 
arise for example from differing ion channel, receptor and transporter expression 
levels specific to maturation stage. On the other hand, species differences between 
human- and rodent-expressed genes are also acknowledged (Masjosthusmann et al., 
2018; Xu et al., 2018). Furthermore, differences in the neuron cytoarchitecture or, 
for example, the location or spreading of proteins can largely influence neuron 
functional properties and responses to external conditions (Beaulieu-Laroche et al., 
2018). Investigation of the maturation stage and interspecies differences between the 
human and rodent models can help validate the utility of hPSC-derived networks as 
platforms for in vitro studies including human neurological disorders. 
6.4 Development of in vitro models for astrogliosis 
The fourth aim of the thesis focused directly on astrocytes, specifically on how they 
respond to specific inflammatory conditions and how their response affects neuronal 
viability and function (Study III). In neuropathological conditions, the astrocyte 
response depends on the degree and type of stimulation and is therefore highly 
context dependent (Liddelow, S. A. et al., 2017). In study III, astrocytes were treated 
with cytokines IL-1β and TNF-α for seven days to mimic neuroinflammatory 
conditions, in which microglia activation and cytokine secretion stimulate 
astrogliosis (Clausen et al., 2008; Shinozaki et al., 2017). Because the biological 
characterization of hPSC-derived reactive astrocyte models is limited, the most 
common properties known to be involved in astrogliosis were evaluated. Detailed 
characterization revealed considerable changes in the astrocyte intermediate filament 
network, proliferation, homeostatic role and secretion profile, suggesting a change 
to a reactive state. Most other reports on stem cell-derived reactive astrocytes have 
been published within the past few years (Lundin et al., 2018; Perriot et al., 2018; 
Ponath et al., 2018; Roybon et al., 2013; Santos et al., 2017; Tcw et al., 2017). These 
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publications are still mostly focused on treatment with a limited set of stimulants and 
analysis of a few well-characterized inflammatory factors from astrocytes. 
Nevertheless, some interesting observations have already been made regarding 
hiPSC-derived astrocytes. First, they are able to respond to cytokine treatments and 
are thus immunocompetent (Lundin et al., 2018; Perriot et al., 2018; Roybon et al., 
2013). Second, they are sensitive to inflammatory treatment in a time- and dose-
dependent manner (Lundin et al., 2018; Tcw et al., 2017), and co-stimulation with 
different cytokines may elicit synergistic effects (Perriot et al., 2018). Third, the 
percentage of astrocytes responding to the stimulation may vary depending on the 
stimulant used and the analyzed factors describing activation (Santos et al., 2017). 
Together, these data elucidate the complex nature of astrocyte reactivation in hPSC 
models. 
Interestingly, in our study, the neuron-specific effects of astrocytes were mostly 
beneficial, and no directly toxic responses were reported (Study III). Analysis was 
based on astrocyte-secreted factors, and the collected ACM did not compromise 
neuronal viability during the 48 h of exposure. Previous work involving different 
combinations of astrocyte stimulants and varying exposure times demonstrated a 
decreased number of neurons and directly toxic effects on human neurons 
(Liddelow, S. A. et al., 2017; Santos et al., 2017). Continuation of this work would 
require careful consideration of stimulants, optimization of exposure times and even 
concentration of the factors found in ACM. Showing responses of hPSC-derived 
neurons has been challenging and may need more sensitive detection methods. One 
potential approach is the analysis of neuronal functionality. In this setup, both 
control and reactive astrocyte ACM were shown to induce transient increases in 
spike and burst rates, further demonstrating that astrocytes do not secrete significant 
levels of detrimental factors that would silence network activity (Study III). ACM 
has been previously shown to promote functional activity on MEA and even more 
so when astrocytes are in direct contact with the neurons (Fukushima et al., 2016; 
Odawara et al., 2014). Due to a lack of previous studies, an interesting future 
direction would be co-culturing reactive astrocytes and neurons on MEAs; however, 
selective astrocyte stimulation and sustainment of a reactive phenotype should be 
controlled. 
Astrocyte direct contact and ACM-mediated influence on axonal growth were 
studied under controlled conditions utilizing a microfluidic platform (Study III). 
With microfluidic devices, it is possible to create compartmentalized culture 
environments and study specific cell-to-cell interactions (Neto et al., 2016; Ristola et 
al., 2019; Sarkar et al., 2018; Taylor et al., 2005). Here, the utilized microfluidic device 
 92 
isolated neuronal and astrocyte somas and allowed the study of axonal growth and 
axonal interaction with astrocytes. At the same time, fluidic isolation provided by the 
narrow microtunnels connecting cell areas restricted fluid flow and allowed selective 
stimulation of astrocytes. The inflammatory niche created by stimulated astrocytes 
was supportive of axonal growth, confirming the polarization of astrocytes into a 
neurosupportive phenotype. The interactions of neurons and astrocytes in 
inflammatory conditions elucidated by the controlled microfluidic platform have not 
been previously described in the literature. However, an interesting report from Park 
and colleagues (2018) presented the use of microfluidics technology to study the 
recruitment of microglia and their toxic actions on a mixed neuron-astrocyte culture 
in an Alzheimer’s disease model. Creating more elaborate culture setups in which the 
complexity of the brain can be mimicked and the interactions of several contributing 
cell types can be dissected will be the direction of future studies. 
6.5 Future perspectives 
Evaluating the properties of the developed stem cell models and how they compare 
with the validated rodent models provides important information for future studies. 
The last chapter follows the major topics discussed in this thesis and provides some 
important critiques and options for future avenues. These are the four underlined 
points: 1) differentiation and maturation of hPSC-derived neurons, 2) increasing 
functional activity of neurons, 3) role of astrocytes in neuronal signaling in health 
and disease, and 4) complex co-culture settings for in vitro modeling. 
The hPSC-derived neuronal cells generated with various methods, including 
those described here in studies I and II, represent fetal-stage cells that, according to 
gene expression analysis, do not mature even after months of in vitro culture to match 
the adult expression profile (Stein et al., 2014). Considering this imperfect match is 
important, especially when applying hiPSC-derived neurons for modeling late-onset 
neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. An 
increasing number of papers are carefully describing the plausible pathophysiological 
phenotypes of disease-specific hiPSC-derived neurons (Brennand et al., 2015). MEA 
technology is also attracting interest as a high-throughput method for characterizing 
functional deficits (García-León et al., 2018; Mehta et al., 2018; Wakeman et al., 
2017). It will be important to verify how the observed functional changes in these 
developing stage networks relate to the network dysfunctions observed in the adult 
and aging brain. 
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Because hPSC-derived networks mimic many of the cellular and functional 
properties of in vivo networks, as shown in studies I and II, they provide a valuable 
tool for investigating both fundamental questions in human developmental biology 
as well as mechanisms of disease. Further development of culture methods has 
resulted in even better resemblance. Improvements in culture conditions utilizing an 
increasing number of different neuroactive factors and high glucose levels may 
eventually risk altering normal development and lead to unnatural, almost epileptic 
firing. Chronic exposure to growth factors is reported to change, for example, ion 
channel and transporter expression (Lepski et al., 2013; Livesey et al., 2014). These 
issues should be considered when designing culture conditions for particular 
experiments. 
Astrocytes play an important role in neurodevelopment by promoting 
synaptogenesis and synapse remodeling (Clarke and Barres, 2013) and therefore 
provide perhaps a more natural option for the support of neuron growth and 
functionality. The development of neurons and astrocytes is intertwined, and 
astrocytes provide important cues for neuronal differentiation and maturation and 
vice versa (Baldwin and Eroglu, 2017; Stogsdill et al., 2017). In our culture systems 
(Studies I and II), astrocytes were generated endogenously, and they developed 
alongside neurons. Adding rodent astrocytes, especially in later stages of neuronal 
differentiation, is not the most physiological approach (Klapper et al., 2019). Despite 
the many benefits of astrocyte co-culture, it is also good to keep in mind the powerful 
metabolic role of astrocytes. They can protect neurons against toxicants and mask 
defective neuronal phenotypes in models of neurodegenerative disease or insult 
(Engle et al., 2018; Tieu et al., 2001). 
Astrocyte reactivation is dominant in all neurodegenerative diseases and injuries 
of the CNS. We presented a detailed characterization of hPSC-derived reactive 
astrocytes in one set of conditions (Study III). According to previous rodent work, 
it is now clear that astrocyte reactivation does not represent a single cellular 
phenotype but rather a mixture of two or more unidentified reactive astrocyte 
polarization states (Liddelow, Shane A. and Barres, 2017). How the reactivation of 
hiPSC-derived astrocytes corresponds to the extreme astrogliosis observed in vivo is 
not currently known. The use of more elaborate gene expression panels or single-
cell RNA sequencing to classify different reactive astrocyte phenotypes and how they 
match the in vivo setting could clarify the validity of hiPSC models. It is unclear 
whether astrocytes are beneficial or detrimental under pathological circumstances 
and how they interact with other CNS cells. These questions will be at the forefront 
of future studies. 
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To our knowledge, study III of this thesis was the first report showing a 
controlled co-culture setting involving human stem cell-derived neurons, astrocytes 
and inflammatory components utilizing microfluidics technology. Including 
astrocytes and possibly other CNS cells, such as oligodendrocytes and microglia 
together with neurons, will make the in vitro model more credible and in vivo-like. 
Cytoarchitecturally intricate cultures such as brain organoids could also provide an 
interesting possibility for co-cultures. Furthermore, organoids with different cell 
types or brain region-specific cells can be combined into so-called brain assembloids 
and even organized in a controlled way using microfluidic devices for studying 
circuitries (Amin and Paşca, 2018; Hartlaub et al., 2019; Kelava and Lancaster, 2016). 
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7 SUMMARY AND CONCLUSIONS 
This research aimed to evaluate the potential of hPSC-derived neuronal cells to form 
mature functional networks, which are essential for hPSC model utility in 
neuroscience applications. Additionally, the role of astrocytes in the neuronal 
networks during normal and inflammatory conditions was considered. Based on 
these results, the following conclusions can be drawn: 
 
1. Both of the tested differentiation methods, neurosphere and adherent 
culture, recapitulate the developmental events occurring in vivo. Directed 
chemical induction can accelerate development and improve culture 
homogeneity over more spontaneous differentiation. The suitability of 
the selected method should be considered based on target applications. 
 
2. The extended differentiation time of hPSC-derived networks increases 
the share of endogenously formed astrocytes and promotes the 
development of functionally mature activity types. Furthermore, a 
specific LN521 culture substrate supports the emergence of electrical 
activity and stabilizes the maintenance of functional networks, providing 
more representable, completely human-specific models. 
 
3. The similar time frames and stages of activity development between 
hPSC-derived neuronal cultures and rodent counterparts validates the 
stem cell systems for studying network biology. The observed variation 
in the activity features between rodents and humans can be linked to 
maturation stage or interspecies differences. This could provide new 
insights into the low predictive value of rodent models for human 
outcomes. 
 
4. Reactivation of healthy hPSC-derived astrocytes shows many 
characteristics distinctive of astrogliosis and the astrocytes transform into 
a neurosupportive phenotype, inducing neuronal responses at the 
functional level. Astrocytes can be combined in a controlled co-culture 
 96 
model together with neurons to assess cell interactions during 
inflammation. Experiments combining several CNS cell types under 
disease-specific settings to better mimic in vivo conditions are warranted 
in future studies. 
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Long-term neural differentiation of human pluripotent stem cells (hPSCs) is associated with enhanced neuronal
maturation, which is a necessity for creation of representative in vitro models. It also induces neurogenic-to-
gliogenic fate switch, increasing proportion of endogenous astrocytes formed from the common neural progen-
itors. However, the signiﬁcance of prolonged differentiation on the neural cell type composition and functional
development of hPSC-derived neuronal cells has not been well characterized. Here, we studied two hPSC lines,
both of which initially showed good neuronal differentiation capacity. However, the propensity for endogenous
astrogenesis and maturation state after extended differentiation varied. Live cell calcium imaging revealed that
prolonged differentiation facilitated maturation of GABAergic signaling. According to extracellular recordings
with microelectrode array (MEA), neuronal activity was limited to fewer areas of the culture, which expressed
more frequent burst activity. Efﬁcient maturation after prolonged differentiation also promoted organization of
spontaneous activity by burst compaction. These results suggest that although prolonged neural differentiation
can be challenging, it has beneﬁcial effect on functional maturation, which can also improve transition to differ-
ent neural in vitromodels and applications.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Human pluripotent stem cell (hPSC)-derived neurons hold a great
promise for modeling neurodevelopment as well as pathologies with
genetic background (Suzuki and Vanderhaeghen, 2015). Additionally,
hPSC-derived neuronal cultures represent a promising platform for
neurotoxicity testing (Johnstone et al., 2010; Ylä-Outinen et al., 2010)
and a therapy option, for example, in Parkinson's disease and spinal
cord injury (Li et al., 2015; Lindvall, 2015). hPSCs includehuman embry-
onic stem cells (hESCs) (Thomson, 1998) and human induced pluripo-
tent stem cells (hiPSCs) (Takahashi et al., 2007), both of which have
their advantages and disadvantages. hESCs are considered to have
fewer obstacles to differentiation because they do not carry any previ-
ous epigenetic memory of former cellular identity (Kim et al., 2010),
whereas hiPSCs are associated with fewer ethical problems and wider
utilization potential in applications such as modeling of hereditary dis-
eases (Du and Parent, 2015). hPSCs can be differentiated into spontane-
ously active functional neuronal networks (Heikkilä et al., 2009;
Toivonen et al., 2013), but to gain greater beneﬁts from hPSC-derived
neural cells for various applications, their basic characteristics need to
be studied and evaluated in more detail in vitro, especially at the level
of functional development.
Achieving functional maturation of hPSC-derived neuronal cells in
vitro still remains a challenge in the ﬁeld.When compared to rodent pri-
mary neurons, the functional state of hPSC-derived neuronal cultures
can be considered immature. Traditionally, the survival in long-term
culture and functional maturation of hPSC-derived neural cultures has
been enhanced with primary rodent astrocytes in cocultures (Frega et
al., 2017; Johnson et al., 2007; Odawara et al., 2014). After all, astrocytes
have been recognized as active regulators of neuronal development and
function (Clarke and Barres, 2013). However, for most hPSC-derived
neuronal applications, for example disease modeling, a completely
human cell-based system is a necessity. At the same time many differ-
entiation protocols for hPSC-derived neurons typically produce a vary-
ing proportion of astrocytes from the common neural progenitors
(Lappalainen et al., 2010; Pasca et al., 2015; Shi et al., 2012). Still this
change in cell type composition is not often discussed. Overall, the sig-
niﬁcance of prolonged differentiation on neural cell type composition
and network level functional studies describing this development are
still largely lacking.
Here, we describe how prolonged neural differentiation affects the
generation of endogenous astrocytes and impacts the functional
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development of hPSC-derived neural cultures. Typically, extended dif-
ferentiation of hPSC-derived neurons is supported by rodent astrocyte
coculture but here only hPSC-derived cultures were used. Our
neurosphere differentiation method recapitulates the in vivo develop-
mental stages in which the switch from neurogenesis to gliogenesis oc-
curs over time (Lappalainen et al., 2010; Miller and Gauthier, 2007;
Zhang et al., 2001). Accordingly, we selected two time points of
neurosphere differentiation, the standard 8 week and the prolonged
15 week time point, which were quantitatively analyzed for neuronal
and astrocytic markers using immunocytochemistry and gene expres-
sion analysis. Microelectrode array (MEA) technique was used to mea-
sure spontaneous electrical activity repeatedly in large populations of
neurons. In contrast, calcium (Ca2+) imaging allowed detection of indi-
vidual cell type speciﬁc activity in neurons and astrocytes. Together,
Ca2+ imaging andMEA systemwere validated as useful tools in provid-
ing extensive information about hPSC-derived neural cultures, and indi-
cated functional maturation of neuronal cells after prolonged
differentiation.
2. Materials and methods
2.1. Maintenance of human pluripotent stem cells
The human embryonic stem cell (hESC) line Regea 08/023 (passages
14–66) and the human induced pluripotent stem cell (hiPSC) line
04311.WT (passages 24–45) were used in this study. The cell lines
were derived at the Institute of Biosciences and Medical Technology
(BioMediTech), University of Tampere, Finland. BioMediTech received
approval from the Finnish Medicines Agency (FIMEA) to perform re-
searchusinghuman embryos (Dnro 1426/32/300/05). Supportive state-
ments were also obtained from the regional ethics committee of
Pirkanmaa Hospital District for the derivation, culture, and differentia-
tion of hESCs (R05116) and hiPSCs (R08070). An informed consent
was obtained from all subjects who provided cell samples. All methods
were carried out in accordancewith relevant guidelines and regulations.
The hESC line Regea 08/023 was generated as previously described
(Rajala et al., 2010; Skottman, 2010). The hiPSC line 04311.WT was de-
rived fromhuman skinﬁbroblasts following a previously published pro-
tocol using Sendai virus technology (Ojala et al., 2016) (Supplementary
Fig. 1). The hPSC-lines were cultured on top of a human feeder cell layer
(CRL-2429, ATCC, Manassas, VA, USA) and were passaged weekly
(Rajala et al., 2007). The medium consisted of knockout Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 20% knockout
serum replacement, 2mMGlutamax (all fromGibco, Thermo Fisher Sci-
entiﬁc Waltham, MA USA), 1% nonessential amino acids, 50 U ml−1
penicillin/streptomycin (both from Lonza Group Ltd., Basel, Switzer-
land), 0.1 mM 2-mercaptoethanol (Gibco, Thermo Fisher Scientiﬁc)
and 8 ng ml−1 basic ﬁbroblast growth factor (bFGF, R&D Systems Inc.,
Minneapolis, MN, USA). The undifferentiated stage of both human plu-
ripotent stem cell (hPSC) lines were regularly monitored with gene and
protein expression analyses of pluripotency markers (Nanog, Oct-3/4,
TRA-1-81 and TRA-1-60) and markers for different germ layers
(human alpha-smooth muscle actin, human alpha-fetoprotein, and
Nestin). All cultures maintained normal karyotypes and were myco-
plasma free.
2.2. Neural differentiation
Neural differentiation of hESCs (Regea 08/023) and hiPSCs (04311.
WT) was performed using a free-ﬂoating neurosphere culture
(Lappalainen et al., 2010). hPSC colonies were mechanically cut into
small clusters and transferred into six-well ultra-low attachment plates
(Nunc, Thermo Fisher Scientiﬁc) for neural differentiation. Neural dif-
ferentiation medium (NDM) consisted of 1:1 DMEM/F-12:Neurobasal
medium supplemented with 1× B27, 1× N2, and 2 mM Glutamax (all
from Gibco, Thermo Fisher Scientiﬁc), 25 U ml−1 penicillin/
streptomycin (Lonza Group Ltd.) and 20 ng ml−1 bFGF (R&D Systems
Inc.). The medium was changed three times per week, and the
neurospheres were mechanically passaged once per week. Cells were
differentiated in neurosphere culture for standard 8weeks or prolonged
15 weeks and plated under adherent culture conditions for maturation
up to 5 weeks (Fig. 1A, experimental setup). For adherent culture the
neurospheres were mechanically cut into small 50–200 μm in diameter
clusters containing on average 5000–10,000 cells. The number of plated
clusters was relative to culture area: 10 clusters for MEA experiments,
20 clusters for calcium imaging experiments, 20 clusters for immunocy-
tochemistry and PCR experiments. Cells were plated either on glass cov-
erslips or MEA dishes coated with 0.05% PEI and 20 μg ml−1 mouse
laminin (both from Sigma-Aldrich, St. Louis, MO, USA). For adherent
culture bFGF was omitted from the NDM. After one week of adherent
culture, 4 ngml−1 bFGF and 5 ngml−1 brain-derived neurotrophic fac-
tor (BDNF, Prospec, Rehovot, Israel) were added to the NDM to support
neuronalmaturation. The culturesweremaintainedwith threemedium
changes per week.
2.3. Immunocytochemistry
Protein expression in cultures was characterized with immunocyto-
chemical staining as previously described (Lappalainen et al., 2010). The
following primary antibodies were used: MAP-2 (rabbit, 1:400,
Millipore, Billerica, MA, USA: AB5622), MAP-2 (chicken, 1:4000, Novus
Biologicals, Littleton, CO, USA: NB300-213), βIII-tubulin (rabbit,
1:2000, GenScript, Piscataway, NJ, USA: A01627), βIII-tubulin (chicken,
1:4000, Abcam, Cambridge, MA, USA: ab107216), GFAP (chicken,
1:4000, Abcam: ab4674), synaptophysin (mouse, 1:2000, Sigma-Al-
drich: s5768), vGlut (guinea pig, 1:1000, Millipore: AB2251), GABA
(rabbit, 1:1000, Sigma-Aldrich: A2052), GAD67 (mouse, 1:100,
Millipore: MAB5406), TH (mouse, 1:800, Sigma-Aldrich: T1299), sero-
tonin (rabbit, 1:800, Sigma-Aldrich: S5545), and S100β (mouse, 1:500,
Abcam: ab11178). For secondary antibody labeling, Alexa Fluor 488
(1:400), Alexa Fluor 568 (1:400) or Alexa Fluor 647 (1:200) dye
(Thermo Fisher Scientiﬁc) was used as appropriate. The cells were im-
aged using an Olympus IX51 microscope (10×, NA = 0.3 and 20×, NA
=0.45 objectives) equippedwith an Olympus DP30BW camera (Olym-
pus Corporation, Hamburg, Germany). For synaptophysin staining, an
LSM780 Laser Scanning Confocal Microscope (40× objective, NA =
1.4) with a Quasar spectral GaAsP detector (all from Carl Zeiss, Jena,
Germany) was used.
To quantify the neuron-to-astrocyte ratio at the 8 and 15 wk. time
points, cells were plated under adherent culture conditions and were
stained after 2 and 4 wks for neuronal (MAP-2 + β-tubulin) and astro-
cyte (GFAP) markers. The numbers of biological and technical repeats
are listed in Supplementary Table 2. Distinct cell types were automati-
cally counted using CellProﬁler (Carpenter et al., 2006) and CellProﬁler
Analyst (Jones et al., 2008) software. The results of the automated anal-
ysis were evaluatedmanually, and samples with fewer than 200 cells or
a false classiﬁcation result were excluded from the ﬁnal analysis.
2.4. RT-PCR analysis and qRT-PCR array
Total RNA was isolated from 8 + 5 wks and 15 + 5 wks differenti-
ated cells using the NucleoSpin RNA XS kit (Macherey-Nagel, Düren,
Germany) according to the manufacturer's instructions. The concentra-
tion and quality of the RNA were monitored spectroscopically. For each
sample, 800 ng of total RNAwas reverse transcribed into cDNAwith the
High Capacity cDNA Reverse Transcription kit (Applied Biosystems,
Thermo Fisher Scientiﬁc, Foster City, CA, USA) according to the manu-
facturer's instructions.
To investigate brain region speciﬁcity and chloride transporter ex-
pression, a standard RT-PCR analysis was performed (target genes,
primer sequences and exact annealing temperatures in Supplementary
Table 1). For each reaction, an aliquot of 2.5 ng cDNA was used with
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Fig. 1.Differentiation of hESC- andhiPSC-derived neurons and astrocytes. (A) hPSCswereﬁrst differentiated in neurosphere culture for 8 or 15wks and thenplatedunder adherent culture
conditions for maturation up to ﬁve weeks before characterization with immunocytochemical staining (ICC), PCR, Ca2+ imaging (CA), and microelectrode array (MEA). (B) At 8 + 1 wk.
timepoint RNAwas extracted from cultures and RT-PCRwasperformed for forebrain (FOXG1 andOTX2),midbrain (LMX1A) and hindbrainmarkers (GBX2) (n=1).Human fetal brain RNA
was used as control. The displayed bands were cropped from a single image of one gel (Supplementary Fig. 5A). (C) Representative images of immunocytochemical staining of neuronal
(MAP-2+ β-tubulin) and astrocyte (GFAP)markers after standard (8+wks) and prolonged (15+wks) differentiation. 4′,6-diamidino-2-phenylindole (DAPI) nuclear staining is in blue.
(D, E) The percentages of neurons and astrocytes were counted using CellProﬁler analysis tools. The data are presented as the distribution of the percentages of neurons and astrocytes at
each time point. The median and interquartile ranges are indicated by lines, and the whiskers indicate the minimum and maximum of the data. A non-parametric Mann-Whitney U test
was used for the statistical analysis, and p-values b0.05 were considered signiﬁcant. Signiﬁcant p-values are presented in the images. The number of samples analyzed is presented in
Supplementary Table 2. (F, G) At the 8 + 5 and 15 + 5 wk. time points, qPCR was performed to evaluate various neural precursor cell (NPC) markers and markers of mature neurons
and astrocytes (n = 1, 3 technical replicates). The bars represent the fold change in gene expression between 8 + 5 and 15 + 5 wks, and they correspond to the left y-axis. The dots
indicate the variable expression levels of genes compared to the housekeeping gene GUSB, and they correspond to the right y-axis (logarithmic).
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0.2 mM of both forward and reverse primers, 1 × PCR buffer (–MgCl,
+KCl), 1.5 mMMgCl2, 0.1 mM dNTP mix and 0.25 U/μl Taq DNA poly-
merase (Qiagen, Hilden, Germany). The cDNA was ampliﬁed using 37
PCR cycles with an initializing step at 95 °C for 3min, DNA denaturation
at 95 °C for 30 s, annealing at 60–68 °C (Supplementary Table 1) for 30 s
and elongation at 72 °C for 1 min. A 5 min elongation step ﬁnalized the
reaction. The PCR products were separated electrophoretically on a 1.5%
agarose gel in Tris/Borate/EDTA buffer containing GelRed (Biotium,
Hayward, CA, USA) and visualized using BioRad ChemiDoc MP system
(Bio-rad Laboratories, Inc., Hercules, CA, USA).
To investigate astrocyte, neural precursor and general neuron genes,
a gene expression array analysis of a subset of 14 genes of interest (Sup-
plementary Table 1) was performed using a custom TaqMan® Array
(Applied Biosystems) according to the manufacturer's instructions. For
each reaction, 6 ng of cDNA was used with TaqMan® Universal PCR
Master Mix (Applied Biosystems). The analysis was performed using
the ABI Prism 7300 real-time PCR system (Applied Biosystems). The
data were normalized to the expression of the housekeeping gene
GUSB, and the data from the 15 + 5 wks time point were further com-
pared to the 8 + 5 wks time point. Relative expression values were de-
termined using the comparative 2−ΔΔCt method, and the quality of the
PCR products was monitored with a melt curve analysis. The analysis
consisted of three technical replicates.
2.5. Ca2+ imaging
Ca2+ signaling of 8 and 15 weeks differentiated cells was studied
after 2 and 4 wks of adherent maturation. Cells were loaded with 4
μM of Fluo-4 AM (Thermo Fisher Scientiﬁc) diluted in NDM for 30 min
at 37 °C and 5% CO2, followed by washing with NDM for another
30 min at 37 °C and 5% CO2. Culture were imaged every 0.5 s while
being continuously perfused with physiological solution at 36 ± 0.5 °C
at a rate of 2 ml/min (RC-22 perfusion chamber, TC-344C temperature
controller, SH-27B in-line solution heater; Warner Instruments Inc.,
Hamden, USA). The physiological solution contained 140 mM NaCl,
10 mM HEPES, 10 mM D-glucose, 3.5 mM KCl, 1.25 mM NaH2PO4,
2 mM CaCl2 and 1 mM MgCl2 (all from Sigma-Aldrich) dissolved in
dH2O. The ﬂuorescent imaging system consisted of an Olympus IX61
inverted microscope (10× and 20× objectives, NA = 0.5), an Andor
iXon 885 EMCCD camera (Andor Technology, Belfast, Northern Ireland)
and a Polychrom V monochromator (TILL Photonics, Munich, Ger-
many). Images were acquired with TILL Photonics Live Acquisition soft-
ware and analyzed with SimplePCI software package (Hamamatsu
Corporation, Sewickley, PA, USA). Neuronal cells were identiﬁed by
their morphology and ability to quickly respond to elevated extracellu-
lar K+ (50mM). Ca2+ signalingwas considered related to action poten-
tials if it was blocked by the voltage-gated sodium channel antagonist
tetrodotoxin (TTX, 1 μM, Tocris Bioscience, Bristol, UK). GABA (100
μM, Sigma-Aldrich) and glutamate (50 μM, Sigma-Aldrich)were applied
to test for the presence of functional receptors for these major neuro-
transmitters. The ﬂuorescence intensity was normalized to the resting
level, and amplitude of the GABA and glutamate responses in each cell
was calculated as a fraction of the response to high-K+ depolarization
in the cell. The numbers of biological and technical repeats are listed
in Supplementary Table 2.
2.6. Microelectrode arrays
The development of spontaneous electrical activity in 8 and 15 wks
differentiated cells was measured for 5 wks with a MEA system
(Heikkilä et al., 2009). Recordingswere obtainedwith anMEA60 ampli-
ﬁer and 60-6wellMEA200/30iR-Ti-w/o arrayswith 9 electrodes perwell
(Multi Channel Systems [MCS], Reutlingen, Germany; Fig. 4A). A cus-
tom-made 6-well silicone chamber, SpikeBooster, was used to culture
neural cells on MEA dishes as previously described (Kreutzer et al.,
2012). The temperature was maintained at 37 °C with a TC02
temperature controller (MCS). Cultures were measured twice per
week for 10 min, and the two weekly measurements were averaged
for analysis (Supplementary Table 2, experimental repeats). The control
of measurements and the detection of spikes were performed with
MC_Rack software (MCS). A sampling rate of 50 kHz was used for the
measurements. Spikes were detected from 200 Hz high-pass ﬁltered
data when their amplitude crossed the threshold of−5 × standard de-
viation (SD) of noise. Electrodes with a total spike frequency N0.033 Hz
(2/min) were experimentally determined to present biological activity
(i.e., to be active electrodes; Supplementary Fig. 4A–C). The spike
count and burst analysis were performed using a custom-made script
for MATLAB (MathWorks, Natick, MA, USA) (Kapucu et al., 2012) with
further modiﬁcations. Additional conditions were applied to the analy-
sis to ensure the validity of burst detection: burst detectionwas only ap-
plied to channels where the total spike frequency was at least 0.167 Hz
(10/min), and a minimum of three spikes was considered to form a
burst. Furthermore, if the automatically detected burst inter-spike inter-
val threshold exceeded 2000 ms, the channel was considered not to
have bursts and was excluded from the burst analysis.
2.7. Statistical analysis
Due to the non-Gaussian distribution of the data, the non-paramet-
ric KruskalWallis test (with Dunn's post hoc – test) andMann-Whitney
U test were used. All the statistical tests were performed with SPSS Sta-
tistics software (version 23.0).
3. Results
3.1. hPCS differentiate efﬁciently into neuronal population with varying
proportion of astrocytes
Using our simple neurosphere differentiation method (Lappalainen
et al., 2010), we have tested the neural differentiation capacity of sev-
eral hESC and hiPSC lines (Lappalainen et al., 2010; Toivonen et al.,
2013) and have chosen the in-house derived hESC line Regea 08/023
and the hiPSC line 04311.WT for a detailed study of neuron and astro-
cyte differentiation and functionality (Fig. 1A). Cells were differentiated
in suspension for either standard 8 week period or prolonged 15 week
period and plated in adherent culture for maturation and experiments.
For clarity, the names of the study's time points refer to both differenti-
ation and maturation time points. For example, 8 + 2 wks refers to
8weeks of differentiation in neurosphere culture, and 2weeks of adher-
ent maturation (Fig. 1A).
To examine the brain regional identity of the cells,we performed RT-
PCR to 8 + 1 wk. samples and detected strong expression of forebrain
(FOXG1, OTX2) and hindbrain (GBX2) markers, and minor expression
of midbrain marker (LMX1A) (Fig. 1B). Expression of midbrain marker
EN1 and hindbrain marker HOXA2 were not detected. RT-PCR analysis
conﬁrmed that the culture represents a mixed neural cell population.
In order to determine the differentiation capacity of the two hPSC
lines, neuronal cells were immunostained with microtubule-associated
protein 2 (MAP-2) andβ-tubulin antibodies, and astrocyteswith glialﬁ-
brillary acidic protein (GFAP) antibody. Quantiﬁcation of the neuron-to-
astrocyte ratio in the hESC line revealed good capacity to give rise to
both neurons and astrocytes (Fig. 1C and D, for cell counts see Supple-
mentary Fig. 2). Neuronal cells were efﬁciently produced, but their pro-
portion was decreased with prolonged differentiation time from 73% at
8 + 4 wks to 44% at 15 + 4 wks (Fig. 1D). Astrocyte proportion in-
creased gradually at the expense of neuronal cells from 2% at 8
+4wks to 51% at 15+4wks (Fig. 1C and D). At the same time, propor-
tion of cells without any neural staining was diminished from 25% at 8
+ 4 wks to 5% at 15 + 4 wks. In line with the immunocytochemical
data, the gene expression analysis revealed upregulation of astrocyte
markers (BLBP, GFAP, ALDH1L1, S100B, SLC1A3, SLC1A2, and GLUL) after
prolonged differentiation (15 + 5 wks) (Fig. 1F). Such robust changes
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were not observed with neural precursor cell (NPC) markers (PAX6,
MSI2H) or neuronmarkers (NF68, NF200, RBFOX3,MAP2, SYN1) (Fig. 1F).
The hiPSC line was shown to have a good capacity for neuronal dif-
ferentiation but limited astrogenesis (Fig. 1C and E). The hiPSC line efﬁ-
ciently produced neuronal cells after standard differentiation time, and
the proportion remained also high after prolonged differentiation: 80%
at 8 + 4 wks and 70% at 15 + 4 wks (Fig. 1E). Contrary to the results
obtained with hESC line, the increase in astrocyte proportion in hiPSC
line was very modest, from 3% at 8 + 4 wks to 5% at 15 + 5 wks (Fig.
1E). The proportion of cells without any neural staining slightly in-
creased from 17% at 8 + 4 wks to 25% at 15 + 4 wks. Furthermore, at
the gene expression level, astrocyte markers were not upregulated in
the hiPSC line (Fig. 1G). To summarize, these ﬁndings demonstrate
that the hiPSC line (04311.WT) did not undergo astrocyte enrichment
Fig. 2. Immunocytochemical characterization of neural cell types. Immunocytochemical staining veriﬁed speciﬁc neuronal subtypes expressing GABA, GAD67 and vGlut in both (A) hESC-
and (B) hiPSC-derived 8+4wks and 15+4wks old cultures (n=1). (C, D) Synaptophysin staining co-localizedwith theneuronalmarkersMAP-2+β-tubulin in all analyzed cultures (n
=3). GFAP-positive astrocytes were sometimes found in close proximity to synaptophysin-positive neuronal processes after prolonged differentiation (15+ 4wks). Insets below show a
magniﬁed viewof synaptophysin staining alongneuronal processes. (E, F) Astrocytes expressing the cell type-speciﬁcmarkers S100β andGFAPwere found in all the cultures (n=1).DAPI
nuclear staining is shown in blue.
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as efﬁciently as the hESC line (Regea 08/023). On the other hand, NPC
and neuron markers were expressed at comparable level in both hPSC
lines supporting overall good neuronal differentiation capacity.
3.2. Immunocytochemical characterization of hPSC-derived neural cultures
The majority of neurons were positive for GABAergic or glutamater-
gic markers in both 8 and 15 wk. differentiated cultures (Fig. 2A and B).
Neurons expressing the presynaptic marker synaptophysin were de-
tected at all the studied time points (Fig. 2C and D). Combined staining
of synaptophysin with the neuronal markers revealed organized
synaptophysin-positive boutons in neuronal processes. Occasionally,
astrocyte processes were found aligned with synaptophysin-positive
neuronal processes (Fig. 2C and D). Astrocytes were characterized
with GFAP and S100 calcium-binding protein B (S100β) staining, and
in most cases, both markers were co-localized (Fig. 2E and F). As stated
earlier, the proportion of GFAP-positive astrocytes was increased after
prolonged differentiation especially in the hESC line (Fig. 1) (Fig. 2E).
Some astrocytes sent several-hundred-micrometer-long processes
which often closely intertwined with neuronal axons and dendrites.
3.3. Prolonged differentiation enhances maturation of GABAergic system
To study the basic functional properties of the hESC- and hiPSC-de-
rived neural cultures, we monitored intracellular Ca2+ dynamics using
Fluo-4 AM dye (Fig. 3). First, we imaged spontaneous Ca2+ signaling
and its blockage by tetrodotoxin (TTX). Next, γ-aminobutyric acid
(GABA) and glutamate were applied to demonstrate for the presence
of functional receptors for these major neurotransmitters. Finally, a
high concentration of KCl was used to induce depolarization and volt-
age-gated Ca2+ channel activation. The subsequent immunocytochem-
ical staining veriﬁed that Ca2+ signals were detected from both neurons
and astrocytes (Fig. 3A–C). Examples of neuronal and astrocyte Ca2+
signals are presented in Supplementary Movies 1 and 2.
Spontaneous neuronal Ca2+ transients were detected at all the stud-
ied time points in both hPSC lines. Neurons exhibited Ca2+ events with
single spikes and high-frequency oscillations (Fig. 3B andMovie 1). TTX
reversibly blocked spontaneous Ca2+ signaling in a subset of neurons
(Fig. 3B), indicating that the activation of Na+ voltage-gated channels
due to depolarization is a critical step for spontaneous, action poten-
tial-related Ca2+ signaling in neuronal cells (Fig. 3E and F).
Responses to GABA and glutamate application conﬁrmed the pres-
ence of functional receptor-operated channels in neurons. Glutamate
induced an instant, strong Ca2+ elevation in the majority (85–99%) of
the analyzed neurons (Fig. 3G and H). The amplitudes of the glutamate
responses are presented in Supplementary Fig. 3A. In contrast to gluta-
mate treatment, the neuronal responses to GABA application varied
considerably between studied time points. In most cases, GABA had an
excitatory effect increasing intracellular Ca2+ (Fig. 3B) but occasionally
spontaneous activity of neurons was attenuated by GABA treatment
(Fig. 3D). In the hESC line, the proportion of neurons responding to
GABAwith a Ca2+ rise (excitatory action) decreased progressively dur-
ing both prolonged differentiation and adherent maturation. GABA re-
sponse decreased from 76% at 8 + 2 wks to 24% at 15 + 4 wks (Fig.
3I). The reduction in excitatory GABA response over time was not as
prominent in the hiPSC line as in the hESC line. In hiPSC line, proportion
of GABA-responsive cells decreased from 61% at 8 + 2wks to 51% at 15
+ 4 wks (Fig. 3J). The changes in GABA response amplitudes are pre-
sented in Supplementary Fig. 3C and D. To support these resultswe per-
formed RT-PCR analysis of chloride transporter genes NKCC1 and KCC2,
important for the developmental change of GABA response from excit-
atory to inhibitory (Ben-Ari et al., 2012). In both hPSC lines, the expres-
sion of NKCC1, a marker of early development, was strongest in 8
+ 1 wk. time point after which it was down-regulated (Fig. 3K). KCC2
expression, which starts later in development, was observed at 15 + 1
wk. time point (Fig. 3K).
All in all, both of the studied hPSC lines demonstrated similar trends
in the development of pharmacological responses over time. Matura-
tion of GABAergic system was observed as a result of prolonged
differentiation.
3.4. Prolonged differentiation promotes maturation of spontaneous activity
Spontaneous electrical activity in neuronal cultures was measured
using MEA (Fig. 4A and B) as previously described (Heikkilä et al.,
2009). Signiﬁcant differences between hPSC lines, as well as numerical
details (medians and averages) are presented in Supplementary Table
3. To verify the dependency of activity on excitatory and inhibitory syn-
aptic factors, we used a pharmacological test battery containing N-
Methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA)/kainate and GABA receptor ligands
(Supplementary Fig. 4).
The hESC-derived cultures followed an activity development curve
after standard differentiation with a high-activity peak at 8 + 3 and 8
+ 4 wks (Fig. 4C, E and G). Similar clear curves were not detected in
the hiPSC-derived cultures after standard differentiation (8+ wks; Fig.
4D, F and H) or from either of the hPSC lines after prolonged differenti-
ation (15+wks; Fig. 4C–H). All in all, thereweremore active electrodes
in the hESC-derived cultures, and prolonged differentiation signiﬁcantly
reduced the proportion of active electrodes per culture with both hPSC
lines (Supplementary Table 2 and Fig. 4C and D).
Spike frequency in active electrodes is a frequently used measure of
neuronal activity (Fukushima et al., 2016). The median and average
spike frequency values are listed in Supplementary Table 3 (see also
Supplementary Movie 3). In the hESC-derived cultures, the spike fre-
quency reached a maximum during the high-activity peak at 8
+ 4 wks, with a median value of 0.276 Hz (Fig. 4E). At the correspond-
ing time point after prolonged differentiation (15 + 4 wks), the spike
frequencywas signiﬁcantly reduced to 0.132Hz (p=0.020). Similar re-
ductions in spike frequency were observed with the hiPSC-derived cul-
tures (Fig. 4F).
Spontaneous bursts were detected in all the studied groups (Fig. 4C
and D). Prolonged differentiation (15+ wks) signiﬁcantly reduced the
proportion of burst-detecting electrodes (Fig. 4C and D). Nonetheless,
in those burst-detecting electrodes, burst counts increased signiﬁcantly
in both hPSC lines (Fig. 4G and H). In the hESC line, the greatest increase
in burst number was detected between 8 + 2 and 15 + 2 wks, from 30
to 81 bursts per electrode (p= 0.012). In the hiPSC line, the highest in-
creasewas already between 8+ 1 and 15+ 1wks, from 25 to 80 bursts
per electrode (p = 0.046).
According to these results, prolonged differentiation affected the or-
ganization neuronal activity similarly in both hPSC lines by condensing
the activity to fewer electrodes, which in turn expressed more frequent
burst activity. The spike frequency and burst counts in active electrodes
were similar between the hPSC lines verifying that the level of activity
development was comparable.
3.5. Prolonged differentiation affects burst characteristics
After concluding that both hPCS lines develop similar bursting activ-
ity, we next studied in detail the basic burst characteristics: spike fre-
quency in bursts, burst duration and number of spikes per burst (Fig.
5). Numerical details (median and mean values) of burst parameters
and signiﬁcant differences between the hPSC lines are presented in Sup-
plementary Table 4. Prolonged differentiation (15+ wks) of the hESC-
derived cultures signiﬁcantly increased the spike frequency in bursts
at 4 out of 5 time points (Fig. 5A). The difference was most notable be-
tween 8 + 3 and 15 + 3 wks, with median frequency values of 11 Hz
and 25 Hz (p b 0.001). In contrast, in the hiPSC line, spike frequency in
burstswas reduced as result of prolonged differentiation. This reduction
was most evident between 8 + 3 and 15 + 3 wks, when the median
values were 19 Hz and 5 Hz (p = 0.002, Fig. 5B).
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Fig. 3. Ca2+ signaling after standard and prolonged differentiation. (A) For calcium imaging experiments neural culture was loaded with Fluo-4 AM Ca2+ indicator. On the left a representative
pseudocolor image of Fluo-4 loaded culture where red indicates high and blue indicates low Ca2+ levels. On the right is the same ﬁeld after immunocytochemical staining of neuronal cells
(MAP-2 + β-tubulin) and astrocytes (GFAP). DAPI nuclear staining is in blue. Neurons are marked with small region of interest (ROI) and numbering, and astrocytes are marked with large ROI
and letters. Typical traces of (B) neuronal and (C) astrocyte Ca2+ signals. (D) Example traces showing attenuation of spontaneous neuronal Ca2+ signaling by GABA. Cultures showed both
spontaneous activity and responses to pharmacological treatments. (E, F) Percentages of neuronal cells silenced by TTX (1 μM) treatment after standard and prolonged differentiation. Percentage
of neuronal cells responding to (G, H) glutamate (Glut, 50 μM) and (I, J) GABA (100 μM) applications. The data are presented as the distribution of the percentages at each time point. The
median and interquartile ranges are indicated by lines, and the whiskers indicate the minimum and maximum of the data. A non-parametric Mann-Whitney U test was used for the statistical
analysis, and p-values b0.05 were considered signiﬁcant. Signiﬁcant p-values are presented in the images. See also Supplementary Fig. 3 for response amplitudes. The number of samples
analyzed is presented in Supplementary Table 2. For all analyses (E-J), cells with neuronal morphology responding to high K+ application were included. (K) The expression of chloride channel
genes NKCC1 and KCC2was determined with RT-PCR in both cell lines at 8 + 1 and 15 + 1 wk. time points (n = 1). The RT-PCR products from the two hPSC lines were analyzed on separate
gels and image exposure times for the two gels were identical. Otherwise the bands representing different genes and time points were cropped from a single image of one gel (Supplementary
Fig. 5B and C).
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Burst duration was signiﬁcantly reduced by prolonged differentia-
tion (15+ wks) at 4 out of 5 time points in the hESC-derived cultures
(Fig. 5C). The difference was most prominent between 8 + 3 wks and
15 + 3 wks, with median values of 476 ms and 223 ms (p b 0.001). In
the hiPSC-derived cultures, however, prolonged differentiation in-
creased the burst duration; the median duration was 286 ms at 8
+ 3 wks and 1883 ms at 15 + 3 wks (p = 0.001, Fig. 5D). The number
of spikes per burst was unaffected in most time points (medians be-
tween 4 and 6; Fig. 5E and F). Almost all the signiﬁcant changes in
spike frequency in burst and burst duration occurred at the same time
points (Fig. 5A and B vs. C and D). Therefore, it appears that changes in
burst duration were responsible for the differences in spike frequency
in bursts.
To summarize, after prolonged differentiation the hESC-derived cul-
tures demonstrated increased spike frequency in bursts, which was as-
sociated with reduced burst duration. Prolonged differentiation did not
support similar burst development in the hiPSC-derived cultures.
4. Discussion
In our culture system, prolonged differentiation resulted in a switch
from neurogenesis to astrogenesis recapitulating the in vivo develop-
mental stages, as previously described (Itsykson et al., 2005; Nat et al.,
2007). We characterized the effects of prolonged differentiation on
cell type composition, and studied neuronal function using Ca2+ imag-
ing and MEA. Here, we report that prolonged neuronal differentiation
enhances the functional maturation of hPSC-derived neuronal cultures.
Propensity for astrogenesis varied substantially between the studied
hPSC lines in long-term follow-up. The neuron-to-astrocyte ratio was
similar in both hPSC lines after standard 8 weeks of differentiation but
after prolonged 15 weeks of differentiation, the ratio was strikingly dif-
ferent. The astrocyte proportion in the hiPSC linewas very modest, only
5%, whereas the hESC line produced up to 50% of astrocytes. Earlier
studies also showed variation in neuron and astrocyte differentiation
among hPSC lines regardless of their origin (Emdad et al., 2012;
Toivonen et al., 2013). Especially in hiPSC lines, incomplete transgene si-
lencing and epigenetic differences can affect differentiation capacity
(Hatada et al., 2008; Kim et al., 2010). Although pluripotency-inducing
transgenes were silenced in the hiPSC line used in the present work,
possible methylation of astrocyte-speciﬁc genes might delay astrocyte
differentiation (Hatada et al., 2008; Majumder et al., 2013). Generally,
differentiation capacity is known to be related to intrinsic properties
of the particular hPSC line (Emdad et al., 2012; Hu et al., 2010;
Toivonen et al., 2013).
The neuronal cells produced a mixed population of glutamatergic
neurons with a subset of GABAergic neurons, as demonstrated by im-
munocytochemistry and functional measurements. These results are
in linewith a recent report characterizing the generation of glutamater-
gic and GABAergic neurons from hPSCs using another neurosphere dif-
ferentiation protocol (Floruta et al., 2017). Here, both hPSC lines
showed similar properties respective to action potential generation
and glutamate responsiveness. hPSC-derived neurons also responded
at comparative levels to high K+ and glutamate applications similarly
as previously described by Forostyak et al. (2013). After standard
8 weeks differentiation, our GABAergic population was immature and
responded to GABA application with excitation. Also, we detected ex-
pression of chloride transporterNKCC1, which is prominently expressed
in early GABAergic development (Ben-Ari et al., 2012). During
prolonged differentiation, we observed a typical reduction in the excit-
atory GABAergic response and concurrent increase chloride transporter
KCC2, a mature marker for chloride transporter development (Ben-Ari
et al., 2012). Together these changes imply developmental maturation
of the GABAergic system as a result of prolonged differentiation.
MEA experiments showed that spontaneous neuronal activity could
be repeatedly measured from all the studied time points. The analysis
revealed varying electrical activity patterns, resulting in a non-Gaussian
distribution of the data. A very comprehensive, large-scale study by
Wagenaar and colleagues showed similar MEA data distribution with
rodent primary neuronal networks (Wagenaar et al., 2006). Although
MEA studies with rodent-derived neuronal cultures provide a well-
established reference for future applications, even primary human and
primary rodent cultures are far from comparable. Human cultures
tend to have a signiﬁcantly slower rate of activity development, lower
percentage of active electrodes and spike counts in comparison to ro-
dent cultures (Napoli and Obeid, 2016). The current results show that
also human stem cell-derived cultures have a comparatively low per-
centage of active electrodes and low spike counts. Therefore the charac-
teristics of hPSC-derived cultures need to be considered in MEA
experimental design, execution and data analysis.
MEA analysis revealed that prolonged differentiation decreased the
overall spike frequency and condensed electrical activity to particular
areas in the culture. Although the overall level of activity seemed to de-
crease in prolonged differentiation, the remaining activity organized
from single spikes into bursts with increasing bursting frequency. As
bursts are thought to represent more mature neuronal function, the in-
crease in burst number after prolonged differentiation should be ex-
pected. The observed reduction in the percentage of active and burst
detecting electrodes could be attributed to synaptic pruning
(Yamamoto and López-Bendito, 2012; Benders et al., 2015) or the in-
crease in proportion of astrocytes at the expense of neurons after
prolonged differentiation. Even though, the amount of spontaneous
spike and burst activity was in a comparable level between the studied
hPSC lines after prolonged differentiation, closer analysis revealed dif-
ferences in their activity patterns. In the hESC line prolonged differenti-
ation was associated with burst compaction. Mature compact bursts
were not formed similarly in the hiPSC line. This, and the slight increase
of non-neuronal and non-astrocytic cells in the hiPSC line after
prolonged differentiation may reﬂect aberrant differentiation, which
supports the observation that not all cell lines mature as efﬁciently
after extended culture times (Emdad et al., 2012; Toivonen et al.,
2013). Also, the studied hESC line produced a substantial amount of en-
dogenous astrocytes (N50%) which could partly help in stabilizing neu-
ronal activity and support compaction of burst activity in long-term
culture. However, dissecting these processes pharmacologically in as-
trocytes alone is very challenging, and new approaches are needed to
address these questions. Even though hPSC-derived neuron cocultures
with rodent astrocytes are relatively well established, the cocultures
with human astrocytes need to be better validated.
In conclusion, we found that the studied hPSC lines underwent neu-
rogenic-to-gliogenic switch during prolonged differentiation. However,
there were striking differences in the efﬁciency of astrogenesis which
should be considered also more carefully in the ﬁeld. Despite its chal-
lenges, prolonged neural differentiation induces functional changes
which mimic the development occurring in vivo, and in the future it
can be utilized in development of more representative hPSC-derived
neural models.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.scr.2018.01.018.
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Fig. 4. Spike and burst activity development after standard and prolonged differentiation. (A) Activity was measured with 9 electrodes per well. (B) Spikes were detected when their
amplitude exceeded a threshold of 5 × standard deviation of background noise. Vertical scale bar is 100 μV and horizontal 2 s. (C, D) The percentage of active (colored bars, no
texture) and burst detecting electrodes (colored bars, striped) was calculated from spike and burst counts determined using a custom-made MATLAB algorithm. (E, F) The spike
frequency in active electrodes was calculated from the same data. (G, H) The number of bursts in burst-detecting electrodes was also calculated. The numbers of spikes and bursts (E-
H) are presented as scatter plots on a logarithmic scale; each dot represents a single electrode, the horizontal line indicates the median, and whiskers indicate the interquartile range.
See also Supplementary Table 3. The numbers of analyzed cultures and electrodes are presented in Supplementary Table 2. Statistical signiﬁcance was calculated using the Mann-
Whitney U test, and a p-value b0.05 was considered signiﬁcant. Signiﬁcant p-values are presented in the images.
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Tanja Hyvärinenͷ, Anu Hyysaloͷǡ͸, Fikret Emre Kapucu͹ǡͺ, Laura Aarnosͷ, Andrey Vinogradovͷ, 
Stephen J. Eglenͻ, Laura Ylä-Outinenͷ & Susanna Narkilahti  ͷȗ
Human pluripotent stem cell (hPSC)-derived neurons provide exciting opportunities for in vitro 
modeling of neurological diseases and for advancing drug development and neurotoxicological 
studies. However, generating electrophysiologically mature neuronal networks from hPSCs has been 
ǤǡơǦ
ƤǦͻ͸ͷǤȋȌ
network events and compare the activity development of hPSC-derived networks to that of widely 
used rat embryonic cortical cultures. In both of these networks, activity developed through a similar 
sequence of stages and time frames; however, the hPSC-derived networks showed unique patterns 
of bursting activity. The hPSC-derived networks developed synchronous activity, which involved 
glutamatergic and GABAergic inputs, recapitulating the classical cortical activity also observed in 
rodent counterparts. Principal component analysis (PCA) based on spike rates, network synchronization 
Ǧơ
ǡƪǦƤơǤ
ǡǦƤ
ǡǦƤ
modeling network dysfunctions.
Human pluripotent stem cell (hPSC)-derived neurons possess great promise for unraveling the mechanisms of 
diseases with genetic susceptibility1. They also provide a human-specific model for in vitro research in neuro-
toxicology and drug discovery with the potential of reducing the use of animal studies2. Multiple differentiation 
protocols have been developed for hPSC-derived cortical neurons, all of which aim at the fast and consistent 
production of neurons3–6. Several methodological advances have improved the controllability of culture con-
ditions, for example, feeder-free cultures of hPSCs and defined mediums devoid of serum7,8. Additionally, an 
efficient neural induction of the default anterior central nervous system (CNS) phenotype has been achieved 
with a simple dual SMAD inhibition method by blocking the TGF-β and BMP signaling pathways with small 
molecules9. More recently, defined culture matrices such as human recombinant extracellular matrix (ECM) 
proteins have emerged as potent alternatives for mouse laminin or Matrigel, which are animal-derived products 
known to suffer from batch-to-batch variation10–12. Defined ECM molecules are used both in culture of hPSCs 
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and in neural differentiation and have even been shown to improve the functional maturation of neurons10–13. 
These improvements, among others, are essential for making neural differentiation methods more controllable 
and comparable between different laboratories and pave the way for more reliable findings in the application of 
hPSC-derived neurons.
The emergence of neuronal network activity during development is important in regulating neuronal migra-
tion, differentiation and apoptosis14–16. During CNS development, including that of the cerebral cortex, network 
formation starts as the newly born neurons elongate their axonal projections, find paths and form synaptic con-
nections16. After the initial formation of excessive functional connections, the developing networks undergo 
refinement of some connections and strengthening of others16. Large populations of neurons generate synchro-
nous activity that has a central role in fine-tuning connectivity during CNS development16,17. These synchronous 
oscillations have been described in the cerebral cortex of premature human fetuses at approximately 20 weeks 
of gestation18,19 and in the mouse and rat cortexes at birth (P0)20,21. Wide-ranging oscillatory activities in the 
cortex dominate throughout development, ensuring neuronal survival and maturation22,23, and in adults, they 
are believed to be involved in cognitive and perceptual functions and motor actions24. The cerebral cortex and 
its functional dynamics are also affected in many neurological disorders25–27. hPSC-derived neurons have been 
shown to develop membrane properties similar to native neurons in vivo and have been reported to respond 
to pharmacological manipulation and electrical stimulation, as expected from their in vivo counterparts28–30. 
Although network-level events are central in both healthy and pathological states, modeling of network-level 
activity with hPSC-derived neurons is still less described in the literature31–34.
Microelectrode arrays (MEA) have been used to measure the connectivity and network activity in neuronal 
cultures, brain slices and even in awake animals28,35–37. A clear advantage of MEAs is that they measure the activ-
ity from a population of neurons simultaneously, providing information about network events. They also enable 
repeated measurements of the same networks over time, allowing follow-up of developmental events or, for exam-
ple, long-term drug responses38. For in vitro research, multiwell-format MEAs also facilitate higher throughput 
analyses13,39. These features make MEAs a potential tool for disease modeling, drug screening and toxicology 
using hPSC-derived neurons. So far, most MEA culture and signal analysis protocols have been established with 
rodent networks, which are often considered “gold standards” in the field40,41. However, direct transfer and vali-
dation of these methods to hPSC-derived networks has not been straightforward28,42–44.
Here, we report that the differentiation of hPSC-derived cortical cultures on defined human recombinant 
laminin-521 (LN521) substrates is repeatable and results in the generation of cortical neurons, which form func-
tionally active networks. We utilize MEA technology to characterize the development of hPSC-derived neuronal 
network activity and compare it with the activity of rat embryonic cortical networks in vitro. The results con-
firm that spontaneous activity arises through similar developmental stages and on comparable time scales in 
both hPSC-derived and rat cortical networks. Both network types show typical synchronous activity; however, 
hPSC-derived networks present unique characteristics in burst patterns that distinguish them from their rat 
counterparts. The present data validate hPSC-derived neuronal networks as a reliable model for cortical activity 
development and consolidate their utilization in applications such as disease modeling, where network malfunc-
tions are considered key characteristics.
Results

ͻ͸ͷǤ To achieve con-
trolled, repeatable protocol producing cortical neurons, we utilized and modified previously described methods 
for culturing hPSCs and differentiation of neurons that can form spontaneously active networks6,11 (Fig. 1a). The 
hPSCs were cultured in feeder-free conditions using LN521 substrate and Essential 8 (E8) medium according to 
the protocol from Hongisto et al. (2017). The neural differentiation protocol was modified from Shi et al. (2012) 
and further optimized for the LN521 substrate to achieve more defined culture conditions and to support the 
functional development of neuronal networks, as we have previously described13.
To assess the repeatability of the optimized culture protocol, experiments were performed with one human 
embryonic stem cell (hESC) line (08/023) and two human induced pluripotent stem cell (hiPSC) lines (10212.
EURCCs and IMR90-4). All hPSC lines expressed the pluripotency marker Oct4 when grown as a monolayer 
culture on LN521 substrate in E8 medium (Fig. 1b). After a 12-day neural induction stage with dual SMAD 
inhibition, the pluripotency marker Oct4 was downregulated, and homogenous expression of neuroectodermal 
markers Sox2 and Pax6 was apparent, indicating efficient neural conversion (Fig. 1b). In addition, the anterior 
cortical fate of the cells was identified by FoxG1 staining (Fig. 1b).
After the neural induction stage, vimentin- and Pax6-positive neural stem and progenitor cells (now referred 
to as NPCs) could be efficiently expanded and differentiated in FGF2-containing media (Fig. 1a,c, Supplementary 
Fig. S1). Differentiation induced the emergence of first Tbr2- and MAP2-positive cortical neurons (Fig. 1c). 
Furthermore, NPCs could be cryopreserved at day 21 to create master cell banks. As a comparison to LN521 
substrate, we also tested neural induction on the commonly used Matrigel matrix. Cells cultured on Matrigel 
matrix showed similar homogenous Pax6 staining, and the subsequent differentiation on mouse laminin gener-
ated FoxG1- and vimentin-positive NPCs (Supplementary Fig. S2).
After thawing, the NPCs were expanded until day 32 and then used for experiments (Fig. 1a). Neuronal matu-
ration was promoted in the presence of neurotrophic factors BDNF, GDNF, cAMP and ascorbic acid. The number 
of Pax6-positive NPCs gradually decreased from 93–98% at day 12 to 35–41% at day 46 in all studied hPSC lines, 
suggesting neuronal maturation (08/023, p < 0.001; 10212.EURCCs, p = 0.009; and IMR90-4, p = 0.009; Fig. 1d). 
Taken together, neural induction and expansion of NPCs on LN521 substrate was efficient, and the produced cells 
represented an anterior cortical phenotype.
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ǦƤǤ Neurogenesis produced neurons specific for both 
deep and upper cortical layers. The early-born deep layer neurons were identified by immunocytochemical 
staining of transcription factors COUP-TF-interacting protein 2 (CTIP2) and T-box homeobox protein 1 (Tbr1) 
(Fig. 2a, Supplementary Fig. S3a), both having similar temporal expression patterns in the studied hPSC lines. 
Higher CTIP2 expression, 19–35%, was detected at day 46 and decreased thereafter to 16–18% by day 74 (08/023, 
p = 0.802; 10212.EURCCs, p = 0.001; and IMR90-4, p < 0.001; Fig. 2b). Similarly, Tbr1 expression showed a 
minor decrease from 6–13% to 3–8% from day 46 to day 74 (08/023, p < 0.001; 10212.EURCCs p = 0.117, and 
IMR90–4, p = 0.066; Fig. 2b). Additionally, later-born upper layer neurons positive for POU domain transcrip-
tion factor Brn2 (also known as POU3F2) and special AT-rich sequence-binding protein 2 (Satb2) were detected 
in the cultures (Fig. 2a, Supplementary Fig. S3a). The Brn2-positive neurons appeared first in all hPSC lines 
with higher expression at day 46, 30–47%, followed by a decrease to 24–27% at day 74 (08/023, p = 0.002; 10212.
EURCCs, p < 0.001; and IMR90-4, p = 0.050; Fig. 2b). The number of Satb2-positive late-born neurons was low 
at the studied time points (Fig. 2b). A very modest increase was detected, ranging from 0–2% to 0–7% between 
days 46 and 74 (08/023, p = 0.052; 10212.EURCCs, p < 0.001; and IMR90-4, p = 0.371; Fig. 2b). In conclusion, the 
differentiation protocol produced both deep and upper layer cortical neurons in a similar manner for all studied 
hPSC lines.
ǦǤ Next, the cell type composition of 
the hPSC-derived neural cultures differentiated on LN521 substrate was characterized by MAP2 and βIII-tubulin 
Figure 1. Neural induction of hPSCs. (a) Both hPSC culture and neural differentiation were performed on 
LN521 substrate. Cortical neurons were induced with dual SMAD inhibition, expanded in the presence of 
FGF2, and matured with support by a selection of neurotrophic factors. Neural progenitor cells (NPCs) could 
be cryopreserved at day 21 and plated at day 32 for final experiments, including microelectrode array (MEA) 
measurements. (b) Three different hPSC lines (one hESC line, 08/023 and two hiPSC lines, 10212.EURCCs 
and IMR90-4) were characterized for their efficiency in producing neuroectodermal cells in response to 12-day 
neural induction by dual SMAD inhibition. Cells were stained for pluripotency marker Oct4 at the pluripotent 
stage and after 12 days of neural induction. The presence of early neuroectodermal markers was evaluated 
with Sox2, FoxG1 and Pax6 staining. (c) After 21 days of differentiation, the culture contained vimentin- and 
Pax6-positive NPCs that could be cryopreserved. Additionally, the first Tbr2- and MAP2-positive neurons 
were detected at this time point. (d) The percentages of Pax6-positive cells were quantified at four time points 
of differentiation (mean ± s.e.m., n = 5–14, data derived from 1–3 independent differentiations). Statistical 
analysis was performed with the Mann-Whitney U test to compare differences between day 12 and day 46 
within each hPSC line, and significant p-values are presented in the image. The scale bar is 50 μm in all images.
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staining for neurons and S100β and GFAP staining for astrocytes (Fig. 3a). For comparison studies on the MEAs, 
the rat embryonic cortical cells were also cultured and characterized with the same markers (Fig. 3a).
The number of neurons and astrocytes was quantified from hPSC-derived cortical cultures. The percentage 
of MAP2-positive neurons was 61–79% at day 46 and decreased significantly to 45–51% at day 74 in the studied 
hPSC lines (08/023, p = 0.004; 10212.EURCCs, p = 0.017, and IMR90-4; p < 0.001; Fig. 3b). In contrast, the num-
ber of S100β- and GFAP-positive astrocytes increased in a temporal manner, suggesting subsequent astrogenesis 
from the common neural progenitor pool. The percentage of S100β-positive astrocytes increased significantly 
from 2–15% to 30–38% between day 46 and day 74 in the studied hPSC lines (08/023, p < 0.001; 10212.EURCCs, 
p < 0.001; and IMR90-4, p < 0.001; Fig. 3b). GFAP expression appeared later, as only 0–4% GFAP-positive astro-
cytes were detected at day 46, while later, at day 74, their number was significantly increased to 15–26% (08/023, 
p < 0.001; 10212.EURCCs, p < 0.001; and IMR90-4, p < 0.001; Fig. 3b). Interestingly, almost all GFAP-expressing 
astrocytes were also S100β-positive (Supplementary Fig. S3b). The neuronal population was further characterized 
as consisting of both vGlut1-expressing glutamatergic neurons and GABA- and GAD67-positive GABAergic neu-
rons (Fig. 3c). Importantly, both hPSC-derived and rat embryonic cortical neurons formed structural synapses 
identified with juxtaposed synaptophysin and PSD-95 puncta (Fig. 3d). In summary, both rat and hPSC-derived 
cortical neurons established synaptically connected networks that were intermingled with astroglia.
Development of spontaneous activity in hPSC-derived and rat cortical networks. To study the 
spontaneous activity of hPSC-derived cortical networks differentiated on LN521 substrate and compare their 
functional properties to the widely used rat embryonic cortical networks, we followed network development with 
regular MEA measurements over 100 days. The hPSC-derived cortical cells were plated on MEAs at day 32 of 
Figure 2. Development of cortical layer-specific neurons. (a) Immunocytochemical staining verified the 
presence of cortical layer-specific neurons expressing the early-born deep layer markers CTIP2 and Tbr1 and 
the later-born upper layer markers Brn2 and Satb2. Images are representative of the 08/023 hPSC line. Scale 
bar is 50 μm. (b) The number of positive cells for cortical layer-specific markers was quantified from neuronal 
cultures differentiated from all three hPSC lines at days 46 and 74 of differentiation, and the data are presented 
as the mean ± s.e.m. (for each hPSC line n = 5–51, data from 1–3 independent differentiations). Mann-Whitney 
U test was performed to determine statistically significant differences in time within each hPSC line. Significant 
p-values are presented in the images.
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differentiation (now called day 1 on MEA), and primary rat cortical neurons (from E17-E18 embryos) were plated 
directly on MEAs (Fig. 4a). Cell density has been shown to be critical for the timeframe of activity development on 
MEAs34,45, and therefore, cells were plated at high densities (Fig. 4b). Measurements performed on 64-electrode 
MEAs (8 × 8 grid) revealed that this facilitated the detection of activity from hPSC-derived networks soon after 
plating (Fig. 4c). The hPSC-derived networks expressed widespread activity from day 3 on MEA onwards, and the 
percentage of active electrodes (>10 spikes/min) ranged from 53% to 84% over 35 days on MEA. The rat networks 
showed latency in the onset of activity development (Fig. 4c). In the rat networks, the number of active electrodes 
was 2% at day 3 on MEA, reaching almost 100% on day 21 and then declining towards day 35.
The median spike rate per well increased early in the hPSC-derived networks, starting from day 3 and through 
day 14 on MEA (Fig. 4d). However, the rat networks showed higher spike rates during the most active state at 
days 24 to 28 on MEA (Fig. 4d). Here, the peak activity for both groups was detected after 24 days on MEA (hPSC 
median 4.4 Hz and rat median 6.1 Hz, Fig. 4d). After 35 days, the rat networks experienced a typical terminal 
decline in activity, while hPSC-derived networks settled on a plateau (Fig. 4d,e). We also looked at activity devel-
opment in hPSC-derived neurons differentiated on the commonly used mouse laminin substrate (Supplementary 
Fig. S4). Similar to our earlier reports13, the activity development of hPSC-derived neurons was more efficient on 
LN521 substrate compared to mouse laminin, as indicated by both the number of active electrodes and spike rate 
in the networks.
Figure 3. Maturation of hPSC-derived and rat embryonic cortical cultures. (a) Immunocytochemical staining 
of neurons (MAP2 and βIII-tubulin) and astrocytes (GFAP and S100β) in hPSC-derived (hPSC line 08/023) 
and rat primary cultures. Dapi nuclear staining is shown in blue. Scale bar represents 50 μm. (b) The number of 
neurons and astrocytes was quantified from cultures differentiated from all three hPSC lines at days 46 and 74. 
Quantitative data are presented as the mean ± s.e.m. (MAP2 n = 7–42, S100β and GFAP n = 9–44, data derived 
from 1–3 independent differentiations). The Mann-Whitney U test was performed between time points within 
each hPSC line, and significant p-values are presented in the images. (c) The hPSC-derived neuronal cultures 
consisted of vGlut1-positive glutamatergic and GABA- and GAD67-positive GABAergic neurons. Dapi nuclear 
staining is shown in blue, and the scale bar represents 50 μm. (d) Both hPSC-derived (day 61) and rat embryonic 
(day 22) cortical cultures formed networks with excitatory synapses positive for synaptophysin (Syn) and PSD-
95. Insets show higher magnification, and the scale bars are 10 μm in all images.
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Representative images of firing patterns detected with single electrodes and entire MEA arrays revealed the 
developmental organization of uncorrelated spike trains into highly synchronous bursts in both hPSC-derived 
and rat networks from day 14 to 24 on MEA (Fig. 4e,f). In hPSC-derived networks, this synchronous bursting was 
still apparent after 98 days on MEA (Fig. 4e). Taken together, hPSC-derived networks differentiated on LN521 
substrate develop activity across the MEA array in a comparable time period to the rat networks. They can reach 
spike rates close to that of the rat counterparts and maintain activity for almost 100 days on MEA.
Both hPSC-derived and rat neurons form highly connective networks. Functional connectivity 
is typically measured as simultaneously occurring events of activity originating from spatially distant areas46. 
To determine how array-wide activity develops in hPSC- and rat-derived networks, we performed connectivity 
analysis based on the entropy between electrode pairs47. Representative connectivity maps showing results from 
one network of hPSC and rat groups over 10 minutes of recording revealed a gradual increase in functional con-
nections over time (Fig. 5a,b). The first functional connections were observed in hPSC-derived networks after 
21 days on MEA and in rat networks after 14 days on MEA (Fig. 5a,b). Connections expanded and strengthened 
Figure 4. Developmental changes in the spontaneous activity of hPSC-derived and rat cortical networks 
on MEA. (a) hPSC-derived cortical neurons were differentiated for 32 days before plating on MEAs. Rat 
cortical neurons were dissected from E17-E18 embryos and directly plated on MEAs. (b) Phase contrast 
images showing hPSC-derived and rat networks on a MEA. The scale bar is 200 μm. (c) Percentage of active 
electrodes per MEA well in hPSC-derived and rat networks over time. Electrodes detecting >10 spikes/min 
were considered active. (d) Development of spike rate (Hz) per MEA well in hPSC-derived and rat networks 
over time. hPSC network data are from line 08/023. Both hPSC and rat network data consist of n = 12 networks 
per group. Data are presented as Tukey box plots. Mann-Whitney U test was performed to compare differences 
between hPSC-derived and rat networks, and significance within each time point is denoted in the images as 
*p < 0.05, **p < 0.01 and ***p < 0.001. (e) Representative images of the spontaneous activity recorded from 
single electrodes of hPSC-derived networks over 5 minutes and (f) from rat networks over 1 minute at different 
time points. Raster plots below show the intensity of spike activity on a MEA during a 10 min recording.
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progressively in both hPSC-derived and rat networks (Fig. 5a,b). When connectivity strength (CorSE) values were 
quantified, a considerably higher level of connectivity was observed in rat networks compared to hPSC-derived 
networks between 10 and 21 days on MEA (Fig. 5c). The strongest network connectivity was detected after 24 
days on MEA (hPSC median CorSE 0.48 and rat median CorSE 0.60). While rat networks were silenced after 
35 days on MEA, in hPSC-derived networks, the connectivity persisted between certain areas of the networks 
over several days (Fig. 5a–c). We further complemented the analysis by calculating the spike time tiling coeffi-
cient (STTC), which measures network synchronization in pairs of electrodes48. The results from STTC analysis 
confirmed the earlier observations with CorSE analysis, showing that although both hPSC-derived and rat net-
works form connections across the culture, in the rodent data, the synchronous activity was initiated earlier and 
involved a larger fraction of the network (Fig. 5d).
ơǦǤ Spontaneous bursts arise dur-
ing early activity development in the cerebral cortex and are important for neuronal circuit formation16. The 
tonic firing detected soon after cell plating gradually transformed into bursts with a rich repertoire of patterns, 
which could be reliably detected from both hPSC-derived and rat neuronal signals (Fig. 6a). The number of 
bursts and the percentage of spikes participating in the bursts progressively increased in both network types 
(Fig. 6b,c). During the peak of activity, the percentage of spikes recruited into bursts was generally higher in rat 
networks than in hPSC-derived networks, which also presented substantial spiking between condensed bursts 
(Fig. 6a,c). The hPSC-derived networks initially fired short bursts at a high frequency (Fig. 6b,d). When the well 
median values were examined at day 14, the burst frequency was 33 bursts per min, the burst duration was 0.4 sec, 
and bursts contained fewer than 13 spikes (Fig. 6b,d,e). Once networks matured, less frequently occurring and 
longer-duration bursts became the more dominant form of activity (Fig. 6a,b,d). During the peak of activity at 
day 24, the burst frequency was 11 bursts per min, the burst duration was 0.7 sec, and bursts contained 34 spikes 
(Fig. 6b,d,e). In the rat networks, the generation of bursting activity was steady, and the highest number of bursts, 
15 per min, was detected during the peak of activity on day 24 (Fig. 6b). At that point, the median burst duration 
was 0.3 sec (Fig. 6d). Thus, hPSC-derived networks expressed longer bursts than the rat networks. Although 
rat bursts consisted of a similar number of spikes as observed in hPSC-derived networks (Fig. 6e), the spike 
Figure 5. Analysis of functional connectivity development. (a) Functional connectivity maps from the hPSC-
derived network over 10 minutes of recording between days 21 and 42 on MEA and (b) from the rat network 
between days 14 and 35 on MEA. Electrodes in an 8 × 8 array with functional connections (lines) are presented 
during the measurement time. An arbitrary connectivity strength (CorSE) value of 0.7 was used as the threshold 
for plotting. (c) Average connectivity strength (CorSE) is calculated from all channel pairs for hPSC-derived and 
rat networks. (d) Network synchronization of hPSC-derived and rat networks described by the spike time tiling 
coefficient (STTC). Data hPSC data are from line 08/023. Both hPSC and rat network data consist of n = 12 
networks per group; data are shown as Tukey box plots. Mann-Whitney U test was performed to compare the 
two groups at each time point. Statistical significances are marked as *p < 0.05, **p < 0.01 and ***p < 0.001.
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frequencies in bursts were different across all time points (Fig. 6f). The median spike frequency in bursts was 
below 40 Hz in the hPSC-derived networks, whereas in rat networks, up to 100 Hz was observed during the peak 
of activity (Fig. 6f). Taken together, the hPSC-derived and rat networks express bursts that differ mostly in four 
properties: temporal development of bursts, burst duration, percentage of spikes recruited in bursts and spike 
frequency inside bursts.
hPSC-derived and rat networks show similar pharmacological responses. Next, we evaluated 
whether the observed network activity was synaptically driven and whether we could pharmacologically manip-
ulate activity in both network types. Experiments were carried out once synchronous activity was well established 
after 29 days on MEA for hPSC-derived networks and after 22 days on MEA for rat networks. Typical firing 
patterns showed that common glutamatergic and GABAergic agonists and antagonists evoked similar responses 
in both hPSC-derived and rat networks (Fig. 7a,b). The glutamatergic agonist kainic acid reduced the spiking 
activity and disorganized the synchronous network bursts down to tonic spike trains in both groups similarly 
(Fig. 7a–c), as observed earlier49. A concentration-dependent response to kainic acid was also observed with the 
rat networks (Supplementary Fig. S5). In both network types, the glutamatergic AMPA/kainate antagonist CNQX 
and the NMDA antagonist D-AP5 both efficiently reduced activity, verifying that the synchronous network events 
involve synaptic inputs (Fig. 7a–c).
The presence of the inhibitory system is not often observed in hPSC-derived forebrain cortical cultures50, 
and therefore, we tested the effect of the GABA and GABAA receptor antagonist gabazine on network activ-
ity (Fig. 7a,b). GABA suppressed the excitatory activity in both groups but more efficiently in the rat networks 
(Fig. 7c). Gabazine blocked GABAergic signaling in both rat and hPSC-derived networks, leading to increased 
spike rates (Fig. 7c). Finally, we confirmed that the activity recorded with MEAs originated from neuronal excita-
tion, since all activity was silenced with the voltage-dependent sodium channel blocker tetrodotoxin (TTX, 
Fig. 7a–c). In summary, both hPSC-derived and rat networks presented network activity that was sensitive to 
synaptic modulators, and most importantly, the networks contained a functional inhibitory system.
Ǧ
rat-derived networks. Principal component analysis (PCA) can efficiently cluster MEA data based on 
activity feature profiles and has been used for studying the properties of various brain region-specific cells and 
the effects of chemical exposure40,51. Therefore, we applied PCA to obtain conclusive results from the functional 
comparison between the hPSC-derived and rat networks. Both network types may have variability in the onset 
of activity and synchrony; therefore, analysis was performed on three separate experiments at the time point 
showing the highest spike rate and two of its neighboring measurement days (Supplementary Figs. S6 and S7). 
To measure the differences, we used several spike, burst and synchrony features. A clear segregation of the 
Figure 6. Burst features in hPSC-derived and rat cortical networks. (a) Raster plots showing typical spike and 
burst activity of one electrode from both hPSC-derived and rat data at day 24 on MEA. The green horizontal 
lines denote detected bursts. Temporal changes in burst features including (b) number of bursts per minute, 
(c) percentage of spikes in burst, (d) burst duration, (e) number of spikes in bursts, and (f) spike frequency in 
bursts. Data consist of n = 12 networks for both hPSC-derived (hPSC line 08/023) and rat networks and are 
presented as Tukey box plots. Mann-Whitney U test was performed to compare differences between the two 
groups at each time point, and significance is denoted as *p < 0.05, **p < 0.01 and ***p < 0.001.
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hPSC-derived and rat recordings was observed when the 7-dimensional feature vectors were plotted onto the 
first three principal components (Fig. 8). The first principal component (PC1) accounted for more than half of the 
variation (52%) between the two networks, and PC2 and PC3 explained 27% and 14% of the variation, respec-
tively. However, there was a slight overlap between the second hPSC batch (hPSC 2) and the first rat batch (Rat 1), 
suggesting that single datasets cannot be reliably used to discriminate between two types of recordings. In fact, in 
Figure 7. Pharmacological responses of hPSC-derived and rat cortical networks. (a) Typical activity patterns 
in response to different pharmacological treatments recorded from single electrodes of hPSC-derived networks 
at 29 days on MEA over 2 minutes and (b) from rat networks at 22 days on MEA over 1 minute. (c) Percentage 
change in spike rate compared to baseline measurement from the same well. Data consist of n = 4 networks 
for hPSC networks (hPSC line 08/023) and n = 7 for rat networks and are presented as a Tukey box plots. 
Mann-Whitney U test was performed to compare differences between the treatment groups, and significance is 
marked as *p < 0.05, **p < 0.01 and ***p < 0.001.
Figure 8. Principal component analysis of features of MEA activity of hPSC-derived and rat datasets. Principal 
component analysis (PCA) was performed to cluster hPSC-derived and rat MEA data based on seven activity 
features. Analysis was performed on three separate hPSC-derived (hPSC 1–3) and rat data sets (Rat 1–3) 
that all included 4–12 networks. Data were analyzed from time points showing the highest spike rates during 
development and two of their neighboring measurement time points. Data are plotted in 3-dimensional space, 
where each of the principal components accounts for the amount of variation of the data shown in parenthesis. 
Each data point in the scatter plot represents one network at a particular time point.
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the rat networks group, internal variation among the three individual experiments was well explained by the first 
PC. The hPSC-derived networks were better explained by the second PC, and although variability within experi-
ments was observed, a clear segregation between the three independent hPSC experiments (hPSC 1-hPSC 3) was 
not evident. In conclusion, PCA was used as a promising tool for summarizing multiple activity features from 
different MEA experiments. It successfully displayed differences in the individual MEA recordings and identified 
two separate clusters for hPSC-derived and rat networks suggestive of their distinct functional characteristics.
Discussion
We established here hPSC-derived cortical networks using highly defined culture methods resulting in consist-
ency of differentiation and distinct functional properties. We have previously shown improved functionality of 
neurosphere-differentiated networks on MEA with laminin alpha5 substrates13. We now apply LN521 substrate 
for hPSC culture11 and the subsequent adherent neuronal differentiation, and for the first time, we show a detailed 
network-level functional comparison between hPSC-derived and rat embryonic cortical cultures. The results 
demonstrate that hPSC-derived cortical networks present unique activity patterns, but the stages of development 
over time reflect those observed in rat cortical networks. Thus, these results validate the hPSC-derived networks 
as a representative model for cortical activity development in vitro.
Over the years, increasing knowledge of the key signaling molecules involved in neurodevelopment has been 
utilized for the improvement of neuronal differentiation methods9,52. Less attention has been drawn to the ECM 
components, although they are known to mediate cellular effects through signaling via membrane receptors53,54. 
Laminins are a major class of ECM molecules and are essential during embryogenesis and neural development, 
regulating neuronal proliferation, differentiation and migration53,55. The human recombinant laminin isoform 
LN521 has been shown to support the pluripotency of hPSCs in feeder-free culture7,11,12 and has been applied 
to dopaminergic differentiation of multiple hESC and hiPSC lines10,56. We have also demonstrated that laminin 
α5 substrates, including LN521, improve the functional activity of hPSC-derived neuronal networks on MEA13. 
Therefore, here LN521 was chosen as the sole substrate for maintaining the undifferentiated hPSCs11 and for sup-
porting efficient neural induction, cortical differentiation and functional development. Using optimized meth-
ods, all three of the studied hPSC lines presented over 90% neural conversion as shown by Pax6 staining after 
dual SMAD inhibition, and the generated NPCs expressed typical markers of the forebrain cortical phenotype. 
Importantly, the NPCs were cryopreservable, and with further maturation, they readily differentiated into mature 
neural cell types, neurons and astrocytes. The neuron population showed typical temporal profiles of cortical layer 
marker expression, in which the deep layer neurons were produced first followed by generation of upper layer 
neurons, similar to previous reports6. The majority of the neurons consisted of glutamatergic projection neurons 
and GABAergic interneurons, and the formation of structurally mature synapses was observed.
Both neurons and astrocytes are derived from the same neuroepithelial pool in a distinct temporal order with 
neurogenesis preceding astrogenesis57. Here, the glial switch was apparent during differentiation, as all hPSC lines 
produced first MAP2-positive neurons followed by an increased expression of S100β and GFAP, phenotypical 
markers for astrocyte progenitors and mature astrocytes, respectively. After 74 days of differentiation, over 30% 
of the cell population consisted of S100β-expressing astrocytes, of which at least half were double-positive for 
GFAP, while neurons accounted for approximately 50% of the cells in the culture. Many of the previous cortical 
differentiation protocols have described lower amounts of astrocytes (<10%), even after 80–100 days of differen-
tiation4,6,58. Astrocytes are known to promote synaptogenesis and functional maturation of neurons and are also 
important for the synchronization of networks59,60. Consequently, hPSC-derived neurons are often cocultured 
with rodent astrocytes to improve functional activity29,38. However, major drawbacks of these cocultures include 
species differences and the risk of masking the phenotypes of hiPSC-derived neurons, which is particularly crit-
ical for studies focused on disease modeling61. Attempts have been made to overcome the species differences by 
replacing rodent cells with hPSC-derived astrocytes31,62. We and others have previously shown functionally active 
networks with neurons and astrocytes differentiated through EB or neurosphere aggregate stage34,63,64. Here, we 
also present a humanized, fully adherent culture where astrocytes originate endogenously from the same NPCs as 
neuronal cells and are able to support the functional development of the networks.
Functional activity arises during early embryonic development and is essential for neuronal survival, migra-
tion and differentiation14,17. The hPSC-derived neuronal cells are generally considered functionally immature, 
resembling those of the late embryonic stages in rodents, and indeed, transcriptional profiling has shown sim-
ilarity between hPSC-derived neural cultures and the cells of mid-gestational human embryos4,65,66. Here, we 
show that the time scale for in vitro functional activity development between late-embryonic stage rat cortical 
networks and hPSC-derived cortical networks predifferentiated for one month are highly similar. Measurements 
in high-throughput multiwell MEAs demonstrate that activity can be detected from the hPSC-derived networks 
starting already from the early recording days, and the most active stage can be reached within a comparable time 
to that of rat cortical networks. Rat cortical cells developed functionally connected networks in 14–21 days on 
MEA, as similarly described by others41,42. Additionally, hPSC-derived neuronal networks formed robust syn-
chrony across the culture as early as 21 days (3 weeks) on MEA. Previous studies have typically reported longer 
times, up to 20 weeks on MEA, for hPSC-derived networks to reach full maturation32,38,62. Furthermore, our 
data reveal that the hPSC-derived and rat cortical networks undergo similar phases of development in activity 
patterns. Both networks initially fire uncorrelated single spikes and tonic spike trains, and upon maturation, an 
increasing connectivity is observed when the activity is orchestrated into highly synchronous network bursts.
Spontaneous bursting is observed in the developing cerebral cortex and is considered important for the for-
mation of neuronal circuits16. The hPSC-derived networks initially fired comparatively short bursts at high fre-
quency, but as the networks matured, the bursts became less frequent and longer in duration. Over the recoding 
period, hPSC-derived cortical networks were characterized by bursts with longer durations and lower spike fre-
quencies compared to rat counterparts. Additionally, they presented a higher number of spikes outside the bursts, 
1 1SCIENTIFIC REPORTS |         (2019) 9:17125  | ǣȀȀǤȀͷͶǤͷͶ͹;ȀͺͷͻͿ;ǦͶͷͿǦͻ͹ͼͺͽǦ;
www.nature.com/scientificreportswww.nature.com/scientificreports/
all of which may reflect species-specific differences or different states of maturity between the two cell types. In 
both hPSC-derived and rat cortical networks, activity was synaptically driven, as shown by the inhibition with 
glutamatergic antagonists and application of GABA. We also confirmed the presence of a functional inhibitory 
system in both networks, as demonstrated by the increased activity upon pharmacological modulation with a 
GABAA receptor antagonist. To date, only a few studies have reported robust burst firing of hPSC-derived neu-
ronal cultures31,34,38,67, and the activity often arises from purely excitatory glutamatergic networks lacking inhib-
itory GABAergic inputs50.
We demonstrated an extensive, direct in vitro comparison between rat cortical networks held as the “gold 
standard” in the MEA field and human-derived networks, which have been less covered by previous reports68–71. 
PCA analysis based on spike rates, network synchronization and burst features effectively identified differences 
between the two network types; thus, this approach seems potential for future studies. There is an increasing 
interest in disease modeling to better understand pathology at the network level and to exploit hPSC-derived 
neurons in drug screening and neurotoxicological studies31,72–74. Validation of methods is of importance70,74, as 
variability in hPSC-derived neuronal culture protocols, functional measurements and analysis procedures may 
at worst lead to falsely assumed conclusions on disease-specific phenotypes. Standardization also supports eval-
uations of human and rodent networks for drug screening and toxicological analysis and helps to avoid false 
negative or positive hits that may compromise further studies.
Based on our results, we report reproducible differentiation of hPSC-derived cortical networks and their sta-
ble functional development on MEA. The hPSC-derived networks differ from rat in vitro counterparts mostly 
by their unique bursting properties, whereas the stages of activity development reflect the rodent cortical net-
works in many ways. Detailed quantification of the functional similarities and differences between the rodent 
and human in vitro networks utilizing the current state-of-the-art methods offers a foundation for future studies 
involving healthy and pathological networks.

Ǥ The hPSC lines used in this study consist of the 
in-house derived hESC line Regea 08/02375 (total passages 29–31, feeder-free passages 6–8), the in-house derived 
hiPSC line 10212.EURCCs76 (total passages 38, feeder-free passages 6) and the commercial hiPSC line IMR90-477 
(WiCell, total passages 46, feeder-free passages 5–9). Lines Regea 08/023 and 10212.EURCCs were derived at the 
Faculty of Medicine and Health Technology (MET), Tampere University, Finland, which has approval from the 
Finnish Medicines Agency (FIMEA) for research utilizing human embryos (Dnro 1426/32/300/05) and support-
ive statements from the regional ethics committee of Pirkanmaa Hospital District for the derivation, culture, and 
differentiation of hESCs (R05116) and hiPSCs (R08070). Informed consent was obtained from all subjects who 
provided cell samples. All methods were carried out in accordance with relevant guidelines and regulations. The 
hPSC lines were maintained on top of a human foreskin fibroblast feeder cell layer in Dulbecco’s modified Eagle’s 
medium (DMEM) containing 20% KnockOut Serum Replacement (both from Thermo Fisher Scientific) as 
described previously78. Before neural differentiation, hPSCs were transferred and expanded in feeder-free culture 
on recombinant human laminin-521 (LN521, Biolamina, Sweden) and E8 medium (Thermo Fisher Scientific) 
according to a previous publication11. The pluripotency of hPSC lines was regularly monitored with immunocy-
tochemical staining of Nanog, Oct-3/4, SSEA-3, SSEA-4, TRA-1-81 and TRA-1-60, and the capacity to produce 
different germ layers in the EB formation assay was verified by staining for α-smooth muscle actin, α-fetoprotein, 
and Nestin. All cultures maintained normal karyotypes and were mycoplasma free.
ơǤ The neural differentiation protocol was modified from a previously published 
method6. hPSCs were detached using TrypLE Select (Thermo Fisher Scientific) and plated at a density of 5 × 105 
cells/cm2 on 100 μg/ml poly-L-ornithine (PO, Sigma) and 15 μg/ml LN521 or Matrigel matrix (Corning)-coated 
plates in E8 medium containing 10 μM ROCK inhibitor (Y-27632, Sigma). Neural maintenance medium was 
used as a basal medium and consisted of 1:1 DMEM/F12 with Glutamax and Neurobasal, 0.5% N2, 1% B27 with 
Retinoic Acid, 0.5 mM GlutaMAX, 0.5% NEEA, 50 μM 2-mercaptoethanol (all from Thermo Fisher Scientific), 
2.5 μg/ml Insulin (Sigma) and 0.1% penicillin/streptomycin (Thermo Fisher Scientific). During the neural 
induction stage (days 1–12, Fig. 1a), the maintenance medium was supplemented with 100 nM LDN193189 and 
10 μM SB431542 (both from Sigma), and the medium was changed daily. At day 12, the cells were detached with 
StemPro Accutase (Thermo Fisher Scientific) and plated at a density of 2.5 × 105 cells/cm2 on PO and either 
LN521 or mouse laminin (Sigma)-coated well plates in neural induction medium containing 10 μM ROCK 
inhibitor. For neural proliferation (days 13–25), the maintenance medium was supplemented with 20 ng/ml 
fibroblast growth factor-2 (FGF2, Thermo Fisher Scientific). At days 17, 21 and 25, the neural progenitor cells 
were passaged with StemPro Accutase and replated in medium containing 10 μM ROCK inhibitor. At day 21, 
the NPCs were cryopreserved in the same medium containing 10% DMSO (Sigma). For final maturation (days 
26–130), the medium was changed to maintenance medium supplemented with 20 ng/ml brain-derived neuro-
trophic factor (BDNF, R&D Systems), 10 ng/ml glial-derived neurotrophic factor (GDNF, R&D Systems), 500 μM 
dibutyryl-cyclicAMP (db-cAMP, Sigma) and 200 μM ascorbic acid (AA, Sigma). At day 32, the cells were plated 
for experiments at a density of 50,000 cells/cm2 on plastic well plates or 1 × 106 cells/cm2 on microelectrode arrays 
(MEAs). Plastic well plates were coated with PO and either LN521 or mouse laminin as before and MEAs with 
0.1% poly-ethylene-imide (PEI, Sigma) and either 50 μg/ml LN521 or mouse laminin. Medium changes were 
performed every two to three days.
Primary rat cultures. Cortex tissue was harvested from embryonic days 17–18 Wistar rat embryos as 
described previously79. Local authority approved the animal license (County Administrative Board of Southern 
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Finland, ESAVI/10300/04.10.07/2016) to conduct the described procedures. All experiments were performed 
according to institutional guidelines and regulations (University of Helsinki internal license number: KEK17-
016). The medium consisted of Neurobasal, 2% B27, 2 mM GlutaMAX and 1% penicillin/streptomycin (Thermo 
Fisher Scientific). The plating density for the experiments was 100,000 cells/cm2 on plastic cell culture wells 
or 2.5 × 105 cells/cm2 on MEAs. Plastic well plates and MEAs were coated with 25 μg/ml poly-D-lysine (PDL, 
Sigma). The media was changed every two or three days.
Immunocytochemical staining. Immunocytochemistry was performed as previously described80. Primary 
antibodies consisted of βIII-tubulin (rabbit, 1:2000, GenScript: A01627), βIII-tubulin (chicken, 1:200, Abcam: 
ab41489), Brn2 (goat, 1:400 Santa Cruz: sc-6029), Ctip2 (rat, 1:500, Abcam: ab18465), FoxG1 (rabbit, 1:500, 
Abcam: ab18259), GABA (rabbit, 1:1000, Sigma-Aldrich: A2052), GAD67 (mouse, 1:100, Millipore: MAB5406), 
GFAP (chicken, 1:4000, Abcam: ab4674), MAP2 (rabbit, 1:400, Millipore: AB5622), MAP2 (chicken, 1:4000, 
Novus Biologicals: NB300-213), Oct4 (goat, 1:200, R&D Systems, AF1759), Pax6 (rabbit, 1:1000, BioLegend: 
901301), PSD-95 (mouse, 1:50, Abcam: ab2723), Satb2 (mouse, 1:200, Abcam; ab51502), S100β (mouse, 1:500, 
Abcam: ab11178), Sox2 (mouse, 1:200, R&D Systems: MAB2018), synaptophysin (rabbit, 1:2000, Abcam: 
ab32127), Tbr1 (rabbit, 1:1500, Abcam: ab31940), Tbr2 (rabbit, 1:1000, Abcam: ab23345), vGlut1 (rabbit, 1:2000, 
Synaptic Systems: 135303) and vimentin (mouse, 1:500, Dako: M0725). Secondary antibodies consisted of Alexa 
Fluor 488 (1:400), Alexa Fluor 568 (1:400) or Alexa Fluor 647 (1:200) dyes (all Thermo Fisher Scientific). The cells 
were imaged using an Olympus IX51 microscope with an Olympus DP30BW camera (Olympus Corporation, 
Hamburg, Germany), an LSM780 laser scanning confocal microscope with a Quasar spectral GaAsP detector 
(all from Carl Zeiss, Jena, Germany) and a Nikon A1R + laser scanning confocal microscope with an A1-DUG 
GaAsP Multi Detector Unit. CellProfiler81 and CellProfiler Analyst82 software were used for quantification.
Ǥ Extracellular recordings were obtained with an Axion Maestro 
system controlled by AxIS software (Axion Biosystems, Atlanta, GA, USA) with a 12.5 kHz sampling rate. Cells 
were plated on CytoView MEA 12 for recording spontaneous activity development and on CytoView MEA 48 for 
pharmacological experiments (both from Axion Biosystems). CytoView MEA 12 and 48 plates contained 64 or 
16 electrodes per well, respectively. Recordings were performed under 37 °C temperature control, and a 5% CO2 
atmosphere was provided during measurements exceeding 10 min. Spontaneous activity was measured twice a 
week for 10 min for a total of 14 weeks.
For pharmacological tests, 30 min of baseline activity was measured followed by a 30 min treatment 
follow-up. Pharmacological experiments were performed on rat cortical networks after 22 days on MEA and for 
hPSC-derived networks after 29 days on MEA. The pharmacological reagents used included kainic acid (1–5 μM, 
Sigma), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptor antagonist 6-cyano-7
-nitroquinoxaline-2,3-dione (CNQX, 50 μM, Abcam), N-methyl-D-aspartate (NMDA) receptor antagonist D-(-)- 
2 amino-5-phosphonopentanoic acid (D-AP5, 50 μM, Sigma), γ-aminobutyric acid (GABA, 10 μM, Sigma), 
GABAA receptor antagonist gabazine (30 μM, Sigma) and voltage-gated sodium channel blocker tetrodotoxin 
(TTX, 1 μM, Tocris). All pharmacological agents were added into separate MEA wells in 30 μl volumes with 
higher concentrations, thus resulting in the final concentrations as stated above.
Ǥ Spike detection was performed according to the stationary wave-
let transform-based Teager energy operator (SWTTEO) algorithm that was presented previously83 and revised 
for biological data43. The algorithm was implemented in a custom-made MATLAB (MathWorks) script. During 
initial method testing, it was confirmed that the method reliably detects low-amplitude signals typical for 
hPSC-derived networks and the pharmacologically evoked fast tonic spiking that can be challenging to separate 
from the baseline noise, as shown in the examples in Supplementary Fig. S8. In short, data were prefiltered with 
an elliptic bandpass filter with a 200 Hz lower passband and a 3000 Hz upper passband frequencies. The spike 
detection method uses a low threshold value for the initial threshold-based spike detection to detect low ampli-
tude spikes. Here, a threshold value of 4.5 × the estimate of the noise standard deviation was applied according 
to previous publication84. Next, extra steps were performed to remove possible false positive spikes using the 
SWTTEO algorithm. The number of spikes extracted by threshold detection was fed to the SWTTEO analysis, 
and the corresponding spike list was produced. Finally, only the spikes detected by both methods were considered 
true positive events. Electrodes detecting >10 spikes per minute were considered active electrodes and included 
in the analysis.
Burst analysis was performed utilizing the R-package meaRtools85. For burst detection, the logISI algorithm 
was integrated into the analysis code86 with minor modifications. When calculating burst features, only bursting 
electrodes were concerned. Parameters were set according to the original publication except for the minimum 
number of spikes in the burst, which was set to 5. A single modification to the original algorithm was added to 
merge short bursts in cases when the computed inter-spike interval threshold was less than 100 ms. Here, a cutoff 
of 100 ms was applied as the minimum time required between bursts.
Connectivity analysis was performed using the correlated spectral entropy (CorSE) method described previ-
ously47. Functional connectivity was calculated between all electrode pairs of the MEA during the measurement 
period. Briefly, CorSE quantifies the synchronization of signals by correlation of the temporal changes in their 
spectral contents. Magnitude of correlation gives the connectivity strength. Average CorSE values are calculated 
from all the MEA channels to assess the overall connectivity strength of the whole network. To observe the 
changes in the network formation of the most robust network participants, connectivity maps were plotted for 
the channel pairs, which have CorSE > 0.7.
Principal component analysis (PCA) was used as previously described87 to segregate MEA results from differ-
ent experiments. The data were derived from two differentiations of hESC line 08/023 (named hPSC 1 and 2) and 
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one differentiation of hiPSC line 10212.EURCCs (named hPSC 3). Additionally, MEA data were derived from 
three independent batches of rat embryonic neurons (named Rat 1–3). From each cell batch, the developmental 
time point showing the most significant activity (maximum spike rate) and two of its surrounding time points 
were selected for PCA analysis. The selected time points (days on MEA) were 21, 24 and 28 for hPSC 1 and 2; 70, 
73 and 77 for hPSC 3; 21, 24 and 28 for Rat 1 and 2; and 24, 28 and 31 for Rat 3. A total of 7 features from spike, 
burst and network synchronization analysis were selected. These included the mean firing rate (MFR), burst rate, 
burst duration, spike frequency in burst, spikes in burst, percentage of spikes in bursts and spike time tiling coeffi-
cient (STTC, using default time bin 50 msec). All values were normalized using the standard score method. PCA 
was performed in MATLAB and plotted against the three major principal components.
Statistical analysis. Due to the non-Gaussian distribution of the data, the nonparametric Mann-Whitney U 
test was used. A p-value < 0.05 was considered significant. All statistical tests were performed with SPSS Statistics 
software (version 25.0). Tampere University statistician Heini Huhtala was consulted for the statistical tests.
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author 
on reasonable request. We are planning to publish the MEA data in a subsequent publication, currently in 
preparation.
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Astrocytes are the most abundant cell type in the central nervous system (CNS) and play important roles in 
supporting neuronal cell functions by releasing energy substrates and trophic factors, maintaining homeostatic 
functions and regulating neuronal synaptogenesis and synaptic transmission1–4. During CNS injury and disease, 
astrocytes transform into a reactive phenotype with changed morphology and altered gene expression and secre-
tion profiles4,5. These astrocytes are regarded as immunocompetent cells that can respond to complex inflamma-
tory events by secreting cytokines and chemokines, thereby controlling immune cell activation and migration 
to sites of damage5,6. Astrocytes are considered to play a dual role in CNS pathophysiology, as they can both 
support regeneration and exert detrimental effects on surrounding cells and brain parenchyma6,7. Interestingly, 
two distinct astrocyte phenotypes were recently described in rodent studies: a detrimental A1 type and a benefi-
cial A2 type8,9. Of these, A2 astrocytes were associated with ischemia-induced CNS lesions, while A1 astrocytes 
dominated in inflammation-induced lesions reflecting those in diseases such as multiple sclerosis (MS). However, 
reactivation of astrocytes is a complex phenomenon that possibly results in a mixture of the two phenotypes or 
even several distinct yet unidentified activation states10.
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The majority of the knowledge on reactive astrocytes has been gathered from rodent studies, whereas the 
inflammatory nature of human astrocytes has received less attention9–11. Nevertheless, growing evidence shows 
significant structural and functional differences between human and rodent astrocytes, underlining the relevance 
of further studies focusing on human astrocytes and their behaviors12–14. In vitro studies with human cells have 
typically utilized astrocytes from primary fetal or adult tissues or immortalized astrocytoma cell lines14–17; how-
ever, the availability of human primary astrocytes is limited, and immortalized cells are often criticized as model 
systems. Advancements in the field of stem cell biology have enabled the differentiation of astrocytes from human 
pluripotent stem cells (hPSCs)18–22, providing an unlimited cell source and an option to create disease-specific 
cell lines. Despite these advancements, only a few studies have described the reactivation of hPSC-derived astro-
cytes18,22–25, and even fewer studies have reported the interplay of inflammation or reactive astrocytes with human 
neuronal cells24,26,27.
The development of newly engineered in vitro platforms based on hPSC-derived cells is a promising approach 
for studying the mechanisms of CNS functions and disorders28–30. Microfluidic devices are potent research tools 
for studying the interactions of several cell types in controlled, compartmentalized culture environments31,32. For 
example, multiple cell compartments can be connected via microtunnels, allowing the growth of axons while 
restricting neuronal somas thus facilitating experimentation on cellular processes and cell-to-cell interactions31. 
Advantages in microfluidic technology have already been validated, for instance, in axonal transport and mye-
lination studies33–39. However, less data are available on neuron-astrocyte interactions and neuroinflammatory 
activity26,31. Understanding the complex cellular interplay among several neural cell types can help to reveal 
underlying mechanisms in neurodegenerative diseases and create opportunities for drug discovery.
Here, we studied reactivation using human induced pluripotent stem cell (hiPSC) -derived astrocytes and 
observed their transformation into cells with reactive proinflammatory phenotypes with neurosupportive char-
acteristics. Furthermore, we designed a novel microfluidic co-culture platform including neurons, astrocytes and 
an inflammatory environment that was validated for studying reactive astrocyte-neuron interactions. We are 
convinced that hiPSC-astrocyte model systems can facilitate investigation of specific human cell properties and 
ultimately model human CNS diseases in a dish.
Results
ǦǤ HiPSC-derived astrocytes were first characterized in 
their quiescent resting state for the expression of astrocyte-specific markers at the gene and protein levels. Gene 
expression analysis revealed expression of transcripts typical for developing astrocytes, including S100 calci-
um-binding protein beta (S100β) and vimentin (VIM) (Fig. 1a). Additionally, mature astrocyte genes, such as 
glial fibrillary acidic protein (GFAP) and excitatory amino acid transporters 1 and 2 (EAAT1 and EAAT2, respec-
tively), were expressed (Fig. 1a). Major astrocyte-specific markers were also confirmed by immunocytochemi-
cal staining of GFAP, S100β, glutamine synthetase (GS), aldehyde dehydrogenase 1 family member (Aldh1L1), 
EAAT1 and EAAT2 (Fig. 1b). To confirm that the astrocytes were mostly negative for neuronal markers, the cells 
were stained for microtubule-associated protein 2 (MAP2) (Supplementary Fig. S1). Thus, the culture consisted 
of a heterogeneous astrocyte population with a cell type-specific expression signature.
ǦǦͷβ and TNF-αǤ 
To induce a reactive astrocyte phenotype with inflammatory cytokines and to characterize astrocyte properties, 
an extended seven-day co-stimulation with IL-1β and TNF-α was performed (Fig. 2a). First, the presence of 
cytokine receptors for IL-1β and TNF-α in hiPSC-derived astrocytes was analyzed in the quiescent resting state. 
The expression of IL-1 receptor 1 (IL1R) and IL-1 receptor accessory protein (IL1RAP), as well as that of tumor 
necrosis factor receptor superfamily 1 A (TNFRSF1A), which is important for mediating the signals of these 
Figure 1. Characterization of hiPSC-derived astrocytes. (a) The hiPSC-derived astrocytes expressed 
several astrocyte-specific genes, including GFAP, VIM, S100B, EAAT1 and EAAT2. The data are presented 
as the mean ± s.e.m. (n = 2 with three technical replicates; the data are representative of two experiments). 
(b) Immunocytochemical staining was used to confirm the expression of the major astrocyte markers GFAP, 
S100β, GS, Aldh1L1, EAAT1 and EAAT2.
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Figure 2. IL-1β and TNF-α treatment induces a reactive astrocyte phenotype. (a) Experimental setup for 
astrocyte stimulation with IL-1β and TNF-α and astrocyte characterization. (b) Gene expression analysis 
revealed the presence of TNFRSF1A, IL1R, and IL1RAP transcripts in the astrocytes (n = 2 with three technical 
replicates; the data are representative of two experiments). (c) In control astrocytes, NF-κB was ubiquitously 
expressed in the cytoplasm, whereas after 60 minutes cytokine stimulation, it was activated and translocated to 
the nucleus (white arrows). (d) NF-κB activation was quantified as the percentage of nuclei with translocation 
among the total nuclei (n = 6 cultures; the data were analyzed from two experiments). (e) Immunocytochemical 
staining of the intermediate filament proteins vimentin and GFAP showed morphological changes from 
filamentous to flattened shapes (white arrows) in response to cytokine stimulation. (f) Morphological change 
was quantified based on the vimentin staining of samples on day 7. The circularity of the cells in each group 
is presented as the median and interquartile range, with the whiskers showing the minimum and maximum 
values. Images were analyzed from six cultures derived from three experiments. (g) GFAP expression levels 
decreased following cytokine stimulation (n = 2 with three technical replicates; the data are representative of 
two experiments). (h) GFAP was analyzed at the protein level by western blot analysis, representative cropped 
images of the membranes for the GFAP and β-Actin are shown here and full length of membranes are presented 
in the Supplementary Fig. S4. (i) Quantification of GFAP and β-Actin showed a reduction after cytokine 
treatment. β-Actin was used as a loading control (n = 2; the data are representative of three experiments). 
(j) Cytokine treatment impaired the glutamate uptake capacity of astrocytes (n = 3; the data are representative 
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cytokines, was confirmed (Fig. 2b). However, TNFRSF1B was not detectable in the hiPSC-derived astrocytes 
(Fig. 2b).
Nuclear factor kappa B (NF-κB) is a key transcription factor that has been shown to be activated in reac-
tive astrocytes during neuroinflammation6. Here, NF-κB was ubiquitously present in the cytoplasm of quiescent 
astrocytes but was only present in low amounts in the nuclei (Fig. 2c). However, soon after the initiation of 
cytokine treatment, NF-κB was activated and translocated to the nucleus (Fig. 2c, Supplementary Fig. S2). After 
60 min of cytokine stimulation, a significant portion (over 50%) of the astrocytes showed activation of the NF-κB 
pathway (control [Ctrl] 9.7 ± 0.6 vs. IL-1β/TNF-α treated [Trt] 55.3 ± 1.9, p < 0.001, Fig. 2d).
Reactive astrocytes undergo changes in morphology typically characterized by hypertrophy of main cellu-
lar processes40. Over the 7-day cytokine treatment period, the astrocytes gradually exhibited a morphological 
change from a highly filamentous shape to a flattened polygonal appearance (Supplementary Fig. S3). This typical 
response was most notable upon the staining of the intermediate filament proteins vimentin and GFAP, both 
of which contribute to astrocyte morphology (Fig. 2e). The morphology of the control and treated astrocytes 
was quantified based on vimentin staining at the 7-day time point (Fig. 2f). The circularity index was calculated 
according to the area and perimeter metrics of each cell, with a value of 1 describing a perfectly circular object. 
Quantification confirmed that the astrocytes lost their filamentous shape and adopted a more circular morphol-
ogy in response to cytokine activation (medians Ctrl 0.16 vs. Trt 0.27, p < 0.001, Fig. 2f).
Changes in intermediate filament protein expression have often been considered to be hallmarks of reactive 
astrocytes10. Although the cytokine-stimulated reactive astrocytes showed positive staining for GFAP (Fig. 2e), 
we observed an 8-fold decrease in mRNA levels after the 7-day treatment in the treated cells compared to the 
controls (Ctrl 8.81 ± 0.54 vs. Trt 1.05 ± 0.15, p < 0.001, Fig. 2g). The GFAP protein levels were also confirmed by 
western blot analysis, showing similar decreases as a result of IL-1β and TNF-α treatment (Ctrl 0.73 ± 0.04 vs. Trt 
0.16 ± 0.06, p = 0.010, Fig. 2h–i, Supplementary Fig. S4). Additionally, the vimentin protein levels were studied 
and were found to remain more stable than GFAP protein levels after cytokine treatment (Supplementary Fig. S4).
Uptake of glutamate from the extracellular space is an important function of astrocytes that sustains healthy 
synaptic transmission of neurons4. Impairment in the uptake of glutamate from the culture medium was revealed 
in cytokine-stimulated astrocytes compared to control astrocytes (Ctrl 42.4 ± 1.4 vs. Trt 9.0 ± 0.66, p < 0.001, 
Fig. 2j). In summary, treatment with the cytokines IL-1β and TNF-α activated astrocytes, modified their inter-
mediate filament cytoskeleton and transformed them morphologically and functionally into cells with a reactive 
phenotype.
Ǥ Next, we stud-
ied the effects of cytokines on the viability and proliferation of astrocytes after a 7-day treatment regimen. 
Immunocytochemical staining with the proliferation marker Ki67 showed a slight (5%) but significant increase in 
proliferation in cytokine-treated cells compared to control cells (Ctrl 6.8 ± 0.9 vs. Trt 11.8 ± 0.7, p < 0.001, Fig. 3a–
b). However, this increase did not significantly affect the total nuclei count (Ctrl 1094 ± 28 vs. Trt 1040 ± 55, 
Fig. 3c) or the total DNA amount (Ctrl 95476.7 ± 8299.5 vs. Trt 89263.8 ± 8779.2, Fig. 3d). Upon assessing the 
viability of astrocytes after cytokine treatment, a significant increase in cytotoxicity (Ctrl 1053.0 ± 55.8 vs. Trt 
2677.3 ± 461.2, p = 0.017) and a decrease in viability (Ctrl 38938.2 ± 2347.3 vs. Trt 17999.2 ± 3352.4, p < 0.001) 
in the treated cells compared to the control cells were found (Fig. 3e). In the apoptosis metrics, no statistically sig-
nificant differences were detected between the groups (Ctrl 26026.8 ± 4362.3 vs. Trt 20265.8 ± 3629.6, Fig. 3e). In 
conclusion, cytokine treatment of hiPSC-derived astrocytes caused minor proliferation, but the total cell number 
remained stable due to cytotoxicity.
ƪǤ To reveal whether the astrocytes 
were able to produce an immune response, the gene expression and secretion profiles of inflammatory markers 
were characterized. First, the effects of IL-1β and TNF-α treatment on the expression of the inflammation-related 
genes CCL5, CXCL8, complement component 3 (C3) and lipocalin-2 (LCN2) were studied (Fig. 4a–d). At the 
basal level, none of the transcripts were expressed, whereas treatment for 24 h led to over 300-fold increases in 
the expression of the chemokines CCL5 and CXCL8 (Fig. 4a–b). Recently, C3 has been linked to astrocyte reac-
tivity8,41. Here, C3 expression increased in a time-dependent manner after cytokine treatment, reaching over a 
200-fold change compared to the control level at the 7-day time point (Fig. 4c). The gene expression of LCN2 also 
considerably increased over 7 days, although the change was not as prominent as that for the other transcripts 
(Fig. 4d).
Next, the secretion of 105 inflammatory proteins (see full list in Supplementary Table  1) from 
cytokine-stimulated astrocytes was studied (Fig. 4e; Supplementary Fig. S5a). Treatment induced widespread 
protein secretion at the 24 h and 7-day time points (Fig. 4e and Supplementary Fig. S4a). The most highly secreted 
proteins were chemokines (CXCL10, CXCL5, CXCL8, CCL2, CXCL1, and CCL5), but other inflammatory fac-
tors, such as pentraxin 3 (PTX3), osteopontin (OPN), chitinase-3 like 1 (CHI3L1), Serpin E1 and adhesion mol-
ecule vascular cell adhesion protein-1 (VCAM1), were also secreted. Among the cytokines, IL-6, IL-1β, TNF-α 
and macrophage migration inhibitory factor (MIF) were detected on medium obtained from the cytokine-treated 
astrocytes.
of two experiments). The data are presented as the mean ± s.e.m. Statistical analysis was performed with 
independent-sample t-tests except in (f), in which statistical analysis was performed with the Mann-Whitney U 
test. Statistical significance: * p < 0.05, ** p < 0.01, and *** p < 0.001.
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IL-6 is a classic inflammatory mediator known to be secreted from astrocytes after reactivation42; therefore, 
the secretion of IL-6 was further investigated. Control astrocytes did not secrete IL-6, but cytokine-stimulated 
astrocytes gradually secreted IL-6, the levels of which reached 2000 pg/ml at the 7-day time point (Fig. 4f). In 
summary, astrocytes responded to cytokine treatment with changes in gene expression and broad secretion of 
proinflammatory factors.
-
Ǥ Astrocyte activation resulted in widespread secretion of inflammatory molecules; therefore, we next 
studied whether astrocyte conditioned medium (ACM) has an effect on neurons. Astrocytes were treated with 
IL-1β and TNF-α for seven days; the treatment was then washed out, and the ACM was collected 48 h later. 
At this stage, the astrocytes still secreted a broad profile of inflammatory factors (Supplementary Fig. S5b). 
In-house-differentiated hPSC-derived neurons were exposed to ACM for 48 h, after which they still retained 
a normal branched neuronal morphology (Fig. 5a). Additionally, ACM treatment did not cause any changes 
in viability or apoptosis or cause cytotoxicity, confirming that the produced reactive astrocytes did not secrete 
neurotoxic factors at detrimental levels (Fig. 5b). Similar results were obtained with commercial hiPSC-derived 
neurons (Supplementary Fig. S6a–b).
The effect of ACM on neuronal functionality was studied with a microelectrode array (MEA) setup, which 
allowed repeated measurements from the same network. In-house-differentiated hPSC-derived neuronal cells 
were first cultured on MEAs for five weeks until mature bursting and synchronic activity was achieved through-
out the network (Fig. 5c–d). Once array-wide activity had developed, the cultures were treated with control ACM 
or reactive ACM, and measurements were performed immediately (acute) and at 1 h, 4 h and 24 h after ACM 
application (Fig. 5e). A naïve control group received the same volume of intact medium (held for 48 h in an incu-
bator similar to that in which the collected ACM was held). Overall, addition of the media induced increases in 
spike rates in all studied groups and, to a lesser extent, increases in burst counts during the 24 h follow-up period 
(Fig. 5e–f, Supplementary Table 2). The magnitudes of these changes were not as great in the commercial neurons 
as in the in-house-differentiated neurons (Supplementary Fig. S6d–e).
Next, activity changes in relation to baseline measurements were studied between the different treatment 
groups (Fig. 5g–h). The control ACM- and reactive ACM-treated networks responded similarly, as no significant 
Figure 3. Viability and proliferation of cytokine-treated astrocytes. (a) Immunocytochemical staining of 
proliferating Ki67-positive cells in control and IL-1β/TNF-α-treated cultures. (b) The number of proliferating 
cells was increased after cytokine treatment. (c) The nuclei count quantified from DAPI staining remained 
similar between the control and treated groups. For Ki67 staining and nuclei counts, images were analyzed 
from 11 cultures derived from four experiments. (d) Additionally, the amount of DNA was similar between the 
groups (n = 6 with two technical replicates; the data are from two experiments). (e) The viability assay showed 
decreased viability and increased cytotoxicity but no significant difference in apoptosis following cytokine 
treatment (n = 3; the data are representative from two experiments). The quantification data are presented as the 
mean ± s.e.m. All statistical analysis was performed using independent-sample t-tests. The significant p-values 
are presented in the graphs. Statistical significance: * p < 0.05, ** p < 0.01, and *** p < 0.001.
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differences between them were detected in spike or burst rates (Fig. 5g–h). This result was confirmed with both 
in-house-produced (Fig. 5g–h) and commercial neurons (Supplementary Fig. S6f–g).
In comparison to the control group, the reactive ACM group demonstrated an immediate increase in spike 
activity (Ctrl -0.168 ± 0.039 vs. reactive ACM 0.025 ± 0.036, p = 0.033) and a decrease in activity at the 24 h time 
point (Ctrl 0.470 ± 0.066 vs. reactive ACM 0.250 ± 0.087, p = 0.045, Fig. 5g–h). However, the control ACM group 
exhibited both increased spike activity (Ctrl 0.349 ± 0.067 vs. Ctrl ACM 0.576 ± 0.095, p = 0.039) and increased 
burst rate (Ctrl 0.579 ± 0.377 vs. Ctrl ACM 2.048 ± 0.535, p = 0.02) at the 1 h time point compared to the control 
group. Similar changes in spike and burst rates were also confirmed with commercial neurons (Supplementary 
Fig. S6f–g). Thus, conditioned medium from reactive astrocytes did not cause any detectable cytotoxicity or 
functional silencing of neuronal networks. In fact, both control and reactive ACM supported functional activity, 
suggesting that astrocytes were neurosupportive rather than neurotoxic under these conditions.

ǦǦ
Ǥ Next, we established a novel platform enabling controlled co-culture of neurons and astrocytes, 
targeted stimulation of astrocytes, and study of neuron-astrocyte interactions (Fig. 6a). The microfluidic 
device is composed of separate compartments for neurons and astrocytes, which are connected via micro-
tunnels and axonal compartment (Fig. 6a,b, Supplementary Fig. S7). Immunofluorescence staining demon-
strated that β-tubulin-positive neuronal somas were restricted to their designated compartments (Fig. 6c–e), 
while NF-H-positive axons grew readily through the microtunnels into the axonal compartment (Fig. 6d). 
GFAP-positive astrocytes were restricted to the astrocyte compartment (Fig. 6c), and direct cell-to-cell inter-
actions could be verified, as astrocyte processes extended through the microtunnels and connected to neuronal 
axons in the neighboring compartment (Fig. 6e,f).
Figure 4. Cytokine treatment results in the inflammatory activation of astrocytes. (a–d) The gene expression 
levels of (a) CCL5, (b) CXCL8, (c) C3, and (d) LCN2 were analyzed in cytokine-treated and control astrocytes 
at the 0-, 1-, 3- and 7-day time points. Robust increases in the expression of all studied genes were detected 
after cytokine treatment (n = 2 with three technical replicates; the data are representative of two experiments). 
(e) Secretion of inflammatory factors into the medium was analyzed at the 24 h and 7-day time points. The 
relative intensity values for the different analytes were calculated by subtracting the intensity values of the 
control samples from those of the cytokine-treated samples at each time point (n = 1 with two technical 
replicates; the data are representative of two experiments). (f) The levels of IL-6 were analyzed at 0, 1, 3 and 7 
day in cytokine-treated and control astrocytes. IL-6 levels increased in a time-dependent manner over 7 days 
in the cytokine-treated samples, while under control conditions, the levels were undetectable (n = 2 with two 
technical replicates; the data are representative of two experiments). The quantification data are presented as the 
mean ± s.e.m.
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Figure 5. Viability and functionality of neuronal cells after exposure to reactive astrocyte conditioned medium. 
(a) Immunocytochemical staining of hPSC-derived neuronal cells exposed to control medium (Ctrl), control 
ACM (Ctrl ACM) and reactive ACM. Neuronal cells stained positive for MAP2 (green) and β-tubulin (red). 
DAPI nuclear staining is shown in blue. (b) The reactive astrocyte conditioned medium did not show an effect 
on the viability, cytotoxicity or apoptosis of neuronal cells after 48 h of exposure (the data are representative of 
two experiments; in each experiment n = 3–6 per group). Statistical analysis was performed using independent-
sample t-tests. (c) The effect of ACM on neuronal functionality was studied with microelectrode array (MEA) 
measurements. The phase-contrast images show neuronal cells cultured on MEAs. (d) Typical spontaneous 
activity in neuronal networks recorded from three electrodes over 5 minutes. The raster blot shows the typical 
network-wide activity from all 16 electrodes of one well over 5 minutes. (e) Spike rate (Hz) development for 
active electrodes before (baseline) and after different medium exposures (acute, 1 h, 4 h and 24 h). (f) Number 
of bursts per minute before and after different medium exposures. For the MEA data, n = 12 networks derived 
from one differentiation. The data are presented as the mean ± s.e.m., and statistical analysis was performed 
using the Friedman test. (g-h) To highlight significant differences between treatment groups, the data from 
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Fluidic isolation of the astrocyte compartment from the neuron compartment was demonstrated with 
FITC-conjugated dextran particles, which did not diffuse to the neuron compartment, as detected by fluorescence 
imaging (Fig. 6g) and measurements of particle concentrations after 24 h (Fig. 6h). However, over 24 h, particles 
did diffuse from the astrocyte compartment into the axonal compartment, verifying the possibility of studying 
humoral effects on axons with this system (Fig. 6g). In summary, the generated platform enabled the isolation of 
different cell types and cell parts, and the control of cell-to-cell interactions and fluid flow.
ƪơƪ 
Ǥ The last aim was to induce the reactive astrocyte phenotype in the microfluidic platform and study 
the effect of reactive astrocytes on axon growth in the axonal compartment (Fig. 7a). To treat astrocytes, IL-1β 
and TNF-α were applied to the astrocyte compartment after the neurons and astrocytes were both plated into 
the microfluidic platform (Fig. 7a). The 72 h cytokine treatment did not cause any major cytotoxic effects on 
either cell type, as only a few dead cells were detected among viable cells (Fig. 7b). Similar to the findings under 
open-well conditions described above, the reactive astrocytes secreted a wide range of inflammatory factors (e.g., 
VCAM1, CCL2, CXCL8, CXCL5, and CHI3L1) (Fig. 7c, Supplementary Fig. S8).
After confirming the proinflammatory phenotype of the astrocytes, the effect of these astrocytes on axonal 
growth was studied by quantifying the number and density of axons extending to the axonal compartment 
(Fig. 7d–g). In addition to devices with co-cultures of control or reactive astrocytes with neurons (treatment 
groups: Neu + Ctrl astro and Neu + Reactive astro), devices with only neurons were included in the study to 
elucidate whether treatment with IL-1β and TNF-α alone had an effect on axons (treatment groups: Neu and 
Neu + IL-1β/TNF-α). Over the 72 h follow-up period, no statistically significant differences were detected in axon 
counts between the groups (Fig. 7e). Furthermore, axonal density was assessed with live-cell calcein-AM color 
staining by quantifying the area coverage in the axonal compartment 72 h after cytokine treatment (Fig. 7f,g). The 
results showed that reactive astrocytes increased axonal density compared to control astrocytes (Neu + Ctrl astro 
4.7 ± 0.6 vs. Neu + Reactive astro 8.2 ± 1.3, p = 0.028, Fig. 7g). Taken together, the results indicate that selective 
cytokine stimulation of astrocytes resulted in an inflammatory environment that had a positive effect on axonal 
growth, demonstrating the suitability of the developed cell model for studying axonal biology.
Discussion
Astrocytes are an acknowledged partner in the inflammatory processes in many neurodegenerative diseases and 
injuries of the CNS5,11. Astrocytes regulate the homeostasis of their surroundings and can have direct effects on 
neurons, both beneficial and detrimental. Human astrocytes are known for their complexity and heterogeneity, 
and some of their structural and functional traits differ from those of rodent astrocytes12–14. Therefore, in this 
study, we used hiPSC-derived astrocytes to create a human cell model system to study the inflammatory activa-
tion of astrocytes and the effects of activated astrocytes on neuronal functionality and axonal growth.
A variety of inflammatory molecules have been studied for their ability to induce a reactive astrocyte pheno-
type in vitro8,23,43. Here, astrocytes were treated with a combination of the cytokines IL-1β and TNF-α, which are 
typically released by activated microglia during neuroinflammation and are capable of stimulating astrogliosis 
in vivo5,44,45 and in vitro18,46–48. Furthermore, co-stimulation with IL-1β and TNF-α has been demonstrated to 
be a more potent trigger of reactivity that stimulation with either of the cytokines independently8,23. To date, few 
reports have described the responses of hiPSC-derived astrocytes to cytokine treatments18,22–25,41. However, many 
astrocyte differentiation protocols use serum to enhance astrocytes production that can promote astrocyte reac-
tivation14,23. Here, astrocytes were cultured in serum-free medium, and under control conditions, the astrocytes 
remained in a quiescent state according to the results of gene expression and secretion profile analysis. We also 
treated astrocytes with the inflammatory cytokines for 7 days as described previously18 to mimic chronic effects. 
During the 7-day activation, we observed a gradual change in the morphology of the astrocytes from fibrous to 
polygonal and a reorganization of intermediate filament proteins, which are typical hallmarks of astrogliosis in 
vivo6. This clear morphological change has previously been demonstrated in vitro with human fetal astrocytes14,46 
but not reported with hiPSC-derived astrocytes18,22,25. Additionally, upregulation of GFAP has been commonly 
described in relation to astrogliosis in vivo10. Interestingly, even though both control and reactive astrocytes 
stained positive for GFAP, more detailed analysis revealed downregulation of GFAP at both the gene and total 
protein levels upon cytokine treatment. Consistent with our data, reductions in GFAP have been reported in 
IL-1-treated human fetal astrocytes49 and in IL-1β- and TNF-α-treated rodent astrocytes at both the gene and 
protein levels8,43. Overall, we showed morphological transformation and alterations in the structural proteins of 
reactive astrocytes following 7-day IL-1β and TNF-α treatment.
Astrocytes are immunocompetent cells, and inflammatory activity upon stimulation is therefore their impor-
tant feature6. The key signaling pathways involved in astrocyte reactivation include NF-κB pathway, which was 
acutely activated after cytokine treatment in the present study. NF-κB activation is known to induce the pro-
duction of proinflammatory cytokines, chemokines and adhesion molecules, which mediate leukocyte recruit-
ment to the CNS, leading to neuroinflammation7,10,50. Here, we demonstrated the secretion of a wide variety of 
chemokines, cytokines and other inflammatory factors by reactive astrocytes. For example, secretion of the typ-
ical inflammatory markers CCL5, CXCL8 and IL-6 was temporally induced after cytokine treatment, which has 
also been previously reported in studies on IL-1β- and TNF-α-treated hiPSC-derived astrocytes18,22. Interestingly, 
panels e-f were reused and are presented as the changes in spike and burst rates compared to the baseline 
measurements. The data are shown as Tukey boxplots. Statistical significances was determined with the Mann-
Whitney U test; * p < 0.05, ** p < 0.01, and *** p < 0.001.
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we observed upregulation of complement component 3 (C3), which has been linked to the neuroinflammatory 
phenotype of reactive astrocytes and has also been detected in demyelinating lesions of MS patients8,9. For the first 
time, we detected CHI3L1, OPN, and PTX3, known astrogliosis-associated markers in vivo9, in hiPSC-derived 
reactive astrocytes; these proteins are also considered candidate diagnostic and prognostic biomarkers for CNS 
diseases51,52. Thus, a broad range of inflammatory factors were discovered in a human model system of astroglio-
sis; however, the specific roles of these factors in neuroinflammatory processes remain to be explained.
Only a handful of studies have addressed interactions between reactive astrocytes and neurons in vitro using 
human cells8,24,26,53. Here, humoral signaling by reactive astrocytes sustained neuronal viability, suggesting 
that the astrocyte secretion profile was not primarily neurotoxic. In contrast, previous studies have described 
decreased numbers of neurons in direct co-cultures of human neurons and IL-1β-stimulated astrocytes24, and the 
humoral effects of TNF-α, IL-1α and complement component 1q (C1q) -stimulated rodent astrocytes have been 
reported to be toxic to human neurons8. Here, responses were also studied on a more sensitive neuronal network 
functionality level54. ACM exposure did not silence neuronal network activity but rather supported function-
ality, suggesting the polarization of astrocytes into a neurosupportive state. Previous studies have shown that 
secreted factors as well as direct cell-to-cell contact with rodent astrocytes can increase the activity of networks 
Figure 6. Description of the microfluidic device for co-culture of neurons and astrocytes and the 
fluidic isolation of the cell compartments. (a) Schematic showing a 3D illustration of the microfluidic 
device. (b) The microfluidic device consisted of two opposing compartments for neurons and a separate 
compartment for astrocytes, all of which were connected to an axonal compartment via microtunnels. 
(c) Immunocytochemical staining showing successful co-culture of β-tubulin-positive neurons and GFAP- 
and vimentin-positive astrocytes in the device and (d) the presence of NF-H-positive axons growing into the 
axonal compartment. (e) GFAP-positive astrocytes were placed close to the microtunnels leading to the axonal 
compartment, and (f) enlargement of the image illustrates cell-to-cell interactions between astrocytic processes 
and axons. (g) To evaluate the fluidic isolation of the astrocyte compartment, dextran-conjugated FITC was 
added to the astrocyte compartment, and its diffusion was evaluated by imaging with fluorescence microscopy 
at 1 h and 24 h. Fluorescence was detected in the axonal compartment after 24 h but was absent in the neuronal 
compartment (the compartments are shown with white dotted lines). (h) The concentration of dextran-FITC 
was measured after 24 h from medium collected from the astrocyte and neuron compartments. The data are 
shown as the mean ± s.e.m. (n = 6; the data are from one experiment). Statistical analysis was performed with 
independent-sample t-tests, and statistical significance is denoted as * p < 0.05, ** p < 0.01, and *** p < 0.001.
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Figure 7. In vitro model for astrogliosis and axonal growth. (a) Experimental design for co-culture of astrocytes 
and neurons in the microfluidic device and astrocyte activation with IL-1β and TNF-α. (b) Both cell types 
remained viable (based on calcein-AM staining) on the platform after cytokine treatment, and very few dead 
cells (revealed by EtHD-1 staining) were observed. (c) Cytokine-treated astrocytes secreted significantly 
higher levels of several inflammatory factors than controls (n = 2; the data are from one experiment). (d) Phase-
contrast images showing axons extending into the axonal compartment at 0 h and 72 h after cytokine treatment. 
(e) The number of axons extending into the axonal compartment (crossing the distance marked with the white 
dotted line) was quantified over 72 h. In addition to devices with co-cultures of control or reactive astrocytes 
and neurons (the Neu + Ctrl astro and Neu + Reactive astro groups), devices with cultures of only neurons were 
established to determine the effects of IL-1β and TNF-α treatment on axons (the Neu and Neu + IL-1β/TNF-α 
group) (n = 4–8 for each group; the data are from two experiments). (f) Axonal growth was also visualized with 
live-cell calcein-AM color staining to estimate coverage in the axonal compartment (the white dotted line). 
(g) Quantification of the area coverage in the axonal compartment revealed that reactive astrocytes supported 
axonal growth compared to control astrocytes (n = 6–13 for each group; the data are from one independent 
experiment). All data are presented as the mean ± s.e.m. Statistical analysis between groups was performed with 
independent-sample t-tests. P-values less than 0.05 were considered to indicate significance, and significant 
differences compared to the control group are presented in the graphs as * p < 0.05, ** p < 0.01, and *** p < 0.001.
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on MEAs55,56. On the other hand, neurotoxic astrocytes have failed to promote synapse function8. Altogether, 
our results suggest that 7-day stimulation of hiPSC-derived astrocytes with cytokines results in an inflammatory 
phenotype that has a supportive rather than a harmful effect on neuronal cells.
To reveal the underlying mechanisms of CNS disorders, the complex cellular interactions between glial and 
neuronal cells should be investigated in more detail. Microfluidic technology can provide in vitro research tools 
that go beyond conventional cell culture methods with the aim of better modeling in vivo environments31,32. Here, 
our microfluidic platform was developed to co-culture the two cell types in a compartmentalized, controlled 
manner to specifically study axonal interactions with glial cells. Co-culture of human neurons and astrocytes 
was successful in the platform, which allowed direct contact between astrocyte processes and axons. Moreover, 
fluidic isolation enabled targeted stimulation of astrocytes in their compartment while also permitting humoral 
effects on neuronal axons extending into the axonal compartment. Activation of astrocytes with IL-1β and TNF-α 
was reproduced selectively in the microfluidic platform, and the inflammatory niche promoted axonal growth, 
further suggesting neurosupportive characteristics. This interpretation is supported by a recent report in which 
IL-1β mediated a potentially neuroprotective astrocyte phenotype expressing axonal permissive transcripts57. A 
microfluidic platform has been previously used for analysis of the neuroinflammatory mechanisms of astrocytes 
and microglia in the neurotoxic environment of Alzheimer’s disease26. Our results present a unique microflu-
idic device designed for studying the interactions of axons and glial cells and further validate the suitability of 
microfluidic platforms as tools for studying the complex interplay among multiple cell types in the contexts of 
neuroinflammation and neurodegeneration.
In conclusion, our results suggest that extended co-stimulation with IL-1β and TNF-α produces a reactive 
astrocyte phenotype with a broad inflammatory secretion profile that displays neurosupportive characteristics 
with regard to neuronal viability, functionality and axonal growth. The mechanism behind the neurosupportive 
effects need to be clarified in the future studies. Furthermore, an in vitro model combining human cells and 
microfluidic technology was developed, and the usefulness of the proposed novel microfluidic platform for inves-
tigation of neuron-astrocyte interactions in an inflammatory environment was demonstrated. Advancing the field 
of in vitro modeling and creating tools for studying intricate cellular interactions in neurological disorders will 
promote the discovery of novel neuroprotective therapeutic targets in the future.

ơǤ The hPSC lines 
Regea 08/02358 and 10212.EURCCs59 used in this study were derived at the Faculty of Medicine and Health 
Technology (MET), Tampere University, Finland. MET has approval from the Finnish Medicines Agency 
(FIMEA) for research utilizing human embryos (Dnro 1426/32/300/05) and has received supportive statements 
from the regional ethics committee of Pirkanmaa Hospital District for the derivation, culture, and differentiation 
of hESCs (R05116) and hiPSCs (R08070). An informed consent was obtained from all subjects who provided 
cell samples. All methods were carried out in accordance with relevant guidelines and regulations. The hiPSC 
line 10212.EURCCs was derived from human skin fibroblasts using Sendai virus technology60. The hPSC lines 
were expanded in feeder-free culture as described earlier61. The in-house-produced neurons were differentiated 
according to the methods in a previous publication62, with some modifications (details in the Supplementary 
methods).
Commercial hiPSC-derived neurons (ax0018) and astrocyte progenitors (ax0083) from healthy donors were 
cultured according to the manufacturer’s protocol (both from Axol Bioscience Inc., UK). The astrocyte progen-
itors were differentiated for 24 days in culture and then treated for 7 days with 10 ng/ml human recombinant 
TNF-α and 10 ng/ml human recombinant IL-1β (PeproTech Inc.). Samples for astrocyte characterization were 
collected during the treatment at the 0 h, 24 h, 72 h and 7 day time points (Fig. 2a).
Ǥ RNA was isolated from astrocytes with a NucleoSpin RNA kit 
(Macherey-Nagel). The concentration and purity of RNA were quantified with a NanoDrop 1000 (Thermo Fisher 
Scientific). RNA was converted to cDNA using a High Capacity cDNA Reverse Transcription Kit (Thermo 
Fisher Scientific). The expression levels of CCL5, CXCL8, GFAP, LCN2, C3, GFAP, VIM, S100B, IL1R, IL1RAP, 
TNFRSF1A and TNFRSF1B (Supplementary Table 3) were analyzed with TaqMan assays using an ABI Prism 7300 
real-time PCR system (Thermo Fisher Scientific). The data were analyzed using the delta Ct method using GUSB 
and GAPDH as endogenous controls.
Ǥ Immunocytochemical staining was performed according to the methods 
in a previous publication63. The used primary and secondary antibodies are listed in the Supplementary Table 4. 
Images were acquired with an Olympus IX51 microscope equipped with an Olympus DP30BW camera (Olympus 
Corporation, Germany) or an LSM780 laser-scanning confocal microscope equipped with a Quasar spectral 
GaAsP detector (all from Carl Zeiss, Germany). CellProfiler64 and CellProfiler Analyst65 software was used to 
perform image analysis. For evaluation of astrocyte morphology, the FormFactor module of CellProfiler software 
was used to calculate circularity index according to the area and perimeter metrics of each cell. Circularity index 
was calculated as 4*π*Area/Perimeter2, with a value of 1 describing a perfectly circular object.

Ǥ Glutamate uptake by cultured cells was analyzed with a glutamate assay kit (Abcam). 
The cells were washed with PBS and with 0.1% BSA in PBS for 30 min + 37 °C. The cells were then incubated with 
100 μM glutamate in PBS for 1 h + 37 °C. Finally, the cells were washed with PBS and lysed with assay buffer. The 
concentration of glutamate in the cell lysate was analyzed according to the manufacturer’s protocol.
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Ǥ A CyQUANT Cell Proliferation Assay (Thermo Fisher Scientific) was used to ana-
lyze the DNA amounts in cultured cells according to the manufacturer’s protocol. Fluorescence was measured at 
520 nm (Wallac Victor 1420, PerkinElmer).
Ǥ Cell viability and caspase-3/7 activation were detected in cultured 
cells with an ApoTox-Glo Triplex Assay (Promega). For positive controls, cells were treated with 1.25 μM stau-
rosporine and 25 μM ionomycin (both from Sigma) for 6 h. Fluorescence was measured at 505 nm and 520 nm 
for viability and cytotoxicity, respectively. Luminescence was measured to detect apoptosis (Wallac Victor 1420).
Ǥ Astrocyte conditioned medium (ACM) from 
cytokine-treated and control astrocytes was collected at the 9-day time point. First, astrocytes were treated for 
7 days with the cytokines IL-1β and TNF-α; thereafter, the cells were washed with PBS, and fresh medium was 
added to the cells. At day 9, the medium was harvested and centrifuged at 400 × g for 5 min at RT, and the super-
natant was collected and stored at -80 °C until use. Neuronal cells (in-house-derived hESC line Regea 08/023) 
were exposed to ACM or control medium for 24 h (MEA analysis) or 48 h (viability assay) before analysis. The 
experiments with ACM also included a control group; the control medium was prepared similarly to the ACM 
but without astrocytes.
Ǥ Protein secretion (see the list of analytes in Supplementary Table 1) into the 
astrocyte culture medium was measured using a Proteome Profiler Antibody Array (Human XL Cytokine Array 
Kit, ARY022B, R&D Systems) according to the manufacturer’s protocol. The membranes were imaged with a 
ChemiDoc imaging system (Bio-Rad), and the intensity of the spots was quantified with Image Lab software 
(Bio-Rad).
The levels of IL-6 in the medium were measured with a human IL-6 uncoated ELISA kit (#88-7066-22, 
Thermo Fisher Scientific) according to the manufacturer’s protocol. The absorbance was measured at 450 nm 
(Wallac Victor 1420).
Ǥ A viability/cytotoxicity kit for mammalian cells (Thermo Fisher Scientific) was used to 
evaluate the viability of cells after ACM treatment and culture in the microfluidic platform. The cultures were 
incubated for 30 min to 1 h at 37 °C with green-fluorescent calcein-AM (0.5 μM) for detection of live cells and with 
red-fluorescent ethidium homodimer-1 (0.5 μM) for detection of dead cells. The samples were imaged immedi-
ately with an Olympus IX51 microscope equipped with an Olympus DP30BW camera (Olympus Corporation) 
and an LSM780 laser-scanning confocal microscope equipped with a Quasar spectral GaAsP detector (Carl 
Zeiss).
Ǥ Neuronal network activity was recorded with an Axion Maestro 
system controlled by AxIS Software (Axion Biosystems, Atlanta, GA, USA) with 12.5 kHz sampling rate as 
described previously66. The hPSC-derived cortical neurons (in-house-derived hESC line Regea 08/023 or com-
mercial hiPSC-derived neurons, ax0018) were plated on CytoView MEA 48 plates with 16 electrodes per array. 
Recordings were obtained under a controlled temperature of 37 °C. Spontaneous activity development was exam-
ined once a week with 10-minute recordings. After five weeks, when synchronous network activity had developed, 
the experiments with astrocyte conditioned medium (ACM) were initiated. The responses to control medium, 
control ACM or reactive ACM were measured for 10 min immediately and at 1 h, 4 h and 24 h after application. 
Analysis methods for spike and burst detection are described in the Supplementary methods section.
Ǥ An in-house-developed microfluidics polydimethylsiloxane 
(PDMS) device (Patent: WO2015092141A1) was used (Fig. 6a, Supplementary Fig. S7). The device contains 
three separate cell compartments and an axonal compartment that are interconnected by microtunnels (Fig. 6b, 
Supplementary Fig. S7). There are two neuronal compartments (length = 4250 μm, width = 3000 μm) that are 
connected to the axonal compartment (length = 1000 μm, height = 100 μm, width = 100 μm) with three micro-
tunnels (length = 250 μm, height = 3 μm, width = 10 μm). The microtunnels allow the extension of axons but pre-
vent the migration of neuronal somas from the neuronal compartment into the axonal compartment (Fig. 6b,c). 
The flow-based astrocyte compartment is connected to the axonal compartment with seven microtunnels 
(length = 50 μm, height = 3.5 μm, width = 10 μm) (Supplementary Fig. S7). The fabrication of PDMS devices are 
described in the Supplementary methods.
ǦƪǤ HiPSC-derived cortical neurons 
(10212.EURCCs) and commercial hiPSC-derived astrocytes (ax0083) were seeded into the neuronal compart-
ments and astrocyte compartment, respectively (see details on Supplementary methods). Three days after cell 
plating, 10 ng/ml IL-1β- and TNF-α-containing medium was added into the astrocyte compartment, and treat-
ment continued for 3 days. After cytokine treatment, the viability of cells was assessed with viability staining, and 
astrocyte-secreted inflammatory factors were analyzed in medium collected from the astrocyte compartment. To 
characterize the astrocytes and neurons in the co-cultures, immunofluorescence staining was performed. First, 
the microfluidics devices were separated manually from the coverslips, and then the cells were fixed with 4% 
PFA and stained according to an immunocytochemical protocol. To evaluate the influences of the astrocytes and 
cytokines on axonal growth, the following experimental groups were established: 1) a group in which neurons 
were seeded in the neuronal compartments (the Neu group), 2) a group in which neurons were seeded in the 
neuronal compartments and cytokine treatment was conducted via the astrocyte compartment (the Neu + IL-1β/
TNF-α group), 3) a group in which neurons and astrocytes were seeded in their compartments (the Neu + Ctrl 
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astro group), and 4) a group in which neurons and astrocytes were seeded in their compartments and cytokine 
treatment was conducted via the astrocyte compartment (the Neu + Reactive astro group). The cells in the devices 
were imaged with phase-contrast microscopy at baseline and at 24 h and 72 h after cytokine treatment. The indi-
vidual axons entering the axonal compartment were counted manually from the images at a distance of 80 μm 
from the axonal microtunnels (the white dotted line in Fig. 7d). The density of the axons in the axonal compart-
ment was evaluated by analyzing the area covered with calcein-AM-stained axons at 72 h after cytokine treatment. 
The analyzed area was a 0.033 mm2 (325 μm × 100 μm) region next to the axonal microtunnels (the white dotted 
line in Fig. 7f), and analysis was performed using CellProfiler software.
Ǥ Statistical analysis of Gaussian-distributed data was performed with independent-sample 
T-tests. If the data followed a non-Gaussian distribution, the nonparametric Mann-Whitney U-test was used. 
Bonferroni correction was used for multiple comparisons.
The MEA data followed a non-Gaussian distribution; therefore, nonparametric tests were selected. To study 
changes in activity within treatment groups over time, the Friedman test for related samples was performed fol-
lowed by the Wilcoxon signed-rank test to compare two related samples. To study differences between groups, 
delta values were calculated (by subtracting the baseline values from the values obtained immediately (acute), 1 h, 
4 h, or 24 h after treatment), and Mann-Whitney U-tests were performed.
A p-value < 0.05 was considered to indicate significance. Statistical significance is denoted as * p < 0.05, ** 
p < 0.01, and *** p < 0.001. All statistical tests were performed with SPSS Statistics software (version 25.0).

The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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